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UDC: 616.441-006.04-089.87 
LONG-TERM RESULTS FOR THE TREATMENT OF PATIENTS 
WITH THE APPLICATION OF ORGAN-PRESERVING 
OPERATIONS IN PAPILARY THYROID CANCER 
Alika Korkelia 
Institute of Problems of Endocrine Pathology named after V. Ya. Danilevsky of National Academy of 
Medical Sciences of Ukraine, 10 Alchevsk St., Kharkiv, 61002, Ukraine, e-mail: ipep@vl.kharkov.ua 
 
Іn order to analyse the changes in the structural and functional state of the thyroid gland, a group of 
185 patients (67.8 %) were examined after the surgical treatment of papillary thyroid cancer. Of these, 
94 patients belonged to the first group – the comparison group where thyroidectomy was performed, and 91 to 
the second – the main group where, mainly, organ-preserving operations were performed. The average 
follow-up was 6.5 ± 5.1 years (varied from 2 to 11 years. 
Hypoparathyroidism in patients receiving replacement therapy was observed in 20 (16.4 %) patients after 
thyroidectomy and only in 4 (6.3 %) patients after organ-preserving techniques (the differences are 
significant, p < 0.05). Side effects of replacement therapy were observed in 21 (17.2 %) patients after 
thyroidectomy and only in 4 (6.3 %) patients after organ-preserving techniques (the differences are 
significant, p < 0.05). Disease recurrence was detected in 4 (3.3 %) patients after thyroidectomy and in 1 
(1.6 %) patient after organ-preserving techniques (the differences are not significant, р > 0.05). 
The use of organ-preserving approaches in the main group allowed improving functional results by 
reducing the frequency of hypothyroidism and side effects of replacement therapy, due to the preservation of 
thyroid secretion and its regulation, without worsening the results of relapse-free survival. 
KEY WORDS: organ-preserving interventions, papillary thyroid cancer, long-term results of treatment 
 
ВІДДАЛЕНІ РЕЗУЛЬТАТИ ЛІКУВАННЯ ХВОРИХ З ВИКОРИСТАННЯМ 
ОРГАНОЗБЕРІГАЮЧИХ ОПЕРАЦІЙ ПРИ ПАПІЛЯРНОМУ  
РАКУ ЩИТОПОДІБНОЇ ЗАЛОЗИ 
Коркеліа А. Г. 
Інститут проблем ендокринної патології ім. В. Я. Данилевського АМН України, вул. Алчевських, 
10, м. Харків, 61002, Україна 
 
З метою аналізу змін структурно-функціонального стану щитовидної залози у віддалений термін 
після оперативного лікування папілярного раку щитоподібної залози була обстежена група з 
185 хворих (67,8 %). З них 94 хворих належали до першої групи – групі порівняння де виконували 
тиреоідектомію, а 91 до другої – основної групі, де, здебільшого, виконували органощадні операції. 
Середній термін спостереження склав 6,5 ± 5,1 років (варіював від 2 до 11 років). 
Гіпопаратиреоз на тлі прийому замісної терапії було відмічено у 20 (16,4 %) хворих після 
тиреоїдектомії та тільки у 4 (6,3 %) хворих після органощадних методик (відмінності достовірні, 
р < 0.05). Побічні ефекти замісної терапії відзначалися у 21 (17,2 %) хворих після тиреоїдектомії та 
тільки у 4 (6,3 %) хворих після органощадних методик (відмінності достовірні, р < 0.05). Рецидив 
захворювання виявлено у 4 (3,3 %) хворих після тиреоїдектомії та у 1 (1,6 %) хворого після 
органощадних методик (відмінності недостовірні, р > 0.05). 
Застосування органоощадних підходів в основній групі дозволило поліпшити функціональні 
результати, зменшивши частоту гіпотиреозу і побічних ефектів замісної терапії, за рахунок 
збереження тиреоїдної секреції і її регуляції, не погіршуючи результати безрецидивного виживання. 
КЛЮЧОВІ СЛОВА: органощадні втручання, папілярний рак щитоподібної залози, віддалені 
результати лікування 
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ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ БОЛЬНЫХ С ПРИМЕНЕНИЕМ 
ОРГАНОСОХРАНЯЮЩИХ ОПЕРАЦИЙ ПРИ ПАПИЛЯРНОМ  
РАКЕ ЩИТОВИДНОЙ ЖЕЛЕЗЫ 
Коркелиа А. Г. 
Институт проблем эндокринной патологии им. В. Я. Данилевского АМН Украины, ул. Алчевских, 
10, г. Харьков, 61002, Украина 
 
С целью анализа изменений структурно-функционального состояния щитовидной железы в 
отдаленные сроки после оперативного лечения папиллярного рака щитовидной железы была 
обследована группа из 185 больных (67,8 %). Из них 94 больных принадлежали к первой группе – 
группе сравнения, где выполняли тиреоидэктомию, а 91 ко второй – основной группе где, 
преимущественно, выполняли органощадящие операции. Средний срок наблюдения составил 6,5 ± 5,1 
лет (варьировал от 2 до 11 лет). 
Гипопаратиреоз на фоне приема заместительной терапии отмечался у 20 (16,4 %) больных после 
тиреоидэктомии и только у 4(6,3 %) больных после органощадящих методик (различия достоверны, 
p < 0.05). Побочные эффекты заместительной терапии отмечались у 21 (17,2 %) больных после 
тиреоидэктомии и только у 4 (6,3 %) больных после органощадящих методик (различия достоверны, 
p < 0.05). Рецидив заболевания выявлен у 4 (3,3 %) больных после тиреоидэктомии и у 1(1,6 %) 
больного после органощадящих методик (различия недостоверны, p > 0.05). 
Применение органощадящих подходов в основной группе позволило улучшить функциональные 
результаты, уменьшив частоту гипотиреоза и побочных эффектов заместительной терапии за счет 
сохранения тиреоидной секреции, и ее регуляции, не ухудшая результаты безрецидивной 
выживаемости. 
КЛЮЧЕВЫЕ СЛОВА: органощадящие вмешательства, папиллярный рак щитовидной железы, 
отдаленные результаты лечения 
 
INTRODUCTION 
In recent years, there has been a tendency to 
perform organ-preserving interventions for 
papillary thyroid cancer (PTC) such as 
hemithyroidectomy or subtotal resection [1–3]. 
This approach is considered in tumours with 
sizes less than 1 centimetre [2, 4]. However, for 
larger tumours, there is no clear agreement on 
the maximum size of the tumour in which 
organ-preserving operations can be performed 
[3]. 
There are several factors that influence the 
prognosis of disease recurrence and the tactics 
chosen by the surgeon during surgical 
treatment: multimodality, the presence of 
«aggressive» histological forms of PTC, tumour 
size, invasion into the capsule, and extrathyroid 
invasion [2, 5]. In addition, the biological 
properties of the tumour play an important role 
[4, 6]. This study presents an assessment of the 
long-term results of PTC treatment, where the 
choice of organ-preserving operations was 
carried out depending on the prediction of the 
aggressive behaviour of the tumour, which was 
determined in accordance with histological and 
immunohistochemical criteria. 
 
OBJECTIVE 
Evaluation of long-term results of organ-
preserving operations in patients with papillary 
thyroid cancer. 
MATERIALS AND METHODS 
The work was performed in the State 
Institution «Institute of Problems of Endocrine 
Pathology named after V. Ya. Danilevsky of 
National Academy of Medical Sciences of 
Ukraine». There were 273 patients under 
observation with a final diagnosis of PTC. The 
patients were divided into 2 groups: Group I – 
the comparison group – 155 patients with PTC 
in whom only thyroidectomy was used. Group 
II – the main group – 118 patients, where the 
choice of surgical treatment method – 
thyroidectomy or organ-preserving surgery was 
carried out according to the developed 
algorithm. In order to analyse changes in the 
structural and functional state of the thyroid 
gland in a long-term period after the surgical 
treatment, a group of 185 patients (67.8 %) 
were examined. Of these, 94 patients belonged 
to the first group – the comparison group, and 
91 to the second – the main group. The average 
follow-up was 6.5 ± 5.1 years (varied from 2 to 
11 years). 
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 The algorithm for choosing the 
method of operative treatment of patients with 
PTC: The surgical tactic in the comparison 
group was to perform thyroidectomy and lymph 
node dissection in the presence of metastatic 
lymph nodes in all patients. Surgical tactics in 
the main group were based on risk factors 
identified before the operation or after the 
operation. Hemithyroidectomy was performed 
on tumours up to 2 cm in size. If intraoperative 
histological examination revealed multifocal 
tumour growth, capsule invasion or 
extrathyroid invasion, as well as cancer from 
cylindrical cells, in such patients was performed 
thyroidectomy. In the postoperative period, 
resected material investigated 
immunohistochemicaly with quantitative 
determination of TTF1, NIS, Ki67. With 
overexpression of TTF1, the absence of 
expression of NIS, and the high expression 
level of Ki67, a repeated operation (total 
thyroidectomy) was considered to be shown. 
RESULTS AND DISCUSSION 
Analysis of the volume of surgical 
intervention in patients with PTC in the 
comparison group showed that most of them 64 
(54.6 %) were operated on by organ-preserving 
techniques. Among 118 patients, only 55 
(46.6 %) had thyroidectomy, the volume of 
other operations was a subtotal resection of the 
lobe of the gland in 21 (17.8 %) patients, a 
subtotal resection of the whole gland – 9 
(7.6 %), hemithyroidectomy was performed in 
17 (14.4 %) patients. In 16 (13.6 %) patients 
with a multinodular lesion, hemithyroidectomy 
on the affected side and subtotal resection on 
the opposite side were performed. 
Of the 185 patients examined in the long-
term period, 124 (67.02 %) received various 
types of radiation treatment. Of these, 50 
patients (40.3 %) were treated with remote 
gamma-therapy on the thyroid bed and the 
lymphatic drainage path, 56 patients (45.2 %) 
were treated with radioactive iodine (from 1 to 
4 courses), in 18 patients (14.5 %) radiation 
treatments were not used. 
Of the 94 patients in the comparison group, 
a recurrence of thyroid cancer was detected in 3 
(3.2 %) patients from 7 to 1 year after surgery. 
From 91 patients of the main group 
(63 patients where organ-preserving techniques 
were performed and 28 who underwent total 
thyroidectomy), additional nodular formations 
in the residual thyroid tissue, according to 
ultrasound, were found in six patients (9.5 %) 
without an increase in the neck lymph nodes. 
When performing TAPB in these patients, in 
four cases, suspicious malignant changes were 
identified. In two cases, the recurrence of 
colloidal goiter. 
Four patients with suspected malignancy 
were operated on. At the final histological 
examination after re-operation, PTC was 
diagnosed in one patient, in two patients a 
follicular thyroid adenoma and colloid goiter 
nodes were detected. In another patient, 
papillary microcarcinoma was found on the 
background of a multinodular goiter and a 
follicular adenoma – with a lesion of malignant 
growth of up to 4 mm in size. 
Thus, in the late postoperative period, 
among 91 patients who operated on for PTC, a 
true recurrence of papillary thyroid cancer was 
detected only in 1 patient (1.1 %) 7 years after 
the first operation. Another lymphogenous 
relapse was detected in a patient undergoing 
thyroidectomy. 
The analysis of follow-up observation of 
patients with PTC in the postoperative period 
showed very low patient compliance. Only the 
first two or three years the patients regularly 
visited the endocrinologist, in the future these 
visits became random. Patients either stopped 
taking thyroxin at all, or adjusted their dosing to 
their own sensations. As a result, out of 141 
patients who received replacement therapy, 
only 38 (27 %) took thyroxin preparations in 
maintenance dosages. 
An important problem was also the presence 
of side effects of substitution therapy – such as 
tachycardia, extrasystole, pressing pain behind 
the sternum, anxiety, hand tremor that occur 
after taking thyroxin or 30 minutes later, 
Considering that none of the patients taking 
thyroid hormone drugs in the replacement dose 
did not arise recurrence, then when prescribing 
hormonal therapy in a suppressive dosage it is 
necessary to carefully choose between the 
feasibility of achieving the recommended level 
of thyrotrophic hormone and the validity of 
such treatment, giving preference to the latter. 
All of the above suggests that the treatment 
of patients with PTC (surgical treatment in 
organ-preserving volume, followed by radiation 
therapy and the use of suppressive drugs), has 
shown significant effectiveness. That is, 
removal of the tumour, leaving a small number 
of thyroid parenchyma, did not adversely affect 
the incidence of recurrent thyroid cancer. 
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At present, some specialists suggest that in 
case of surgical treatment of PTC, extrafascial 
thyroidectomy must be supplemented with 
prophylactic central lymphatic dissection. It is 
motivated by the fact that micrometastases in 
regional lymph nodes in patients with PTC 
occur very often (more than in 50 % of cases). 
Central lymphodissection is accompanied by an 
increase in the number of postoperative 
complications, such as laryngeal paresis and 
hypoparathyroidism. In the main group, we did 
not perform prophylactic lymphodissection. 
Performed only when we had clinically detected 
lymph node metastases, which were detected in 
40 cases (14.65 %). Observation up to 11 years 
did not reveal a single case of regional or 
remote lymphogenous metastasis. 
Hypothyroidism in patients receiving 
replacement therapy was observed in 20 
(16.4 %) patients after thyroidectomy and only 
in 4 (6.3 %) patients after organ-preserving 
techniques (the differences are significant, 
p < 0.05). Side effects of replacement therapy 
were observed in 21 (17.2 %) patients after 
thyroidectomy and only in 4 (6.3 %) patients 
after organ preserving techniques (the 
differences are significant, p < 0.05). Disease 
recurrence was detected in 4 (3.3 %) patients 
after thyroidectomy and in 1 (1.6 %) patient 
after organ preserving techniques (the 
differences are not significant, р > 0.05). 
These data indicate that the preservation of 
the parenchyma of the thyroid gland can reduce 
the frequency of hypothyroidism, as well as 
reduce the frequency of side effects of 
replacement therapy by maintaining thyroid 
secretion and its regulation. The use of organ 
preserving techniques, according to our data, 
does not significantly affect the risk of tumour 
recurrence. 
CONCLUSIONS 
The use of organ preserving approaches in 
the main group allowed improving functional 
results, reducing the frequency of 
hypothyroidism and side effects of replacement 
therapy, by maintaining thyroid secretion and 
its regulation, without worsening the results of 
relapse-free survival. 
PROSPECTS FOR FUTURE STUDIES 
Further study of the long-term results of 
surgical treatment of patients with papillary 
thyroid cancer will allow us to individualize 
the operational tactics and improve the results 
of treatment. 
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DIAGNOSTICS OF INFLAMMATORY INSIDE THE PLEURAL 
COMPLICATIONS OF THORACIC INJURY 
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The non-specificity of the clinical signs of posttraumatic purulent thoracic complications indicates the 
importance of instrumental diagnostic methods. There is no generally accepted algorithm for examining an 
injured person with a chest injury that would allow timely recognition of purulent complications in the post-
traumatic period. The results of the examination of patients with intra-pleural complications of thoracic injury 
using the spiral computed tomography method, which in dynamics allows objectively documenting the 
dynamics of the pathological process, evaluating the effectiveness of treatment, timely diagnose secondary 
complications, are presented. 
KEY WORDS: thoracic trauma, internal pleural complications, diagnosis 
 
ДІАГНОСТИКА ЗАПАЛЬНИХ ВНУТРІШНЬО ПЛЕВРАЛЬНИХ УСКЛАДНЕНЬ 
ТОРАКАЛЬНОЇ ТРАВМИ 
Косов Є. В., Рожкова О. Ю., Веклич В. М., Барсуков Н. В. 
Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
Не специфічність клінічних ознак посттравматичних гнійних торакальних ускладнень свідчить про 
значущість інструментальних методів діагностики. Немає загальноприйнятого алгоритму обстеження 
постраждалих з ушкодженнями грудей, який дозволив би своєчасно розпізнати гнійні ускладнення в 
посттравматичному періоді. Представлені результати обстеження пацієнтів з внутрішньо 
плевральними ускладненнями торакальної травми за допомогою методу спіральної комп’ютерної 
томографії яка в динаміці дозволяє об'єктивно документувати динаміку патологічного процесу, 
оцінити ефективність лікування, своєчасно діагностувати вторинні ускладнення. 
КЛЮЧОВІ СЛОВА: торакальна травма, внутрішньо плевральні ускладнення, діагностика 
 
ДИАГНОСТИКА ВОСПАЛИТЕЛЬНЫХ ВНУТРИ ПЛЕВРАЛЬНЫХ ОСЛОЖНЕНИЙ 
ТОРАКАЛЬНОЙ ТРАВМЫ  
Косов Е. В., Рожкова Е. Ю., Веклич В. Н., Барсуков Н. В. 
Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
 
Не специфичность клинических признаков посттравматических гнойных торакальных осложнений 
свидетельствует о значимости инструментальных методов диагностики. Нет общепринятого 
алгоритма обследования пострадавшего с повреждения груди, который позволил бы своевременно 
распознать гнойные осложнения в посттравматический период. Представлены результаты 
обследования пациентов с внутри плевральными осложнениями торакальной травмы с помощью 
метода спиральной компьютерной томографии, которая в динамике позволяет объективно 
документировать динамику патологического процесса, оценить эффективность лечения, своевременно 
диагностировать вторичные осложнения. 
КЛЮЧЕВЫЕ СЛОВА: торакальная травма, внутренне плевральные осложнения, диагностика 
 
INTRODUCTION 
There is an increase in the proportion of 
breast damages in the structure of injuries in 
peacetime from 12.5 % in the late 70s of the 
 Kosov E. V., Rozhkova O. Y., Veklych V. M., 
Barsukov N. V., 2018 
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20th century to 25 % at present [1]. Severe 
chest injury is the cause of both early 
mortality due to bleeding and hypoxia, and 
late mortality associated with the 
development of septic complications and 
multiple organ failure [2]. 
Purulent process due to thoracic trauma 
may develop as in the pleural cavity and the 
lungs and heart cavity shirt, mediastinum and 
chest wall [3]. For posttraumatic purulent-
inflammatory thoracic complications include 
the following types of purulent 
complications: pleural empyema, lung 
abscess, pericarditis, mediastinitis [4]. 
Empyema of the pleura – the most common 
purulent complication, the issues of its 
diagnosis and treatment are highlighted in the 
literature quite widely, although most 
scientific research is based on the analysis of 
its nontraumatic etiology. According to 
various data, 7–16 % empyema of the pleura 
has traumatic etiology [5–6]. However, some 
other post-traumatic inflammatory 
complications are devoted to a few 
publications based on the study of a small 
number of observations. Post-traumatic 
lesions are lung abscesses that develop as a 
result of breast injury, regardless of the nature 
and severity of the primary lung injury [7]. 
According to the generalized data, 
pneumonia develops in 20–40 % of 
observations after a combined injury [8]. In 
the event of breast injury, pneumonia 
develops more often after the gunshot trauma 
(8–18 %) against the background of blood 
loss and large hematoma of the lung [5], 
abscesses of the lungs are found much less 
frequently – from 0.9 % to 2.8 % [4]. 
Purulent mediastinitis continues to be one 
of the most severe forms of generalized 
surgical infection, worldwide mortality 
ranges from 23–48 % [4], reaching with 
anaerobic mediastinitis 68–80 % [6]. High 
mortality with purulent mediastinitis is 
connected, first of all, with its later diagnosis. 
[2, 6]. 
Diagnosis of pleural empyema in spiral 
computed tomography (SCT) is based on 
signs such as heterogeneity of the contents of 
the pleural cavity with gas inclusions and 
thickening of the pleura leaves [4]. According 
to [4], using SCT can also diagnose the phase 
of development of empyema of the pleura and 
choose a rational volume of intervention in 
the onset forms of suppuration. 
Important information can be obtained 
from SCT in patients with purulent 
pulmonary complications [1]. Significant 
difficulties are the differential diagnosis 
between the hematoma of the lung and 
progressive pneumonia on the background of 
hematomas in the period from 1 to 3 weeks 
after the closed injury. Similar difficulties are 
noted in the differentiation of inflammatory 
changes in the lungs from their damage in 
case of chest injury [6–7]. SCT – a picture of 
mediastinitis, according to some data [6], 
allows to differentiate the nature of the 
inflammation of cell mediastinum. 
Thus, the analysis of domestic and foreign 
literature suggests that the frequency of post-
traumatic purulent thoracic complications has 
no tendency to decrease, the lethality remains 
at a very high level. The problem of 
prediction, diagnosis and treatment of 
purulent complications of chest damage is not 
sufficiently studied. 
Not specificity of clinical signs of post-
traumatic purulent thoracic complications 
testifies to the importance of instrumental 
diagnostic methods. Until now, chest X-ray is 
the most common method of diagnosing chest 
lesions. The literature data indicate that there 
is no comparative analysis of the sensitivity 
of such X-ray methods as ultrasound 
diagnosis (USD), computer tomography 
(CT), depending on the nature of the injury 
and complications. There is no generally 
accepted algorithm for examination of 
victims with chest injuries, which would 
allow timely recognition of purulent 
complications in the post-traumatic period. 
OBJECTIVE 
Improve the outcome of treatment for 
injuries with injuries and closed chest injury 
by improving the methods of early diagnosis 
of inflammatory intra-pleural complications. 
MATERIALS AND METHODS 
The results of the examination of patients 
with intra-pleural complications of thoracic 
trauma with the help of the SCT method are 
presented. 
In the empyema of the pleura I–II phase, 
47 victims were examined, including after 
chest injury (CI) – (18) and closed chest 
trauma (CCT) – (29). 42 patients who had 
pulmonary suppuration, including after injury 
(7) and CCT (35), were also investigated at 
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different times after chest injury. In all 
observations of pulmonary suppuration after 
injury, the primary SCT study was performed 
at the stage of development of purulent 
process. 
At mediastinitis, 27 patients suffered from 
SCT on different occasions (from day one to 
four months) after injury (17) and closed 
injury (10). In all 17 examined patients with 
mediastinitis after wounds, inflammatory 
changes of fibrous mediastinum of general or 
restricted nature were detected. Phlegmon 
mediastinum was diagnosed in 10 patients 
early in the post trauma period. 
RESULTS AND DISCUSSION 
At empyema of pleura I-II phases in all 
SCT observations there was a heterogeneity 
of pathological intra pleural content, its 
density varied in a wide range, from –30 to 
+60 ODN. The presence of small inclusions 
of gas density in the contents of the pleural 
cavity was found in 91.4 %, the horizontal 
level of the fluid – 12.3 %. In the vast 
majority of patients, the inequality of the 
contours of the pleura leaves with their 
thickening was detected (92.7 %). The nature 
of the changes in the leaves of the pleura 
depended on the prescription of the 
pathological process until the time of the 
study, the thickness of the parietal leaf varied 
within 3-11 mm, visceral – 2–7 mm. 
According to the SCT, the pleural 
empyema (EP) was diagnosed in 43 patients, 
the sensitivity of the method was 91.4 % 
(90.7 % for injuries and 91.7 % for CCT). 
Mistakenly negative results of SCT were 
noted in 5 observations of EP, including 2 – 
after wounds and 3 – after CCT. 
The absence of small gas inclusions in the 
contents of the pleural cavity was the main 
cause of diagnostic errors. In these 
observations, the diagnosis was verified with 
puncture (4) or autopsy (1). 
Despite the high sensitivity of the method 
of SCT in the diagnosis of purulent process, 
in 7 observations noted the difficulty in 
determining the exact localization of the 
pathological process. So in 6 patients, 
according to SCT, it was not possible to 
differentiate the EP from the lung abscess. 
The diagnosis is clarified only with X-ray 
contrast study after draining purulent foci. 
In one observation, the subpleural chronic 
abscess of the chest wall, which led to the 
development of osteomyelitis of the ribs, was 
considered as a pleural empyema in the SCT 
series. X-ray contrasting pleurography also 
confirmed the presence of a restricted EP. 
The sensitivity of the SCT method to 
pleural empyema was 91.4 %, including 
90.7 % for injuries and 91.7 % for closed 
trauma. 
In all observations of pulmonary 
suppuration after injury, the primary SCT 
study was performed at the stage of 
development of purulent process. The 
pathological process was more often localized 
in the upper lobe (5), less frequently in the 
lower (2), but in no observation did not 
coincide with the anatomical boundaries of 
segments or lung particle. In three patients, 
examined at 5–12 days after injury, areas of 
irregular shape with lesions from 2 to 4 
segments of lung, heterogeneous density from 
-36 to 52 ODN with small inclusions of gas 
density and increased density of adjacent 
pulmonary tissue were detected. These 
changes were treated as abstinent pneumonia 
with multiple destruction cavities. Two of 
them in the lung inflammation zone 
visualized the course of the wound canal in 
the thickness of the lower lobe. In all three 
observations, the pathological content in the 
pleural cavity was visualized, including that 
which is not differentiated from the 
pulmonary changes in one of them. 
In the study of dynamics (18–28 days), 
including after the additional drainage of the 
pleural cavity (2), a decrease in the zone of 
inflammatory changes with the formation of 
rounded ones, including multiple (2) cavities 
with a horizontal fluid level, was noted. In 
4 patients, examined for 12–52 days after 
breast injury, rounded forms of single cavities 
with a density of gas and liquid (horizontal 
level) were detected, with a total volume of 
15 to 256 cm3. The walls of the cavity had a 
value of soft tissue density, thickness from 3 
to 8 mm, perifocally marked increase in the 
density of lung tissue. Such changes indicated 
that there were solid abscesses in the lungs. 
Drainage bronchi were visualized in three 
observations. The pathological process was 
localized within the 2 to 3 segments of the 
lung. 
In the case of closed chest injury, the 
primary SCT was performed for 1–2 days of 
hospitalization in 8 patients, later than 5 days 
in 27. All patients who were examined from 
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the first day after CCT, according to SCT, 
lung changes in the form of polymorphic 
areas of density increase from 256 to 38 ODN 
with fuzzy contours, irregular shape, 
drainage, and with a clear visualization of the 
bronchial lumen that was considered as a 
hemorrhagic hemorrhage or a lung injury. In 
5 of these, lung tissue ruptures with the 
formation of cavities in the thickness of the 
lung tissues filled with liquid density of blood 
and (or) gas were visualized on the 
background of the lung. At studying in the 
dynamics after 7–10 days about the accession 
of the inflammatory process was indicated by 
the lack of regression of the slaughtering 
centers (5) or the growth of infiltrative 
changes in the lungs, which is not 
characteristic of the uncomplicated course of 
the pathological process. 
In the remaining 27 patients who were 
first examined in the stage of development of 
inflammatory complications, judging by the 
amount of primary lung damage was not 
possible. Nevertheless, in 8 of them, thin-
walled cavity formation with liquid and (or) 
gaseous contents was revealed, indicating the 
traumatic nature of the formations in the 
lungs. The diagnosis of pulmonary 
suppuration according to SCT was confirmed 
in 32 out of 35 patients examined for 12–30 
days after CCT, the sensitivity of the method 
was 91.4 %. 
SKT signs of abstinence pneumonia (15) 
were characterized by the presence of 
polymorphic zones of heterogeneity of the 
pulmonary tissue with values of soft tissue 
density and multiple inclusion of round or 
irregular shape with values of density of 
liquid and gas. The prevalence of the 
destructive process varied from 2 to 7 
segments, in 3 observations, it was of two-
sided nature. 
In 17 victims, a single lung abscess was 
found – a rounded form of formation with 
distinct unequal contours of a heterogeneous 
structure with small inclusions of gas density 
or a horizontal level in the total volume from 
139 to 580 cm3. The walls of the cavity had a 
value of the density of soft tissues, their 
thickness varied from 6 to 9 mm. 
The data obtained in the SCT study (the 
nature of suppuration, the amount and 
localization of abscesses, proximity to the 
chest wall, the degree of adequacy of natural 
drainage in the bronchus) were the basis of 
the therapeutic tactic in patients with purulent 
pulmonary complications. 
CT false negative results were obtained in 
three observations during examination of 13–
18 days after injury. In the first observation, 
hematoma was detected in the lung (7 cm in 
diameter) on the background of a rounded 
hemothorax in a volume of 1200 ml and 
compression of the lungs. In two other 
observations, lung abscesses were not 
diagnosed against a background of a limited 
multi-chamber EP and were visualized only 
on a re-study after drainage of the pleural 
cavity. In general, in the case of SCT, the 
complexity of differentiation of intra-
pulmonary and intra-pleural content was 
noted in 6 observations of pulmonary 
suppuration after CCT. 
Thus, the sensitivity of the method in the 
diagnosis of purulent pulmonary 
complications was 92.9 %, including 100 % 
in wounds and 91.4 % in CCT. 
In all 17 examined patients with 
mediastinitis after wounds, inflammatory 
changes of fibrous mediastinum of general or 
restricted nature were detected. The 
phlegmon of mediastinum was diagnosed in 
10 patients early in the aftermath of the 
trauma in the form of a zone with values of 
the density of the fluid of irregular shape, 
with fuzzy contours, heterogeneous structure 
due to areas with soft tissue density and 6 
observations with gas values. In 2 
observations, inflammatory changes were 
localized throughout the anterior 
mediastinum, in 5 – in the upper parts of the 
anterior and posterior mediastinum, and in 3 - 
in the posterior and anterior mediastinum 
throughout (total mediastinitis). Three 
patients with combined wounds in the neck 
and breast, along with inflammatory changes 
in the mediastinum, also revealed a neck 
phlegmon in the form of the lack of 
differentiation of the fiber pretraheal, 
peripheral and around the vascular spaces, 
increasing its density to the values of the fluid 
and inclusion of sites with soft tissue density 
and gas. 
Mediastinal abscess was detected in two 
injured (after 35 and 60 days after injury) in 
the form of formation with liquid density 
values, rounded form, with clear contours, 
heterogeneous structure due to areas with soft 
tissue (capsule) densities in the periphery. 
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In one case, the formation was located in 
the upper parts of the anterior mediastinum, 
in the other – in the lower parts, squeezing 
the right chambers of the heart. Infiltration of 
mediastinum was observed in 5 patients, in 
the dynamics with signs of suppuration in the 
form of a zone with values of soft tissue 
density, irregular shape, with fuzzy contours, 
heterogeneous structure due to sites with 
values of density of the fluid. 
In two cases, infiltrate was localized in the 
lower parts of the anterior mediastinum, in 
the other two – in the upper parts of the 
anterior mediastinum and one in the lower 
parts of the posterior mediastinum. In three 
cases, destructive changes in the bone 
structure of the breast, adjacent to the 
infiltrate, were discovered. 
In 8 out of 10 examined patients with 
mediastinitis after closed chest trauma during 
the initial CT study found a broken sternum 
and retrosternal hematoma in a zone of 
increased density, irregular shape, with fairly 
sharp contours. In the study of the dynamics 
noted an increase in the volume of the 
hematoma and the emergence of 
heterogeneity of its structure at the expense of 
areas with values of density of the fluid and 
gas sections, which was a sign of hematoma 
suppuration. In two observations of the closed 
trauma, destructive changes of the sternoclux 
joint with the presence of infiltrate in the 
adjacent parts of the anterior mediastinum in 
the form of a zone with values of the density 
of soft tissues of irregular shape, with fuzzy 
contours, were diagnosed. 
Sensitivity of SCT in relation to purulent 
mediastinitis, regardless of the nature of the 
damage, was 100 %. 
CONCLUSION 
Thus, the analysis of the results of the 
study indicates the need for a comprehensive 
examination of suspected post-traumatic intra 
pleural thoracic complications. 
In the presence of any manifestations of 
systemic inflammatory response in the post-
traumatic period in patients with chest 
lesions, regardless of the results of the X-ray 
examination, ultrasound examination and 
computed tomography of the chest should be 
performed, which allows to detect the 
accumulation of pathological contents in the 
pleural and pericardial cavity, to assess the 
nature changes in the pulmonary tissue, 
mediastinum, thoracic wall and decide on the 
drainage of lesions fester. 
At the same time, for the correct 
interpretation of some changes in spiral 
computed tomography, including the lung 
abscess that developed in the background of 
pulmonary hemorrhages and mediastinitis 
against the background of hemorrhages in the 
mediastinum and pneumomediastinum, it is 
necessary to compare them with the baseline 
data. This testifies to the necessity of 
performing an early spiral computed 
tomographic examination in patients with 
chest lesions in the presence of any focal 
changes on the review X-ray. 
Spiral computer tomography of the chest 
in dynamics allows to objectively document 
the dynamics of the pathological process, 
evaluate the effectiveness of treatment, timely 
diagnose secondary complications. 
The application of this algorithm allows to 
diagnose the entire spectrum of intra-pleural 
complications in the early stages and to avoid 
diagnostic errors. 
PROSPECTS FOR FUTURE STUDIES 
Detection of the developmental frequency 
and structure of inflammatory intra-pleural 
complications of thoracic trauma. Study of 
distribution and localization of purulent 
process depending on the nature of damage to 
the chest. Setting the factors that significantly 
contribute to the development of septic 
complications after injury and closed chest 
trauma. Conducting a comparative evaluation 
of X-ray methods for diagnosing 
inflammatory complications of thoracic 
trauma and developing a diagnostic 
algorithm. 
Thus, the issue of prediction, diagnosis 
and treatment of inflammatory complications 
of thoracic trauma is largely unresolved, 
which is the basis for further research. 
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Microbial interactions in Staphylococcus aureus–Candida albicans dual-species biofilms is a relevant 
research topic given the significant contribution of these microorganisms to hospital-acquired infections. 
Therefore, the purpose of our investigation was to study the interaction of opportunistic C. albicans and 
S. aureus in vivo and in vitro, both with the participation of normal microflora and in mice with antibacterial 
dysbiosis. The study of mentioned interactions was carried out on 100 white male mice weighing 
approximately 18 grams in vivo and using smears prepared from the grown mixed cultures of C. albicans and 
S. aureus and the Japan JEM 1400 transmission electron microscope for the purpose of electron microscopic 
study of microorganisms in vitro. Healthy mice forming control groups and mice with antibiotic-induced 
dysbiosis (after introduction of vancomycin, gentamicin, ampicillin) were divided into groups to create a 
mono- and associative infection: Ι group was given 1×107 CFU of C. albicans, II group – 1×108 CFU of 
S. aureus, and III group – a mixture of specified concentrations of C. albicans and S. aureus in the same 
proportion. Microorganisms causing monoinfection were being isolated from the body of animals treated with 
antibiotics till the end of the experiments in large quantities unlike in case of the healthy mice. Co-inoculation 
of these microbes in the same dose to animals (co-infection), which were injected with antibiotics, turned out 
to be fatal for them, whereas an adhesive bond was seen between the cells of C. albicans vs. S. aureus in vitro. 
As can be seen, such bacterial-fungal co-infection reduce substantially the effectiveness of antibiotic 
therapy and the likelihood of successful treatment and can not be ignored when choosing the appropriate 
treatment. 
KEY WORDS: C. albicans, S. aureus, colonization, interaction 
 
CANDIDA ALBICANS ТА STAPHYLOCOCCUS AUREUS КО-ІНФЕКЦІЯ У МИШЕЙ ПІСЛЯ 
АНТИБІОТИКО-ІНДУКОВАНОГО ДИСБІОЗУ 
Мурадова С. А., Гурбанова С. Ф., Гаджіева С. В., Аліев М. Г. 
Азербайджанский медицинский университет, вул. Самед Вургун, 167, м. Баку, AZ1022, 
Азербайджан 
 
Мікробні взаємодії в біоплівках двох видів мікроорганізмів, Staphylococcus aureus і Candida 
albicans, є актуальною темою дослідження, враховуючи значний внесок останніх у розвиток 
внутрішньолікарняних інфекцій. Тому метою нашого дослідження стало вивчення взаємодії 
опортуністичних C. albicans і S. aureus in vivo та in vitro як за участю нормальної мікрофлори, так і у 
мишей з антибактеріальним дисбіозом. Вивчення вищенаведених взаємодій проводили на 100 білих 
самцях мишей вагою близько 18 г in vivo і in vitro з використанням мазків, отриманих з вирощуваних 
змішаних культур C. albicans і S. aureus, і японського трансмісійного електронного мікроскопа JEM 
1400 з метою електронно-мікроскопічного дослідження мікроорганізмів. Здорові миші, якы 
сформулювали контрольні групи, і миші з викликаним антибіотиками дисбіозом (після введення 
ванкоміцину, гентаміцину, ампіциліну) були розділені на групи для створення моно- і асоціативної 
інфекції: групі Ι вводили 1×107 КУО C. albicans, II групі – 1×108 КУО S. aureus і III групі – суміш 
зазначених концентрацій C. albicans і S. aureus в тій же пропорції. Мікроорганізми, що спричиняли 
моноінфекцію, виділялися з організму тварин, які отримували антибіотики до кінця експерименту в 
великих кількостях, на відміну від таких у здорових мишей. Спільна інокуляція цих мікробів в тій же 
дозі тваринам (коінфекція), яким вводили антибіотики, виявилася для них фатальною, тоді як in vitro 
був помітний клітинний зв'язок між клітинами C. albicans vs. S. aureus. 
Як бачимо, така бактеріально-грибкова коінфекция істотно знижує ефективність антибактеріальної 
терапії і ймовірність успішного лікування, та не може бути проігнорована при виборі відповідного 
лікування. 
КЛЮЧОВІ СЛОВА: C. albicans, S. aureus, колонізація, взаємодія 
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Мурадова С. А., Гурбанова С. Ф., Гаджиева С. В., Алиев М. Г. 
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Микробные взаимодействия в биопленках двух видов микроорганизмов, Staphylococcus aureus и 
Candida albicans, являются актуальной темой исследования, учитывая значительный вклад последних в 
развитие внутрибольничных инфекций. Поэтому, целью нашего исследования стало изучение 
взаимодействия оппортунистических C. albicans и S. aureus in vivo и in vitro как с участием 
нормальной микрофлоры, так и у мышей с дисбиозом. Изучение упомянутых взаимодействий 
проводили на 100 белых самцах мышей весом около 18 г in vivo и in vitro с использованием мазков, 
полученных из смешанных культур C. albicans и S. aureus. Приготовленные препараты изучали под 
трансмиссионным электронным микроскопом JEM 1400 производства Японии. Здоровые мыши 
контрольных групп, и мыши с вызванным антибиотиками дисбиозом (после введения ванкомицина, 
гентамицина, ампициллина) были разделены на группы для создания моно- и ассоциативной 
инфекции: группе Ι вводили 1×107 КОЕ C. albicans, II группе – 1×108 КОЕ S. aureus и III группе – смесь 
указанных концентраций C. albicans и S. aureus в той же пропорции. Микроорганизмы, вызывающие 
моноинфекцию, выделялись из организма животных, получавших антибиотики до конца эксперимента 
в больших количествах, в отличие от таковых у здоровых мышей. Совместная инокуляция этих 
микробов (коинфекция) в той же дозе животным, которым вводили антибиотики, оказалась для них 
фатальной, тогда как in vitro была замечена клеточная связь между клетками C. albicans vs. S. aureus. 
Такая бактериально-грибковая коинфекция существенно снижает эффективность 
антибактериальной терапии и вероятность успешного лечения, и не может быть проигнорирована при 
выборе соответствующего лечения. 
КЛЮЧЕВЫЕ СЛОВА: C. albicans, S. aureus, колонизация, коинфекция 
 
INTRODUCTION 
Beneficial or harmful interactions between 
C. albicans і S. aureus for the host can both 
develop in a healthy organism and in the case of 
illness [1–3]. Microbial communities are known 
to be functionally diverse microorganisms 
localized in certain places and long-lastingly 
interacting with each other. The 
microorganisms included in these communities 
are in certain symbiotic relationships, 
influencing the biological properties of each 
other, stimulating and/or inhibiting growth and 
reproduction [4–6]. Such relationships 
contribute to the worsening of the course of the 
disease by strengthening the virulence of the 
causative agents of the disease in the human 
body [7–9]. Specifically, exometabolites of 
S. aureus affect the phospholipase activity of 
C. albicans, thereby increasing their 
aggressiveness, contribute to the development 
of antibiotic resistance and activation of other 
features [10–13]. At the same time, C. albicans 
also stimulate some bacterial infections [9, 14]. 
There is the scientific evidence of the diverse 
influence of C. albicans on the structural 
mechanism of the population of the main 
causative agents of nosocomial infections. In 
case of immunosuppressive animals, 
C. albicans can cause an increase and 
reproduction of highly virulent strains in 
populations of E. coli, S. aureus that are 
resistant to antibacterial drugs and their anti-
lactoferrin and antilysocyme activity [15–16]. 
Thus, microbial associates play a certain role 
in the pathogenesis of infectious diseases: the 
dynamics of the isolation of associates may 
change, their prolonged stay in the body (in 
chronic form or as carriage) may also affect the 
ineffectiveness of antibiotic therapy. All these 
issues have not been studied enough, and their 
study is of practical importance, since they have 
been of significance in the diagnosis and 
treatment of associative infections. 
OBJECTIVE 
Purpose of the study was to research on the 
interaction of opportunistic C. albicans and 
S. aureus most frequently encountered in 
infectious pathologies in vivo and in vitro 
conditions, both with the participation of 
normal microflora, and in mice with antibiotic-
induced dysbacteriosis, and to study their 
electron microscopic features. 
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MATERIALS AND METHODS 
The strains of C. albicans and S. aureus used 
in the experiments were isolated from patients 
who applied to the private laboratory of the 
Department of Microbiology and Immunology 
of the Azerbaijan Medical University, and then 
were identified by morphological, cultural, and 
enzymatic features. Suspensions of 48-h culture 
of C. albicans in the amount of 1×107 CFU/ml 
and 1×105 CFU/ml, and prepared from the 24-h 
culture of S. aureus in the amount of 1×108 
CFU/ml and 1×105 CFU/ml were used in the 
experiments. 
In vivo experiments were carried out on 100 
white male mice weighing approximately 
18 grams. 0.20 t mg/ml vancomycin, 0.40 
t mg/ml gentamicin, 0.50 t mg/ml ampicillin per 
100 grams of weight were administered to mice 
orally in a dose of 0.1 ml for 5 days. They were 
used in order to prevent the possible influence 
of normal microbiota of mice on C. albicans 
and S. aureus. Healthy animals and mice with 
antibiotic-induced dysbacteriosis were divided 
into groups to create a mono- and associative 
infection: Ι group was given 1×107 CFU of 
C. albicans, II group –1×108 CFU of S. aureus, 
and III group – a mixture of specified 
concentrations of C. albicans and S .aureus in 
the same proportion. C. albicans were 
administered in the same amounts in the first 
control group of healthy mice, S. aureus – in 
another. 
Infected mice were opened after 1, 3, 7, and 
10 days according to generally accepted rules 
by preparing a homogenate from visceral 
organs (stomach, small and large intestine, 
liver, spleen, kidney) and cultured on Saburo's 
medium with gentamicin and egg-yolk salt 
agar. The resulting colonies were counted based 
on the weight of 1 gram. 
The obtained figures were subjected to a 
variation row, the average number of each row 
(M) and the error (m) were calculated and 
indicated in log10. The difference between the 
indicators of the groups was established by 
means of Mann-Whitney statistical accuracy 
(p ≤ 0.05). 
The in vitro experiments were carried out in 
test tubes with sugar broth, where 0.1 ml from a 
concentration of 1×105 CFU of C. albicans and 
S. aureus were transferred and incubated at 
37°C. Smears were prepared from the 
suspension on the 1, 3, 5. 7, 11, and 15 days of 
the experiment, and inoculated on solid nutrient 
media with sugar agar, Saburo medium. Smears 
were prepared from the grown mixed cultures, 
and then stained using the Gram method. 
Concentrations of 1×107 and 108 CFU/ml 
were used for the purpose of electron 
microscopic study of microorganisms. The 
mixture of microorganisms was kept at 37°C 
for 48 hours, then centrifuged, and the blocks of 
microorganisms were prepared using accepted 
protocols. The obtained materials were then cut 
with diamond knives in an EM UC 7 -LEİCA 
microtome into plates with a thickness of 60 
nm. Sections were stained with uranyl acetate 
and mercuric citrate. Ready-made preparations 
were studied using the Japan JEM 1400 
transmission electron microscope. 
The studies were conducted in the Electron 
Microscope Laboratory under the AMU headed 
by Professor E. Gasymov (with financial 
support from the Science Development 
Foundation under the President of the Republic 
of Azerbaijan. Grant No. EIF-2011-1 (3) -82 / 
44/3-M-6). 
RESULTS AND DISCUSSION 
C. albicans and S. aureus were isolated only 
from the digestive tract of both groups of 
animals, injected with cultures of these 
microorganisms. C. albicans was isolated from 
the stomach of healthy mice in the amount of 
2.81 ± 0.19 CFU on the first day of the 
experiment, on the second day – in the amount 
of 2.40 ± 0.98 CFU; 2.92 ± 0.80 CFU were 
isolated from animals that were given 
antibiotics on the first day of the experiment, 
2.83 ± 0.54 CFU – on the third day, 2.72 ± 0.27 
CFU – on the seventh day, and 2.64 ± 0,45 
CFU – on the tenth day (fig. 1 (1)). 
C. albicans was found in the small intestine 
of healthy animals only on the first day and on 
the second day of the experiment in the amount 
of 2.75 ± 0.03 CFU and 2.3 ± 0.45 CFU, 
respectively. C. albicans isolated from the small 
intestine of animals that were given antibiotics 
in an amount of 2.96 ± 0.27 CFU on the first 
day, 2.94 ± 0.80 CFU on the third day, , 2.88 ± 
0.15 CFU on the seventh day, and in the 
amount of 2.78 ± 0.35 CFU on the tenth day 
(fig. 1 (2)). 
C. albicans was found in the large intestine 
of healthy mice on the first day in an amount of 
2.56 ± 0.71 CFU, on the third day in an amount 
of 2.51 ± 0.15 CFU, on the seventh day it was 
detected only in the colon in an insignificant 
amount (1, 6 ± 0.45 CFU), and on the tenth day 
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microbes were not detected at all. Fungi were 
isolated from the colon in animals receiving 
antibiotics on the first day of observation in the 
amount of 2.86 ± 0.54 CFU, on the third day – 
2.90 ± 0.05 CFU, on the seventh day – 2.92 ± 
0.18 CFU and on tenth day – in the amount of 
2.88 ± 0.06 CFU. 
 
 
 
 
 
 
 
 
                
Stomach   Small intestine    Colon 
Fig. 1. Detection of C. albicans (CFU) in case of mono-infection in healthy mice (1) and in animals that 
were administered antibiotics (2) in the stomach, small and large intestines 
Abscissa: 1 – the first day, 2 – the third day, 3 – the seventh day, 4 – the tenth day. Ordinate: indicates CFU 
 
 
S. aureus was found in the stomach of 
healthy animals only on the first day of the 
experiment (3.48 ± 0.43 CFU). In contrast, 
microbes were excreted from animals that 
were given antibiotics until the end of the 
experiment (3.99 ± 0.88 CFU on the first day, 
3.96 ± 0.71 CFU on the third day, 3.80 ± 0.55 
CFU on the seventh day, 3.62 ± 0.25 CFU on 
the tenth day) (fig. 2 (1)). 
S. aureus was isolated from the small 
intestine of healthy animals only on the first 
day of the experiment (3.47 ± 0.25 CFU), 
whereas it was found in animals that were 
given antibiotics, on the first day in an 
amount of 4.1 ± 0.71 CFU, on the third day – 
3.97 ± 1.12 CFU, on the seventh day – 3.90 ± 
0.83 CFU, and on the tenth day – 3.83 ± 0.35 
CFU (fig. 2 (2)). 
Staphylococci were detected in the large 
intestine of healthy animals only on the first 
and second days of the experiment (2.92 ± 
0.05 CFU). In contrast, they were found in 
animals that were given antibiotics, in an 
amount of 4.02 ± 0.84 CFU on the first day, 
4.01 ± 0.88 CFU on the third day, 3.92 ± 0.91 
CFU on the seventh day, and in the amount of 
3.87 ± 0.81 CFU on the tenth day (fig.2 (3)). 
 
 
 
 
 
 
 
       
Stomach   Small intestine    Colon 
Fig. 2. Detection of S. aureus (CFU) in case of mono-infection in healthy mice (1) and in animals that 
were administered antibiotics (2) in the stomach, small and large intestines 
Abscissa: 1 – the first day, 2 – the third day, 3 – the seventh day, 4 – the tenth day. Ordinate: indicates CFU 
 
 
Oral administration with intervals of C. 
albicans and S. aureus simultaneously to 
animals that were given antibiotics in the first 
24 and 48 hours caused the death of 60 % and 
100 % of the animals, respectively. The 
microbial load of both types of 
microorganisms in the organs of dead animals 
exceeded to a significant degree such load in 
the control groups (p ≤ 0.05). Microbes were 
found not only in the gastrointestinal tract of 
animals, they also colonized the liver, spleen 
and kidneys. The results of the experiments 
are shown in table. 
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Table 
Microbial load in case of co-infection, caused by C. albicans  
and S. aureus of white antibiotic-treated mice (log10) 
 I day II day 
C. albicans 
(CFU/gr) 
S. aureus 
(CFU/gr) 
C. albicans 
(CFU/gr) 
S. aureus 
(CFU/gr) 
Stomach 3,03 ± 0,25 4,2 ± 0,55 3,12 ± 0,13 4,29 ± 0,80 
Small intestine 3,06 ± 0,17 4,06 ± 0,69 3,08 ± 0,05 4,26 ± 0,76 
Colon 3 ± 0,13 4,07 ± 0,88 3,03 ± 0,13 4,19 ± 0,65 
Liver 2,55 ± 0,15 3,61 ± 0,43 2,75 ± 0,65 3,74 ± 0,59 
Spleen 2,51 ± 0,17 3,48 ± 0,35 2,68 ± 0,05 3,59 ± 0,25 
Kidney 2,61 ± 0,35 3,62 ± 0,65 2,83 ± 0,07 3,60 ± 0,35 
 
 
The study of the relationship between 
C. albicans vs. S. aureus in vitro showed once 
again the existence of a relationship between 
these two microorganisms that can be seen in 
smears prepared at different times from a 
mixture of microbes (fig. 3), where there is an 
accumulation of staphylococci around 
Candida fungi (fig. 3, A). You can also 
observe that staphylococci are distributed in 
insignificant amounts in the field of view 
where there are no cells of fungi. And 
staphylococci are arranged in small clusters 
and chains in places where cells of fungi are 
not detected. (fig. 3, B). Thus, staphylococci 
are more intense and with large groups, 
forming a classical cluster of bunches, are 
located around the cells of Candida fungi 
(fig. 3, A–B). 
 
 
 
 
 
 
 
 
 
 
 
A   B  
 
Fig. 3. Smears prepared from the mixed cultures of C. albicans and S. aureus (Gram stain) 
 
We provide electron microscopic 
images for the purpose of introducing some 
clarity on the relationship between these 
microorganisms. 
One can notice the attraction between the 
cells of staphylococci and fungi in the figure 
4, these attractions are hardly noticeable 
(indicated by the arrow in figure 4.A) at the 
beginning of the experiments, and more 
clearly visible (fig. 4 B–C) as the cells 
approach each other; the formation of bridges 
between the cells (fig. 4 D–F) is also 
noticeable. Thus, an adhesive bond is formed 
between the cells of C. albicans vs. S. aureus. 
Reproduction of staphylococci adhered to the 
surface of fungal cells can also be viewed 
(fig. 4 C). 2–3 cells of staphylococci can 
accumulate on the surface of a single cell of 
the fungus (fig. 4 F). 
Normal microflora of healthy organism 
contributes to the elimination of pathogens 
immediately after their introduction to the 
large extent along with other protection 
mechanisms. That is why, cultures of 
C. albicans and S. aureus, orally administered 
to healthy mice, were isolated from the 
digestive tract only in the initial days of the 
experiment. These microorganisms were also 
isolated mainly from the digestive tract, 
where the amount of host-gut microbiota was 
gradually decreased, in animals with 
antibiotic-induced dysbacteriosis. But the 
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studied microorganisms in the body of these 
mice were isolated in larger quantities unlike 
the body of healthy animals, and moreover, 
until the end of the experiment. However 
their number gradually decreased by the tenth 
day. Signs of the disease were observed from 
the first days of the experiment in animals 
that were injected with antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Electron-microscopic image of the relationship between cells  
of C. albicans and S. aureus (arrows indicate adhesion) 
 
 
Despite the significant decrease in normal 
microflora that was observed in animals 
administered with antibiotics, there was a 
gradual restoration of the composition of the 
microflora after cessation of the introduction 
of antibiotics. Detection of C. albicans and 
S. aureus for a long time (throughout the 
experiment) in the digestive tract of animals 
that were injected with antibiotics, in large 
quantities (CFU), was due to a decrease in the 
number of native microflora. The gradual 
restoration of normal microflora was 
accompanied by a gradual decrease in these 
microorganisms. Thus, signs of the disease 
were observed in mono-infections caused by 
C. albicans and S. aureus, both in healthy 
animals and in those who were given 
antibiotics, but no deaths were observed. 
There were no signs of major changes in the 
internal organs. However, co-infection 
induced by the Candida-Staphylococcus 
association in animals with dysbiosis caused 
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by antibiotics was the most difficult – 
accompanied by high rates of development 
and a high degree of mortality. Namely, 
100 % of the animals died within the first 
48 hours during co-infection. An autopsy of 
the dead animals showed an increase in the 
quantity of both microorganisms in the 
digestive tract, liver, kidney and spleen. Such 
results show the marked synergistic effect 
between C. albicans and S. aureus. Namely, 
when staphylococci are the only source of 
infection, a low percentage of dead animals 
are present, and co-infection with C. albicans 
at the same time increases the percentage of 
dead animals and the microbial burden in the 
internal organs, which coincides with the 
results of similar studies [9, 17]. On the basis 
of the data obtained, the causes of death of 
the mice are the mutual reinforcement of the 
physiological properties of the associates and 
reduction of the nonspecific protective system 
of the microorganism through the developed 
dysbacteriosis on the other hand. Microbial 
products have a synergistic effect in 
association, influencing on the growth and 
reproduction of bacteria, on the expression of 
pathogenicity factors [18]. The main factor 
ensuring the microbial pathogen's ability to 
cause an infection with severe flow is the 
amplification of the bacteria virulence under 
the influence of fungi. 
In vitro studies also allowed establishing 
the dependence of staphylococci on Candida 
fungi. The results obtained and electron-
microscopic images confirm the adhesive 
interaction between the cells of C. albicans 
and S. aureus, which led to an intensive 
multiplication of staphylococci on the surface 
of the fungi and formation of a multilayer 
film. As can be seen, S. aureus forms a film 
with the participation of C. albicans in the 
absence of the ability to form separately a 
film in the serum, and reproduce in the form 
of microcolonies based on the biofilm of 
C. albicans. 
The complex interaction between fungi 
and staphylococci that arose under certain 
conditions is due to the presence of certain 
receptors [19–20]. The C. albicans agglutinin-
like sequences (ALS) and specific surface 
glycoproteins in mixed microbial associations 
are important for co-adhesion [21]. 
CONCLUSIONS 
The obtained results showed that the 
relationship between these microorganisms is 
ambiguous. Polymicrobial infection even 
nowadays remains a significant predictor of 
the patient's prognosis deterioration, reducing 
the effectiveness of antibiotic therapy and 
likelihood of successful treatment [22–23]. 
Various interactions arise under conditions of 
mutual enhancement of virulence in the 
animal organism, under conditions of 
quantity and time. Therefore it is especially 
important and necessary to take into account 
these data in case of the treatment of 
polymicrobial aetiology infections. The 
treatment strategy should not only be directed 
against a single pathogen, but also aim to 
destroy the microbial association. 
PROSPECTS FOR FUTURE STUDIES 
It remains relevant to study the effect of 
various therapeutic approaches in order to 
improve the effect on the fungus-bacterium 
association depending on the localization of 
the infection. Given the antibiotic resistance 
of individual bacteria, which significantly 
increases with cooperation with various 
representatives of the fungal flora, it makes 
sense to search for new methods of exposure, 
along with medical management. Further 
exploration of changes in the activity of 
various pathogens during the co-infection 
can make a significant contribution in this 
direction. 
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The article presents the results of studies of markers of connective tissue dysplasia and the content of the 
main fibroblast growth factor in blood plasma in patients with type 2 diabetes. The presence of significant 
correlations between the studied parameters with the occurrence and progression of hypertension in patients 
with type 2 diabetes is established. A regression model for predicting the development of arterial hypertension 
is proposed in patients with diabetes mellitus. 
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НЕДИФЕРЕНЦІЙОВАНА ДИСПЛАЗІЯ СПОЛУЧНОЇ ТКАНИНИ  
ЯК ПОТЕНЦІЙНИЙ ПРЕДИКТОР РОЗВИТКУ АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇ  
У ХВОРИХ НА ЦУКРОВИЙ ДІАБЕТ 2 ТИПУ 
Шерстюк Л. Л., Ніколенко Є. Я. 
Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
У статті наведено результати досліджень маркерів дисплазії сполучної тканини та вмісту 
основного фактору росту фібробластів в плазмі крові у хворих на цукровий діабет 2 типу. Встановлено 
наявність достовірних кореляцій між вивчаємими показниками з виникненням та прогресування 
артеріальної гіпертензії у хворих на цукровий діабет 2 типу. Запропоновано регресійну модель для 
прогнозування розвитку артеріальної гіпертензії у хворих на цукровий діабет. 
КЛЮЧОВІ СЛОВА: артеріальна гіпертензія, цукровий діабет 2 типу, недиференційована 
дисплазія сполучної тканини, основний фактор росту фібробластів, прогнозування 
 
НЕДИФФЕРЕНЦИРОВАННАЯ ДИСПЛАЗИЯ СОЕДИНИТЕЛЬНОЙ ТКАНИ КАК 
ПОТЕНЦИАЛЬНЫЙ ПРЕДИКТОР РАЗВИТИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ У 
БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА 
Шерстюк Л. Л., Николенко Е. Я. 
Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
 
В статье приведены результаты исследований маркеров дисплазии соединительной ткани и 
содержания основного фактора роста фибробластов в плазме крови у больных сахарным диабетом 2 
типа. Установлено наличие достоверных корреляций между изучаемыми показателями с 
возникновением и прогрессирования артериальной гипертензии у больных сахарным диабетом 2 типа. 
Предложено регрессионную модель для прогнозирования развития артериальной гипертензии у 
больных сахарным диабетом. 
КЛЮЧЕВЫЕ СЛОВА: артериальная гипертензия, сахарный диабет 2 типа, 
недифференцированная дисплазия соединительной ткани, основной фактор роста фибробластов, 
прогнозирование 
INTRODUCTION 
Arterial hypertension (AG) is one of the 
most common cardiovascular diseases that 
 Sherstyuk L. L., Nikolenko, Ye. Ya., 2018 
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afflicts more than 1.5 billion people in the 
world, with almost 45 % of them being not 
aware of the presence of high blood pressure 
(BP) [1]. Hypertension is often manifested in 
combination with another pathology, in 
particular, with diabetes mellitus (DM), 
obesity, coronary heart disease (CHD), 
chronic kidney disease (CKD), heart failure 
(CH), and others [2–3]. The most often 
combination is hypertension and diabetes. 
The prevalence of hypertension among 
patients with diabetes is more than 60 %. 
Such a comorbidity significantly increases the 
risk of severe cardiovascular complications 
[4–5]. The presence of hypertension in 
patients with type 1 diabetes is associated 
with an increase in the frequency of severe 
stages of diabetic nephropathy and 
retinopathy; on the other hand, diabetes 
significantly increases the risk of emergence 
and developing hypertension, and 
hypertension is associated with a high risk of 
insulin resistance and metabolic 
abnormalities [6]. When combined with 
hypertension and diabetes, the risk of CHD 
developing increases by 2–4 times, stroke – 
2–3 times, visual loss – 10–25 times, renal 
insufficiency – 15–20 times, gangrene of the 
lower extremities – 20 times [7]. 
Mechanisms of damage of many organs 
and systems in case of diabetes and 
hypertension are discussed by many 
researchers. Endothelial dysfunction due to 
metabolic disorders in diabetes or long-term 
BP increase lead to a breach of 
vasodilatation, thickening of the basement 
membrane of microvessels, metabolic 
disorders in extracellular matrix and initiating 
of large vessels atherosclerotic lesions [8–9]. 
Disturbance of lipid metabolism is essential 
as trigger factor, in addition to 
hyperglycemia. The immediate damaging 
factors may be the end products of glycolysis 
(AGE), products of lipid peroxidation, 
increased activity of angiotensin II, 
proinflammatory cytokines, leukocyte 
adhesion factors, activation of protein kinase 
C and others [10]. Increase of AGE, 
accumulation of circulating fatty acids, 
products of oxidative stress and dysfunction 
of the endothelium lead to accelerated 
apoptosis, reducing angiogenesis and cardiac 
remodeling violation [11]. 
S. Shakya et al. (2015) believe that the 
main target of hyperglycemia is hyaluronic-
containing glycocalyx, located in the 
microvascular endothelium. Its damage leads 
to an increase in the adhesive properties of 
leukocytes and causes the formation of 
proinflammatory cytokines. In turn, this leads 
to the further development of oxidative stress 
and the progression of endothelial disorders 
with an increase in the proinflammatory 
cytokines release. Such a proinflammatory 
condition affects the function of functionally 
active cells (pericytes, smooth muscle cells, 
fibroblasts), which worsens reparative 
processes in vessels and tissues, including 
angiogenesis [12]. One of the mechanisms of 
the pathological effect of hyperglycemia is 
also thought to be the increase in the activity 
of prophylactic factors, in particular, TGF-β, 
which is a modulator of proteoglycan 
synthesis in the extracellular matrix [12–13]. 
is The increase in excretion of type IV 
collagen in patients with diabetes, with 
diabetic nephropathy and nephropathy of 
another genesis serves as an evidence of 
connective tissue metabolic abnormalities 
role in the extracellular matrix [14–15]. 
These data indicate that the target of 
pathological processes taking place in 
hypertension and diabetes is connective 
tissue. On the other hand, the presence of 
feedback is increasingly considered – the role 
of metabolic disorders of connective tissue in 
the emergence of another, in particular, 
vascular pathology. It is known that the 
connective tissue, which constitutes more 
than 50 % of the human body mass, carries 
out not only the supporting-skeleton, 
structural-forming, protective and reparative 
functions in the whole organism, but also 
takes part in almost all processes of 
metabolism. Pathological activation or 
inhibition of the activity of cellular elements 
of the connective tissue and changes in the 
structure of the basic substance can be the 
basis for the development and progression of 
the pathological process, the emergence of its 
complications and the appearance of 
comorbid pathology [16–17]. 
At this time, the disease, the characteristic 
feature of which is the development of 
connective tissue disorders, are defined as 
connective tissue dysplasia (CTD). The 
genetically determined differentiated variants 
of CTD are known that are Ehlers-Danloss, 
Marfan, Sticker's syndrome, and variants of 
CTD with clinical manifestations that are not 
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included in the clinical picture of hereditary 
pathology – undifferentiated CND (UCTD). 
Nowadays clinical variants of UCTD include 
numerical diseases with the presence of 
neurological, skeletal, cardiac, vascular, 
visceral, visual and other manifestations [16, 
18]. The prevalence of CTD is rather high in 
the population, and single phenotypic 
symptoms are found in almost every fourth 
person [16, 19]. It is believed that the 
presence of CTD contributes to the 
development of another pathology. In 
particular, it has been established that diabetic 
neuropathy and nephropathy in children and 
adolescents with type 1 diabetes occur earlier 
and have severe course of disease in the 
presence of signs of connective tissue 
dysplasia [20]. 
Taking into account the value of the 
connective tissue in ensuring of the normal 
structure of all organs and tissues and in the 
processes of tissue remodeling under 
conditions of pathology, it is well-founded to 
study the role of UCTD in the development 
of hypertension, in particular, in patients with 
type 2 diabetes. 
OBJECTIVE 
The purpose of the study is to study the 
possibility of using the clinical signs of 
UCTD as predictors of the development of 
arterial hypertension in patients with type 2 
diabetes mellitus. 
MATERIALS AND METHODS 
The study was performed on the basis of 
the endocrinology department of the Kharkiv 
Regional Clinical Hospital. The study 
included 90 patients aged from 35 to 45 years 
who were on treatment during the period of 
2016–2018 years with an established 
diagnosis of type 2 diabetes mellitus, lasting 
no more than 10 years. 
All patients have undergone a complex 
general clinical, laboratory and instrumental 
examination in accordance to the Order of the 
Ministry of Health of Ukraine No. 1118 dated 
21.12.2012 «Unified clinical protocol of 
primary and secondary (specialized) medical 
aid. Type 2 diabetes mellitus». The diagnosis 
of hypertension was carried out in accordance 
to the Order of the Ministry of Health of 
Ukraine No. 384 dated 24.05.2012, «Arterial 
Hypertension: An Updated and Adapted 
Clinical Invention based on Evidence». 
Diagnosis of UCTD was carried out through a 
comprehensive examination and evaluation of 
the presence of internal (visceral) and 
external (skeletal, skin, articular) signs 
according to T. I. Kadurina (2009) [15]. 
Phenotypic (visceral and/or skeletal) signs 
of UCTD were found in 48 patients (Group I) 
among the patients included in the study and 
42 patients had no signs of UCTD (Group II). 
The control group consisted of 20 practically 
healthy people – donors with an average age 
of 36.3 ± 3.1 years. 
The study of the concentration of the basic 
fibroblast growth factor 2 (FGF2) in blood 
plasma was carried out by immunoassay 
using a Quantikine (Human FGF basic 
immunoassay) reagent kit manufactured by 
R&D Systems, Inc. (USA) on the semi-
automatic analyzer ImmunoChem 2100 in the 
Department of Experimental Pharmacology 
and Toxicology of the the SI «V. Danilevsky 
Institute for Endocrine Pathology Problems of 
the NAMS of Ukraine». 
The obtained results were processed using 
the package of statistical software PSSR (an 
open-source program that does not need a 
license). Quantitative data is given in the 
form of M ± SD (average and standard 
deviation of the mean) for normal data 
distribution or Me [Q25–Q75] (median – 25th 
and 75th quarters) with abnormal data 
distribution. The normality of distribution 
was determined by the Kolmagorov-Smirnov 
criterion, amended by Liliefors. Quantitative 
indices with normal distribution were 
compared using Student's t-test, with an 
abnormal distribution – according to the 
Mann-Whitney criterion. The frequency of 
quality indicators was performed using 
criterion χ2. Correlation analysis performed 
according to Pearson criteria. 
RESULTS AND DISCUSSION 
It was found that the average duration of 
the disease did not differ significantly and 
was in the 1st group (5.1 ± 2.3 years), in the 
2nd group it was 4.2 ± 2.6 years (p = 0.108 
per t-criterion) according to the analysis 
results of the peculiarities of the course of 
diabetes. There was 37 (77.1 %) patients with 
a duration of diabetes up to 5 years in Group I 
and 29 (69.0 %) in group II, 11 (22.9 %) 
patients with a duration of disease from 5 to 
10 years in group I, 13 (31.0 %) – in the 2nd 
group (χ2 = 0.740, p = 0.390) (tab. 1). 
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Table 1 
Features of diabetes mellitus based on the presence of UCTD 
Indicator Group I (n = 48) Group II (n = 42) р 
Duration of DM, years 5,1 ± 2,3 4,2 ± 2,6 0,1081 
Duration of DM:  
up to 5 years 
5–10 years old 
 
37 (77,1 %) 
11 (22,9 %) 
 
29 (69,0 %) 
13 (31,0 %) 
 
0,3902 
Diabetic nephropathy 
– Microalbuminuria 
38 (79,2 %) 
17 (35,4 %) 
20 (47,6 %) 
6 (14,3 %) 
0,0022 
0,0402 
Diabetic retinopathy 25 (52,1 %) 16 (38,1 %) 0,1842 
Diabetic neuropathy 41 (85,4 %) 30 (71,4 %) 0,1052 
Notes: 1 – the significance of the difference based on the t-criterion. 2 – the significance of the difference by 
criterion χ2. 3 – the significance by the Mann-Whitney criterion 
 
 
Diabetic nephropathy was a frequent 
complication of diabetes in the analyzed 
sample of patients. It was diagnosed in 38 
(79.2 %) patients in group І, in 20 (47.6 %) 
patients in ІІ group (χ2 = 9,729, р = 0,002). 
While microalbuminuria (MA) was observed 
in 17 (35.4 %) patients in group І and in 6 
(14.3 %) patients in group ІІ (χ2 = 4,205; р = 
0,040). 
Thus, there is more severe course of 
diabetes with more frequent development of 
diabetic nephropathy with MA, as well as 
with the tendency to increase the incidence of 
diabetic neuropathy and retinopathy in 
patients with the signs of the UCTD. 
The most common accompanying 
pathology in the analyzed group of patients 
was hypertension, which was detected in 45 
(93.7 %) patients in group I, including: stage 
1 hypertension – in 25 (52.1 %), stage 2 
hypertension – in 17 (35.4%) and stage 3 
hypertension – in 3 (6.3 %) patients. 
Hypertension was detected in 22 (52.4 %) 
patients in the II group including: 16 (38,1 %) 
patients with stage 1 hypertension, 5 (11,9 %) 
– with stage 2 hypertension, 1 (2.4 %) – with 
stage 3 hypertension (χ2 = 21.783; p < 0.001) 
(fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Frequency and severity of hypertension in І and II groups of patients 
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Certain patterns have been identified 
depending on the duration of diabetes as a 
result of the analysis of the frequency and 
severity of hypertension. No differences in 
the frequency of hypertension of varying 
stages depending on the duration of diabetes 
was detected in group I (with the presence of 
UCTD) (χ2 = 1,603; p = 0,659). On the 
contrary, clear dependence of hypertension 
stages on the duration of diabetes can be 
traced in patients of II group (without 
phenotypic signs of UCTD) – the frequency 
of hypertension itself and 2nd and 3rd stages 
significantly increases (χ2 = 17,961; 
p < 0,001) in patients with a duration of 
diabetes from 5 to 10 years in comparison 
with patients whose disease lasted less than 5 
years old. These patterns are confirmed by 
the results of the correlation analysis: a very 
weak positive correlation was found at the 
level rS = 0.091 (p = 0.538) in the I group and 
there was a significant positive correlation at 
rS = 0.522 (p < 0.001) in the II group. 
The comparison of frequencies of UCTD 
cases was performed depending on the 
presence of visceral and/or skeletal signs for a 
more detailed study of the effect of UCTD on 
the development of hypertension in patients 
with type 2 diabetes. Only visceral signs of 
UCTD were detected in 31 patients in the Ia 
group, visceral and skeletal symptoms were 
detected in 17 patients who were Ib group 
(fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Frequency of hypertension depending on the type of UCTD 
 
Hypertension was found almost with the 
same frequency in both groups, but its 
structure differed based on stages. Stage 1 
hypertension was detected in 19 (61.3 %) 
patients in the Ia group, stage 2 – in 9 
(29.0 %) patients, stage 3 – in 1 (3.2 %). In Ib 
group, stage 1 hypertension was established 
in 6 (35.3 %) patients, stage 2 – in 8 (47.1 %), 
stage 3 – in 2 (11.8 %). That is, an 
insignificant tendency to the development of 
more severe stages of hypertension due to the 
increase in number of phenotypic signs of 
UCTD, in particular skeletal anomalies, is 
traced (χ2 = 3.718; p = 0,294). 
The results of studies of FGF2 content in 
blood plasma are shown in tab. 2. All patients 
with diabetes included in the study have 
significantly higher median of the content of 
FGF2 than in the control (p < 0.05 by the 
Mann-Whitney criterion). The content of 
FGF2 was significantly higher in group I than 
such of controls or in group II (p < 0.05 
according to the Mann-Whitney criterion in 
both comparisons). No significant differences 
were observed between subgroups Ia and Ib, 
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but there was a tendency for FGF2 to increase 
in patients of Ib group (with the presence of 
visceral and skeletal symptoms of UCTD). 
 
Table 2 
FGF2 content in the blood of patients with type 2 diabetes and in control group (pg/ml) 
Groups Me [Q25; Q75] Min Max 
All patients (n = 90) 28,1 [18,7; 34,2]1 7,4 63,2 
І group (n = 48) 30,8 [21,6; 39,9]1,2 12,8 63,2 
Іa group (n = 31) 30,3 [22,6; 39,7]1,2 12,8 56,2 
Іb group (n = 17) 31,4 [20,5; 47,6]1,2 16,2 63,2 
ІІ group (n = 42) 22,1 [16,2; 29,3]1 7,7 41,2 
Control group (n = 20) 3,6 [1,9; 9,0] 0,8 19,6 
Notes: 1 – the differences are significant compared to the control (p < 0,05 according to the Mann-Whitney 
criterion). 2 – the differences are significant compared to the second group (p < 0,05 according to the Mann-
Whitney criterion) 
 
A correlation analysis of the FGF2 level in 
blood was performed separately in groups I 
and II (parametric Pearson method), which 
resulted in significant differences in the 
strength of the correlation relationships 
between the groups (tab. 3). 
Table 3 
Results of correlation analysis of FGF2 content and other indicators 
Indicators 
І group ІІ group 
r p r p 
Age, years 0,107 0,227 0,649 < 0,001 
Duration of DM, years 0,059 0,877 0,357 0,020 
Hypertension (0 – no, 1–3 st.) 0,564 0,001 0,413 0,006 
Diabetic nephropathy 0,206 0,159 0,372 0,015 
 
Interesting differences have been 
identified as a result of the correlation 
analysis of FGF2 content and other 
indicators. The correlation of FGF2 
depending on age and duration of diabetes 
mellitus was absent in group I – r = 0.107 and 
r = 0.059, respectively (p > 0.05). On the 
contrary, a significant strong positive 
correlation was found between FGF2 and age 
(r = 0.649, p < 0.001) and duration of 
diabetes (r = 0.357, p = 0.02) in group II. 
These patterns are shown in fig. 3, 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Diagram of scattering of FGF2 dependence on age and duration  
of diabetes in І groups of patients 
Series «Medicine». Issue 36 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Diagram of scattering of FGF2 dependence on age and duration  
of diabetes in II groups of patients 
 
 
Data suggests that the content of FGF2 
increases with age and during the course of 
the disease in patients with DM type 2. This 
dependence is absent in the presence of 
UCTD in patients with DM type 2, which can 
be explained by the initial increase in the 
content of FGF2 on the background of 
metabolic disorders of the connective tissue. 
Another interesting regularity is the 
presence of a statistically significant 
correlation between the content of FGF2 in 
patients with diabetes with the presence and 
severity of hypertension in both groups – r = 
0.564 (p = 0.001) and r = 0.413 (p = 0.006) 
respectively in I and II groups. 
Also, there was no significant positive 
correlation with the presence of diabetic 
nephropathy – r = 0.206 (p = 0.159) in 
patients with UCTD (group I). The 
correlation with the presence of diabetic 
nephropathy was significantly positive r = 
0.372 (p = 0.015) in patients of the II group 
(without evidence of UCTD). In addition, the 
presence and severity of hypertension and 
diabetic nephropathy had correlations among 
themselves: in group I there was a significant 
positive correlation – r = 0.451 (p = 0.001), 
and in the second group there was also a 
significant positive correlation r = 0.506 
(p = 001). 
Thus, the presence of UCTD and 
increased content of FGF2 are associated 
with the development and progression of 
hypertension in patients with DM type 2, 
suggesting the possibility of using these 
indicators as predictors of hypertension. But 
for studying this possibility, dynamic 
observation for a long period since the debut 
of the DM is necessary. It is also needed to 
take into account the fairly high cost of 
immuno-enzymatic analysis of the content of 
FGF2. On the other hand, the content of 
FGF2 is closely related to the UCTD, 
therefore, the possibility of using clinical 
signs of UCTD to predict the development of 
hypertension in patients with type 2 diabetes 
has been tested. 
To this end, an analysis of the written 
discharge reports after a previous inpatient 
treatment (from two to five years ago) was 
performed in patients with a duration of type 
2 diabetes for at least 2 years. Such discharge 
reports were available in 78 patients. 
The method of binary logistic regression 
(BLR) is used for the analysis of the 
possibilities of using the UCTD signs as 
predictors of hypertension. The patients 
included in this analysis were divided into 
two groups: 
– I group – patients with DM type 2, in 
whom hypertension was not diagnosed during 
the previous hospitalizations and wasn’t 
found during the last hospitalization, as well 
as patients who have no differences in degree 
of hypertension during the previous and last 
hospitalization – 38 patients; 
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– ІІ group – patients with DM type 2, in 
whom hypertension was not diagnosed during 
the previous hospitalization, but during their 
last hospitalization hypertension was 
detected, as well as patients whose 
hypertension during the last hospitalization 
increased in comparison with the previous 
one – 40 patients. 
Groups are encoded in the order scale: I 
group – «0»; II group – «1». 
In the logistics analysis, two indicators 
were introduced: 
– presence of signs of UCTD, encoded as 
the sum of individual visceral and/or skeletal 
symptoms – x1. 
– duration of DM type 2 in years – x2. 
This indicator was introduced due to the 
influence of the duration of diabetes in 
patients with type 2 diabetes, regardless of 
other indicators. 
According to the results of the analysis, 
the following data was obtained using the 
BLR (tab. 4). 
All regression coefficients of the 
indicators included in the equation are 
reliable, with the value of significance <0.05 
for all indices and constant as an evidenced, 
while the regression coefficient of UCTD has 
a very high significance < 0.001 and 
significantly higher than the duration of the 
DM. This indicates a rather high predictive 
value of UCTD in the development of 
hypertension.
Table 4 
Results of regression analysis of the hypertension development  
or progression in patients with type 2 diabetes 
Indicator B S.E. Wald Statistics Sign. (p) 
x1 2,970 0,689 18,578 0,000 
x2 0,470 0,204 5,320 0,021 
Constant -4,520 1,367 10,927 0,001 
Notes: x1 - signs of UCTD; x2 - duration of type 2 diabetes; B - coefficient of regression B; S.E. - standard 
error of the regression coefficient; p - level of significance of the regression coefficient. 
 
The obtained data allow us to calculate the 
value of z, which can be presented in this 
analysis as: 
z = x1 · 2,970 + x2 · 0,470 + (-4,520) (1) 
 
Further calculation of the hypertension 
development or progression probability of is 
carried out according to the formula: 
 (2) 
ze
P


1
1
  (2) 
The greater final value of P is, the greater 
likelihood of hypertension or its progression 
in patients with DM type 2. The critical 
value, which determines the patient with risk 
of hypertension, is 0.5. 
While checking the predictive ability of 
the generated equation to predict the onset or 
progression of hypertension, the following 
data are established (tab. 5) 
 
Table 5 
Table of classification of observed and predicted values 
Observed value 
Estimated value 
Development of hypertension 
Percentage of correct 
0 (no) 1 (yes) 
Development of 
hypertension 
0 (no) 34 4 89,5 
1 (yes) 5 35 87,5 
Total percentage   88,5 
Notes. Distinguishing value = 0.500 
 
The data obtained indicate that the 
predictive value of the negative outcome is 
89.5 %, the predictive value of the positive 
result is 87.5 %, and the overall predictability 
is 88.5 %. In 34 (87.2 %) cases out of the 39 
patients who had no development or 
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progression of hypertension, patients received 
a correct prediction that characterizes the 
specificity of the BLR equation. A correct 
prognosis was obtained as well in 35 (89.7 %) 
cases out of the 39 patients who had 
hypertension or progression that characterizes 
the sensitivity of the BLR equation. 
Sufficiently high values of predictability, 
specificity and sensitivity suggest that this 
method can be used to predict the onset or 
progression of hypertension in patients with 
type 2 diabetes and to identify patients who 
require active prophylaxis of hypertension, 
even in the absence of other cardiovascular 
risks. 
CONCLUSIONS 
1. The development of hypertension in 
patients with DM type 2 in combination with 
UCTD occurs earlier, is almost independent 
of the duration of diabetes, more pronounced 
hypertension is observed in patients with 
visceral and skeletal symptoms of UCTD. 
This is evidence of the role of UCTD in the 
pathogenesis of hypertension in patients with 
type 2 diabetes. 
2. Essential role in the emergence and 
progression of hypertension in patients with 
DM type 2 is played by metabolic disorders 
of the connective tissue that manifests as 
clinical signs of UCTD. FGF2, which content 
is increased in patients with visceral and/or 
skeletal symptoms of UCTD, is involved in 
its pathogenesis. 
3. The regression model of the prediction 
of hypertension in patients with DM type 2 
with an assessment of the presence of UCTD 
signs and the duration of diabetes has a high 
prognosticity, specificity and sensitivity, 
which makes it possible to apply this method 
in clinical practice to determine patients with 
high risk of development of hypertension. 
PERSPECTIVES FOR FUTURE 
STUDIES 
The data limitation is the age group (from 
35 to 45 years) and the duration of diabetes 
(less than 10 years). In addition, the 
forecasting results were obtained based on the 
analysis of retrospective data. More evidence 
may be obtained in a prospective study 
involving more patients with more extensive 
inclusion criteria. 
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CONDITION OF LIPID PEROXIDE OXIDATION AND 
ANTIOXIDANT SYSTEM IN PATIENTS WITH INFECTIOUS 
MONONUCLEOSIS 
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The indicators of the activity of lipid peroxidation and the antioxidant system were studied in dynamics in 
158 patients with infectious mononucleosis depending on the severity of the clinical course of the disease. 
It is proved that lipid peroxidation is significantly activated in patients with infectious mononucleosis as 
the severity of the disease increases and therefore increases the oxidative activity of blood plasma, the 
concentration of dyne conjugates and malondialdehyde in the blood, decreases the activity of antioxidant 
enzymes of erythrocytes (catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase), 
glutathione peroxidase and glutathione reductase activity in plasma and lowering the concentration of total 
and reduced glutathione in the blood, as well as reduce the antioxidant activity of blood plasma and 
erythrocytes. 
KEY WORDS: infectious mononucleosis, lipid peroxides, antioxidant system, catalase, superoxide 
dismutase, glutathione peroxidase, glutathione reductase, dyne conjugates, malonic dialdehyde, glutathione 
 
СТАН ПЕРЕКИСНОГО ОКИСЛЕННЯ ЛІПІДІВ ТА АНТИОКСИДАНТНОЇ СИСТЕМИ У 
ХВОРИХ НА ІНФЕКЦІЙНИЙ МОНОНУКЛЕОЗ 
Шустваль M. Ф.1, Лядова Т. І.2, Волобуєва О. В.2, Павликова К. В.2, Гаміловська А. П.2 
1 Харківська медична академія післядипломної освіти, вул. Амосова, 58, м. Харків, 61176, Україна 
2 Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
У 158 хворих на інфекційний мононуклеоз вивчені в динаміці показники активності перекисного 
окислення ліпідів і антиоксидантної системи в залежності від тяжкості клінічного перебігу 
захворювання. 
Доведено, що у хворих на інфекційний мононуклеоз протягом наростання тяжкості захворювання 
достовірно активується перекисне окислення ліпідів, в зв'язку з чим підвищуються окислювальна 
активність плазми крові, концентрація в крові дієнових кон'югатів і малонового діальдегіду, 
відбувається ослаблення активності антиоксидантної системи, що асоційоване зі зниженням 
активності антиокислювальних ферментів еритроцитів (каталази, супероксиддисмутази, 
глутатіонпероксидази, глутатіонредуктази), активності глутатіонпероксидази і глутатіонредуктази в 
плазмі крові і зниженням концентрації загального та відновленого глутатіону в крові, а також 
зниженням антиоксидантної активності плазми крові та еритроцитів. 
КЛЮЧОВІ СЛОВА: інфекційний мононуклеоз, перекиси ліпідів, антиоксидантна система, 
каталаза, супероксиддисмутаза, глутатіонтероксидаза, глутатіонредуктаза, дієнові кон'югати, 
малоновий діальдегід, глутатіон 
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СОСТОЯНИЕ ПЕРЕКИСНОГО ОКИСЛЕНИЯ ЛИПИДОВ И АНТИОКСИДАНТНОЙ 
СИСТЕМЫ У БОЛЬНЫХ ИНФЕКЦИОННЫМ МОНОНУКЛЕОЗОМ 
Шустваль Н. Ф.1, Лядова Т. И.2, Волобуева О. В.2, Павликова К. В.2, Гамиловская А. П.2, 
Севастьянова Т. В. 
1 Харьковская медицинская академия последипломного образования, ул. Амосова, 58, г. Харьков, 
61176, Украина 
2 Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
У 158 больных инфекционным мононуклеозом изучены в динамике показатели активности перекисного 
окисления липидов и антиоксидантной системы в зависимости от тяжести клинического течения заболевания. 
Доказано, что у больных инфекционным мононуклеозом по мере нарастания тяжести заболевания достоверно 
активируется перекисное окисление липидов, в связи с чем повышаются окислительная активность плазмы крови, 
концентрация в крови диеновых коньюгатов и малонового диальдегида, происходит ослабление активности 
антиоксидантной системы, что ассоциировано со снижением активности антиокислительных ферментов 
эритроцитов (каталазы, супероксиддисмутазы, глутатионпероксидазы, глутатионредуктазы), активности 
глутатионпероксидазы и глутатионредуктазы в плазме крови и понижением концентрации общего и 
восстановленного глутатиона в крови, а также снижением антиокислительной активности плазмы крови и 
эритроцитов. 
КЛЮЧЕВЫЕ СЛОВА: инфекционный мононуклеоз, перекиси липидов, антиоксидантная система, каталаза, 
супероксиддисмутаза, глутатионтероксидаза, глутатионредуктаза, диеновые коньюгаты, малоновый диальдегид, 
глутатион 
 
INTRODUCTION 
Infectious mononucleosis (IM) is a 
widespread disease of childhood, which has 
been increasingly diagnosed among adults 
recently. The etiological factor of myocardial 
infarction is Epstein-Barr virus (EBV) in most 
cases, which is characterized by a discrete 
symptom complex followed by damage of the 
immune system, namely, the lifetime 
persistence of the virus in B lymphocytes. EBV 
is a lymphotropic agent that causes the 
development of lymphoproliferative syndromes 
and immune deficiency [1–3]. 
Other clinical manifestations are possible in 
addition to the triad of symptoms – 
lymphadenopathy, tonsillitis, hepatospleno-
megaly in case of IM, that are associated with 
heart damage (myocardium, pericardium, 
coronary arteries), central and peripheral 
nervous system (meningitis, meningoence-
phalitis), kidney (nephritis), pancreatitis 
orchites and others [4–6]. 
Previous studies have shown that activation 
of lipid peroxidation, which is accompanied by 
the formation of primary and secondary lipid 
hydroperoxides with toxic properties, plays an 
important role in the pathogenesis of cell 
destruction of various organs [7–9]. However, 
the processes of free-radical lipid oxidation and 
antioxidant protection have been poorly 
understood in patients with IM, and the data 
obtained are contradictory. 
OBJECTIVE 
The aim of the work was to study the state 
of lipid peroxidation and antioxidant system of 
the disease in patients with various forms of 
severity of IM in the dynamics. 
MATERIALS AND METHODS 
158 patients with IM (80 women and 78 
men) aged from 18 to 32 years were examined. 
IM was mild in 58 patients, in moderately 
severe form in 56 patients and 44 patients had 
severe form. The work was performed at the 
Department of General and Clinical 
Immunology and Allergology, Medical Faculty, 
V. N. Karazin Kharkiv National University on 
the basis of the Regional Clinical Infectious 
Diseases Hospital in Kharkiv within the 
framework of the research theme of the 
department «Study of the role of immune, 
autoimmune and metabolic disorders in the 
pathogenesis and consequences of the 
infectious process caused by herpes viruses», 
state registration № 0112U005911. The study is 
open, controlled, conducted in accordance with 
the Declaration of Helsinki and the principles of 
GCP and approved by LEC [10]. 
All patients underwent a complete clinical, 
haematological, biochemical and immune-
logical examination. 
The diagnosis of IM was established on the 
basis of the clinical picture of the disease, 
taking into account epidemiological analysis 
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data and confirmed by detecting EBV DNA in 
serum and saliva of patients with EBV, also 
studied the serological markers of EBV that are 
immunoglobulin’s (IgM, IgG) to capsid (VCA), 
to the nuclear (NA) and early (EA) antigens by 
means of enzyme linked immunosorbent assay 
(ELISA) using the IBL (Germany) and Vector-
Best (RF) kits, detection of EBV DNA by blood 
polymerase chain reaction (PCR). 
A comprehensive study of patients included 
the study of peripheral blood with the detection 
of atypical mononuclear cells, the activity of 
alanine, aspartic transaminases, the content of 
bilirubin fractions in the blood. The state of 
lipid peroxidation (LPO) in patients with IM 
was appreciated according to the content of 
dyne conjugates (DC), malondialdehyde 
(MDA), the serum total oxidative activity 
(TOA). The state of the antioxidant system was 
assessed according to the determination of the 
serum and erythrocytes total antioxidant 
activity (TAA), the activity of catalase, 
superoxide dismutase, glutathione peroxidase, 
glutathione reductase of erythrocytes, total 
glutathione, oxidized and reduced serum 
glutathione. Examination of patients was 
carried out in the first days upon admission to 
the clinic, then on the 5th, 10th, 20th and 30th 
days of treatment. The control group consisted 
of 30 healthy people aged from 18 to 30 years, 
in whom the indicators of oxidative and 
antioxidant activity of blood plasma and 
erythrocytes were determined. 
All patients received standard therapy that 
included anti-viral medications; valaciclovir 
1000 mg 3 times daily, detoxification therapy 
(reosorbilact, 5 % glucose solution), hepatopro-
tectors, antipyretic drugs, antihistamines. 
Statistical processing of the research results 
was carried out using the Statistika 6.0 for 
Windows (Stat Soft Inc., USA) on a personal 
computer with a Pentium II Celeron 850 PPGA 
processor. These results are presented in an 
article with assessing the reliability of 
differences by the Student's criterion at 
p < 0.05. The non-parametric Spearman method 
of correlation analysis was used to balance the 
relationship between various biochemical 
parameters. 
RESULTS 
The clinical picture of IM was typical in 
most patients. Patients complained of general 
weakness, headache, myalgia, arthralgia, sore 
throat when swallowing, sweating, and fever up 
to 38–39.6 ° C, which persisted for 15 to 30 
days and often longer during the early days of 
the disease. Typical changes specific for IM 
were detected in the clinical analysis of blood, 
leukopenia was detected more often at the 
beginning of the disease, which was later 
replaced by leucocytosis (9–10 × 109/l), the 
content of mononuclear lymphocytes and 
monocytes significantly increased, reaching 50–
80 % of the total number of leukocytes. The 
detection of atypical mononuclear was a 
characteristic sign of IM in the blood (20 % or 
more). The duration of preservation of wide 
plasma lymphocytes averaged around 2–3 
weeks, sometimes up to 2 months, the ESR 
remained within the normal range or slightly 
increased in this category of patients. 
An ultrasound examination revealed an 
enlarged liver, spleen, peribronchial and 
peritracheal lymph nodes. 
Anterior and posterior cervical, 
submandibular and axillary lymph nodes were 
enlarged in all patients with IM. 
Cytolytic syndrome was diagnosed in 43 
(76.3 %) patients with moderate-severe course 
of IM and in 30 (88.7 %) patients with severe 
course, which proceeded with an increase of 
direct bilirubin in blood. The level of direct 
bilirubin increased at an average of 15.0 ± 
0.9 µmol/l (p < 0.01), the ALT activity – 1.85 ± 
0.09 mmol/l, ACT – 1.12 ± 0.07 mmol/l 
(p < 0.01) in patients with a moderate-severe 
course of IM. In patients with severe course of 
IM, the level of direct bilirubin in the blood 
increased on average to 23.9 ± 1.1 μmol/l 
(p < 0.01), ALT activity – to 2.24 ± 0, 1 mmol/l 
(p < 0.01), ACT activity – to 1.35 ± 
0.08 mmol/l (p < 0.01), which indicated liver 
involvement in the pathological process. 
The content of direct bilirubin, the activity 
of ALT and ACT in blood in patients with IM 
with a mild course did not significantly differ 
from those in the control group. 
Direct bilirubin content, ALT and ACT 
activity in blood normalized closer to the 20th 
day in the course of treatment in patients with 
moderate-severe IM, whereas in case of severe 
course – to the 30th day, and often later. 
The results of the study of indicators of the 
oxidative and antioxidant systems in patients 
with IM are presented in table, from which it 
follows that TOA of blood plasma (p < 0.01), 
concentration in blood primary (DC) and 
secondary (MDA) lipid hydroperoxides 
(p < 0.01) increase significantly in accordance 
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with the severity of the disease in patients with 
IM. A high direct correlation was found  
(r = 0.65; r = 0.69) between the blood levels of 
DC and MDA, on the one hand, and the overall 
oxidative activity of blood plasma, on the other 
hand, which indicates the important role of lipid 
hydroperoxides in increasing the oxidative 
activity of blood plasma in these patients  
with IM. 
The activation of lipid peroxidation in 
patients with IM of a mild course was 
accompanied by a statistically significant 
decrease in the TAA of blood plasma and 
erythrocytes (p < 0.001), a decrease in the 
activity of erythrocyte antioxidant enzymes – 
catalase (p < 0.001), superoxide dismutase 
(p < 0.001), glutathione peroxidase (р < 0,01), 
an increase in activity of plasma glutathione 
reductase (p < 0.001), reduced glutathione 
(p < 0.001), which indicates an increase in the 
activity of the glutathione system, which is 
involved in the inactivation of lipid hydro-
peroxides in the blood and tissues [11–13]. 
As the clinical, immunological and 
haematological parameters improved while 
treating patients with IM with a mild course, the 
indicators of the LPO decreased and the activity 
levels of the antioxidant system increased, and 
by the 20th day of treatment the concentration 
of DC in the blood decreased to 1.4 ± 0, MDA 
on average 03 μmol/l (p < 0.001), MDA on 
average up to 0.40 ± 0.03 μmol/l (p < 0.001) 
and TOA of blood plasma on average to 3.75 ± 
0.4 % (p < 0.001). The plasma antioxidant 
activity was statistically significantly increased 
by an average of 6.6 ± 0.8 % and of erythro-
cytes by an average of 39.6 ± 1.6 % (p < 0.001), 
the activity of catalase increased on average to 
66.4 ± 2,0 mmol/s.mg protein (p < 0.001) in 
erythrocytes, erythrocyte superoxide dismutase, 
on average, up to 62.2 ± 2.1 units/mg (p 
< 0.001), glutathione peroxidase, on average, 
up to 180.5 ± 9.0 µmol/s.mg protein (p 
< 0.001), blood plasma glutathione peroxidase, 
on average, up to 4.9 ± 0.13 mkkat/l (p < 0.05), 
plasma glugate reductase, on average, up to 2.1 
± 0.03 mkkat/l (p < 0.05), erythrocyte gluta-
thione reductase, on average, up to 76.5 ± 
2.5 µmol/s.mg protein (p < 0, 05), the 
concentration of total glutathione in blood did 
not significantly change (p > 0.05), the content 
of oxidized glutathione in blood decreased, on 
average, to 55.6 ± 6.4 mmol/l (p < 0.05), and 
the level of reduced glutathione increased, on 
average, to 974.8 ± 7.3 μmol/l (p > 0.05) and 
did not significantly differ from the 
corresponding indicators of the control group. 
Analysis of the obtained data (tab. 1) 
showed that severity of the disease increases in 
parallel with the increase of the activity of lipid 
peroxidation and the decrease in the activity of 
the antioxidant system in patients with IM, that 
manifests in an increase in the TOA of blood 
plasma (p < 0.001) , the concentration of DC 
(p < 0.001) and MDA (p < 0.001), and in a 
decrease of the TAA of plasma (p < 0.001) and 
erythrocytes (p < 0.001), the actioxidative 
activity of erythrocyte enzymes – catalase 
(p < 0.001), superoxide dismutase (p < 0.001), 
glutathione peroxidase (p <0.001), glutathione 
reductase (p < 0.001); plasma glutathione 
peroxidase and plasma glutathione reductase (p 
< 0.01), the concentration of total and reduced 
glutathione in blood (p < 0.001) and the content 
of oxidized glutathione in blood (p < 0.001), 
which indicates a pronounced imbalance 
between the processes of radical oxidation of 
lipids and antioxidant protection. 
Table 
Indicators of lipid peroxidation and antioxidant systems in patients with IM (M ± m) 
Indicator 
Control 
(n=30) 
Mild IM 
(n=58) 
Moderate-
severe IM 
(n=56) 
Severe IM 
(n=44) 
Total oxidative activity of 
plasma, % 
4,3 ± 0,3 
6,7 ± 0,45; 
р < 0,001 
9,3 ± 0,52; 
р < 0,001 
12,7 ± 0,75; 
р < 0,001 
Dyne conjugates, μmol/l 
1,2 ± 0,02 
2,4 ± 0,03; 
р < 0,001 
3,7 ± 0,06; 
р < 0,001 
5,1 ± 0,07; 
р < 0,001 
Malonic dialdehyde, moll/l 
0,35 ± 0,015 
0,8 ± 0,03; 
р < 0,001 
2,2 ± 0,04; 
р < 0,001 
2,8 ± 0,04; 
р < 0,001 
Total antioxidant activity of 
plasma, % 
8,2 ± 0,4 
6,3 ± 0,08; 
р < 0,001 
5,4 ± 0,65; 
р < 0,001 
3,6 ± 0,05; 
р < 0,001 
Total antioxidant activity of red 
blood cells, % 
41,5 ± 1,2 
34,2 ± 0,9; 
р < 0,001 
22,7 ± 1,0; 
р < 0,001 
11,4 ± 0,8; 
р < 0,001 
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Continuation of the table 
Erythrocyte catalase activity, 
mmoll/sg protein 
67,2 ± 2,6 
50,4 ± 1,7; 
р < 0,001 
42,6 ± 1,2; 
р < 0,001 
30,4 ± 1,1; 
р < 0,001 
Erythrocyte superoxide 
dismutase activity, units/mg Hb 
63,8 ± 2,3 
53,4 ± 1,8; 
р < 0,001 
43,7 ± 1,8; 
р < 0,001 
36,2 ± 1,5; 
р < 0,001 
Total blood glutathione, mmol/l 1076 ± 8,2 
 
990,0 ± 9,4; 
р < 0,05 
735,6 ± 8,6; 
р < 0,001 
564,7 ± 6,4; 
р < 0,001 
Oxidized blood glutathione, 
mmol/l 
50,4 ± 4,7 
86,5 ± 5,2; 
р < 0,001 
215,6 ± 4,6; 
р < 0,001 
254,5 ± 3,9; 
р < 0,001 
Reduced blood glutathione, 
mmol/l 
940,5 ± 8,3 
990,0 ± 8,2; 
р < 0,001 
524,7 ± 6,0; 
р < 0,001 
326,3 ± 3,6; 
р < 0,001 
Erythrocyte glutathione 
peroxidase activity, µmol/sg 
protein 
183,8 ± 5,6 
159,4 ± 6,1; 
р > 0,05 
91,6 ± 5,2; 
р < 0,001 
62,7 ± 4,5; 
р < 0,001 
Plasma glutathione peroxidase 
activity, mkkat/l 
3,9 ± 0,15 
3,1 ± 0,13; 
р < 0,01 
1,85 ± 0,02; 
р < 0,001 
0,9 ± 0,02; 
р < 0,001 
Glutathione reductase plasma 
activity, mkkat/l 
2,0 ± 0,02 
2,9 ± 0,03; 
р < 0,001 
1,6 ± 0,01; 
р < 0,001 
0,9 ± 0,01; 
р < 0,001 
Erythrocyte glutathione 
reductase activity, µmol/sg 
protein 
73,7 ± 2,6 
96,5 ± 2,0; 
р < 0,001 
62,7 ± 1,9; 
р < 0,001 
53,7 ± 1,9; 
р < 0,001 
Note: Reliability of differences p compared with the control group. 
 
 
The activity of lipid peroxidation decreases 
and the activity of the anti-peroxide system 
increases while conducting antiviral therapy in 
patients with moderate-severe and severe 
course of IM, however, the full normalization 
of the activity indicators of these systems was 
not observed by the 30th day of the disease, 
which is consistent with the data of other 
authors [14], and indicates a severe violation of 
antioxidant protection in patients with severe 
and moderate-severe forms of IM, which may 
be associated with adverse outcomes of IM. 
DISCUSSION 
Lipid peroxidation is one of the most 
important biological processes that constantly 
occurs in the human body and is actively 
involved in the processes of adaptation, anti-
infective protection, removal of endo- and 
exotoxins, tumour cells and destroyed tissues, 
regulation of vascular tone, permeability of cell 
membranes and the vascular wall, haemostasis, 
etc. [13, 15–16]. Under normal conditions, LPO 
flows continuously inside all cells at an 
extremely low level, providing regulation of the 
structure and function of cell membranes [15]. 
The most reactive in this regard cells are of the 
monocyte-macrophage system of the blood, 
Kupffer cells of the liver, alveolar 
macrophages, macrophages of connective 
tissue, Langerhans cells, osteoclasts, glial 
astrocytes, which activated when exposed to 
infection, antibodies, aggregated Ig, leptins, C-
reactive protein, complement components [17]. 
EBV in patients with IM leaves an 
enveloped antigen on the cell membrane, modi-
fying it by penetrating B lymphocytes, which 
leads to activation of NK cells and cytotoxic T 
lymphocytes [18–20], and destruction of 
infected cells. As a result of cytolysis, cell 
degradation products enter the bloodstream, 
which are phagocyted by the means of 
neutrophilic granulocytes and macrophages. 
Granulocyte lysosomes contain the enzyme 
NAD, NAD-P-oxidase, which is activated 
during phagocytosis and catalyses the recovery 
process of molecular oxygen with the formation 
of oxygen with an unpaired electron (O-). The 
intracellular superoxide dismutase (SOD) 
enzyme binds this oxygen with hydrogen 
producing hydrogen peroxide (H2O2), which is 
then cleaved by catalase and glutathione 
peroxidase with the formation of hydroxide 
(HO-) and hydroperoxide (HO2-) radicals, which 
inactivate glutathione. At the same time, 
glutathione is converted to the oxidized form, 
and under the influence of the glutathione 
reductase, it turns into reduced glutathione and 
provides binding of lipid hydroxides [21–23]. 
Glutathione peroxidase and glutathione 
transferase are able to restore the hydroperoxy 
groups of oxidized phospholipids directly in the 
cell membranes without prior hydrolysis by 
phospholipase or free fatty acids. 
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Consequently, glutathione and enzymes of 
its metabolism are one of the most important 
universal defence mechanisms and the central 
link of the homeostatic system of the body, they 
play a primary role in the formation of the 
body's resistance to aggressive factors [24–25]. 
Glutathione is formed in the liver and 
contains glutamic acid, cysteine and glycine. 
Glutathione including functional group of SН 
participates in oxidation-reduction reactions, 
being a donor of hydrogen, passing from 
reduced to the oxidized form. 
The antioxidant enzymes (catalase, 
superoxide dismutase, glutathione peroxidase, 
glutathione reductase, glutathione) maintain 
free radical oxidation at a safe level under the 
normal conditions, they restore syngeneic 
oxygen creating less active forms, and also 
suppress the formation of НО-, НО2-, Н2О2 and 
destroy lipid hydroxides formed in excess 
amount [26]. 
The LPO system is well balanced and 
functions on the basis of feedback, since LPO 
products inhibit the activity of antioxidant 
enzymes. However, activation of LPO is 
accompanied by increased activity of 
glutathione reductase and the concentration of 
reduced glutathione in the blood in patients 
with mild IM, which connects the primary and 
secondary hydroxide lipids, thereby 
significantly accelerating the process of the 
activity antioxidant enzymes recovery (catalase, 
superoxide dismutase, glutathione peroxidase), 
blood plasma antioxidant activity and red blood 
cells. 
The activation of the LPO leads to a deep 
suppression of the antiperoxide system activity, 
and its normalization proceeds at a slower rate 
over a long period in patients with IM of severe 
and moderate-severe course. 
We found a decrease in the activity of 
catalase, superoxide dismutase, glutathione 
peroxidase, glutathione reductase in plasma and 
erythrocytes, the concentration of total and 
reduced glutathione in the blood of IM patients 
with severe and moderate-severe course, that 
indicates a deep disruption of the functioning of 
various parts of the antioxidant system and 
contributes to the increased formation of active 
forms of oxygen, hydroxide and hydroperoxide 
radicals, hydrogen peroxide in cells of the 
antioxidant system causing oxidation of 
unsaturated fatty acids of cell membrane and 
the formation of primary and secondary lipid 
hydroperoxides, which have a toxic effect not 
only on EBV, but also on other cellular 
structures. 
Lipid peroxides are highly reactive and can 
suppress the activity of catalase, superoxide 
dismutase, glutathione peroxidase and 
glutathione reductase, cause the degradation of 
SH-containing compounds, depolymerisation of 
DNA, induce vasospasm, increase the 
permeability of cell membranes, endothelium 
damage, enhance platelet aggregation [27]. 
Oxidized glutathione accumulates in the 
tissues of patients with severe and moderate-
severe IM as a result of a decrease in the 
activity of glutathione reductase, and also has 
toxic properties. Oxidized glutathione 
inactivates membrane ATPase, hexokinase, 
glucose-6-dehydrogenase, inhibits phos-
phorylation and nuclear synthesis of RNA, 
inhibits protein synthesis due to the formation 
of protein-thiol-glutathione crosslinks [28]. 
If the systems of generation and inactivation 
of free radicals are not balanced, the ordered 
structure of the monooxygenase complex can be 
destroyed, and its components can attack the 
polyunsaturated fatty acids of the surrounding 
membranes in the absence of a normal 
substrate. 
In this case, the formation of toxic lipid 
peroxides is possible, and subsequently – 
secondary products of LPO, which disrupt the 
functional state of the liver that plays an 
important role in the processes of detoxification 
in various pathological conditions. Glutathione, 
glutathione peroxidase, glutathione reductase 
and cytochrome P-450 are formed in 
hepatocytes and involved in inactivating of 
primary and secondary lipid hydroperoxides. 
As a result of the toxic effect of active forms of 
oxygen and lipid hydroperoxides in the liver, 
blood circulation is disturbed and hypoxia of 
hepatocytes develops, lipid peroxidation is 
activated in cell membranes and the activity of 
antioxidant enzymes and cytochrome P-450 is 
reduced. These processes result in hepatocytes 
destruction, which is accompanied by an 
increase in direct bilirubin, the activity of ACT 
and ALT in blood. A high direct correlation 
was found between the indicators of plasma 
TOA, direct bilirubin concentration, ALT and 
ACT activity in the blood (r = 0.62; r = 0.64; 
r = 0.62), which indicates the important role of 
the LPO products in the development of 
cytolytic syndrome in patients with severe and 
moderate-severe course of IM. 
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Our study showed that, the process of lipid 
peroxidation increases and the activity of the 
antioxidant system decreases in parallel with 
the severity of the disease in patients during the 
acute period of the IM. Deficiency of 
antioxidant enzymes (catalase, superoxide 
dismutase, glutathione peroxidase, glutathione 
reductase), reduction of their activity and 
concentration of total glutathione in the blood 
of patients with IM lead to the breakdown of 
protective mechanisms and, as a result, to 
increased LPO-free radical chain process, 
which uncontrolled growth causes irreversible 
damage to the membranes of various cells 
underlying visceropathy in patients with IM. 
Consequently, the level of adaptive capacity 
of antioxidant enzymes decreases in patients 
with IM. It may be a result of primary or 
secondary enzymopathies due to the toxic effect 
of reactive forms of oxygen and lipid 
hydroperoxides on enzymes. Our findings 
confirm the expediency of using antioxidants in 
the treatment of patients with IM. 
CONCLUSIONS 
1. Lipid peroxidation significantly increase 
and the activity of the antioxidant system 
decrease in patients with infectious 
mononucleosis in the acute period of the 
disease, as evidenced by the increased 
concentration of dyne conjugates, malonic 
dialdehyde and total oxidative plasma activity 
in the blood, reduced activity of the total 
antioxidant activity of plasma and erythrocytes, 
the decrease in the activity of antioxidant 
enzymes of erythrocytes catalase, superoxide 
dismutase, glutathione peroxidase, glutathione 
peroxidase and glutathione reductase of blood 
plasma, the decrease in the concentration of 
glutathione in the blood. 
2. The most pronounced disorders of lipid 
peroxidation and antioxidant system activity 
were found in patients with moderate-severe 
and severe infectious mononucleosis. 
3. The development of cytolytic syndrome in 
infectious mononucleosis is associated with the 
action of reactive oxygen forms species and 
lipid hydroperoxide. 
PROSPECTS FOR FUTURE 
RESEARCHES 
It seems to be appropriate to study further 
clinical course of IM after using various 
antioxidants in addition to existing therapy to 
test the ability to suppress viral replication and 
to define the most effective compound. 
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Infections caused by EBV are the most common and occupy an important place in the structure of herpes 
aetiology diseases. 
The purpose of this work was to study the characteristics of the cytokine status in patients with chronic 
EBV infection, depending on the level of viral replication. 
We examined 78 patients with chronic EBV infection, the main clinical manifestations of which were 
various immunopathological and immunodeficiency states: Group I – with low, Group II – with medium, 
Group III - with a high degree of viral replication. The Tiff method was used using the Vector-Best reagent 
kits (Novosibirsk, Russia) to study the cytokine profile in the serum of patients with EBV infection. The 
determination of alpha and gamma fractions of serum interferon was carried out using the ELISA method by 
means of the ProCon IF2 plus reagent kit manufactured by Protein Contour LLC (St. Petersburg, Russia). 
As a result of a study of the cytokine status in patients with chronic EBV infection, it was found that in all 
three groups there was a significant increase in both pro-inflammatory (IL-1β, IL-6, TNF-α) and anti-
inflammatory cytokines (IL-10, IL 4, TGFβ1). However, anti-inflammatory cytokinemia was more 
compensated in group I patients compared with patients in groups II and III. A decrease in IFN-α and IFN-γ 
was detected in all patients with chronic EBV infection while studying the interferon status. A correlation was 
found between the level of viral replication and a decrease in the level of IFN-α and IFN-γ. 
The identified features of the cytokine status in patients with chronic EBV infection can be used to 
optimize therapy and help develop a differentiated approach to the immunocorrection of these patients, 
depending on the level of viral replication. 
KEY WORDS: interferon, interleukins, cytokines, chronic EBV infection, viral replication level 
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Інфекції викликані ВЕБ є найбільш поширеними і займають важливе місце в структурі 
захворювань герпесвірусной етіології. 
Метою даної роботи було вивчити особливості цитокінового статусу у хворих на хронічну ВЕБ-
інфекцію, в залежності від рівня вірусної реплікації. 
Нами було обстежено 78 пацієнтів з хронічною ВЕБ-інфекцією, основними клінічними проявами в 
яких були різні іммунопатологичні і імунодефіцитні стани: I група – з низьким ступенем вірусної 
реплікації, II група – із середнім ступенем вірусної реплікації, III група – з високим ступенем вірусної 
реплікації. Для дослідження цитокінового профілю в сироватці крові хворих на ВЕБ-інфекцію 
використовували метод тІФА з використанням наборів реагентів ЗАТ «Вектор-Бест» (Новосибірськ, 
Росія). Визначення фракцій сироваткового інтерферону альфа та гамма здійснювали за допомогою 
твердофазного імуноферментного методу з використанням набору реагентів ProCon IF2 plus 
виробництва ТОВ «Протеїновий контур» (Санкт-Петербург, Росія). 
 Sorokina O. G., Kolesnyk I. V.,  
Malanchuk S. G., Kozlov O. P.,  
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За результатами дослідження цитокінового статусу у хворих на хронічну ВЕБ-інфекцію було 
виявлено, що в усіх трьох групах відзначалося суттєве підвищення як прозапальних (ІЛ-1β, ІЛ-6, 
ФНП-α), так і протизапальних цитокінів (ІЛ-10, ІЛ-4, ТФРβ1). Однак, протизапальна цитокінемія була 
у пацієнтів I групи більш компенсованою у порівнянні з пацієнтами II та III груп. При досліджені 
інтерферонового статусу було виявлено зниження ІФН-α та ІФН-γ в усіх хворих на хронічну ВЕБ-
інфекцію. Було виявлено кореляційний зв’язок між рівнем реплікації вірусу та зниженням рівнем ІФН-
α та ІФН-γ. Виявлені особливості цитокінового статусу у хворих хронічною ВЕБ-інфекцією, в 
залежності від рівня вірусної реплікації, можуть бути використані для оптимізації терапії та 
допоможуть розробити диференційований підхід до імунокорекції таких пацієнтів. 
КЛЮЧОВІ СЛОВА: інтерферон, інтерлейкіни, цитокіни, хронічна ВЕБ-інфекція, рівень реплікація 
вірусу 
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Инфекции, вызванные ВЭБ, являются наиболее распространенными и занимают важное место в 
структуре заболеваний герпесвирусной этиологии. 
Целью данной работы было изучить особенности цитокинового статуса у больных хронической 
ВЭБ-инфекцией, в зависимости от уровня вирусной репликации. 
Нами было обследовано 78 пациентов с хронической ВЭБ-инфекцией, основными клиническими 
проявлениями у которых были разные иммунопатологические и иммунодефицитные состояния: I 
группа – с низкой, II группа – со средней, III группа – с высокой степенью вирусной репликации. Для 
исследования цитокинового профиля в сыворотке крови больных ВЭБ-инфекцией использовали метод 
Тифа с использованием наборов реагентов ЗАО «Вектор-Бест» (Новосибирск, Россия). Определение 
фракций сывороточного интерферона альфа и гамма осуществляли с помощью твердофазного 
иммуноферментного метода с использованием набора реагентов ProCon IF2 plus производства ООО 
«Протеиновый контур» (Санкт-Петербург, Россия). 
В результате исследования цитокинового статуса у больных хронической ВЭБ-инфекцией было 
выявлено, что во всех трех группах отмечалось существенное повышение как провоспалительных 
(ИЛ-1β, ИЛ-6, ФНО-α), так и противовоспалительных цитокинов (ИЛ-10, ИЛ 4, ТФРβ1). Однако 
противовоспалительная цитокинемия была у пациентов I группы более компенсированной по 
сравнению с пациентами II и III групп. При исследовании интерферонового статуса было выявлено 
снижение ИФН-α и ИФН-γ у всех больных хронической ВЭБ-инфекцией. Была обнаружена 
корреляционная связь между уровнем репликации вируса и снижением уровнем ИФН-α и ИФН-γ. 
Выявленные особенности цитокинового статуса у больных хронической ВЭБ-инфекцией, в 
зависимости от уровня вирусной репликации, могут быть использованы для оптимизации терапии и 
помогут разработать дифференцированный подход к иммунокоррекции таких пациентов. 
КЛЮЧЕВЫЕ СЛОВА: интерферон, интерлейкины, цитокины, хроническая ВЭБ-инфекция, 
уровень репликация вируса 
 
INTRODUCTION 
Every year, the impact of adverse 
environmental factors increases on the body 
and, particularly on the immune system. In 
the modern world, infectious diseases occupy 
a leading place in human pathology [1]. 
Among the numerous factors that directly 
affect the immune system, special attention is 
paid to herpesvirus infections. Nowadays 
there is a tendency for the diseases caused by 
herpesviruses to spread widely [2–3]. 
The Epstein-Barr virus (EBV) belongs to 
the Herpesviridae family. Infections caused 
by this virus are the most widespread and 
occupy an important place in the structure of 
herpesvirus aetiology diseases. This is due to 
the high degree of infection of the population 
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all over the world, as specific antibodies to 
this virus are found in almost 95 % of the 
adult population [4–5]. Active proliferation of 
the virus in all organs and systems that have 
lymphoid tissue, leads to structural changes, 
which has a negative impact on the whole 
body [6]. EBV has multiple mechanisms of 
immunosuppression and protection from the 
host's immune response that can lead to the 
formation of a chronic viral infection and 
immunological disorders deepening [7]. It is 
also established that EBV violates the 
mechanisms of the immune response, 
suppresses the production of interferons 
(INFs), blocks the mechanisms of apoptosis. 
A secondary immunodeficiency is formed on 
the basis of these disorders, that promotes the 
development of autoimmune and tumour 
processes in genetically predisposed 
individuals. The study of diseases caused by 
EBV is relevant due to the life-span 
persistence of the virus in the human body, 
the potential for oncogenicity, and the ability 
to reactivate autoimmune diseases, to damage 
the heart, kidneys, joints, and others [2, 8–9]. 
Data obtained from many studies suggest 
a violation of the interferon chain of 
immunity while herpesvirus infections. Low 
content of these cytokines does not provide 
sufficient antiviral effect. In this regard, the 
study of indicators of immunity provided by 
interferons becomes particularly relevant in 
patients with chronic EBV infection [10]. 
Non-specific factors of protection, 
including interferons are the first line 
response while infecting the human body and 
they induce the increase of the body's 
resistance. The course and effects of the 
disease depend on the rate of INF system 
involvement in the process of INF antiviral 
protection. The untimely or reduced 
production of its own IFN, as a rule, leads to 
the chronization of the WEB infection. 
Interferon-alpha (IFN-α) is the most active in 
the early phase of the EBV infection, when 
even the EBV antigens do not spred beyond 
the cell, and products of specific antibodies 
are not possible. α-IFN prevents the spread of 
EBV by providing the antiviral function from 
the site of penetration into the body to distant 
organs and systems. 
Interferon gamma (IFN-γ) is an indicator 
of activity of the cellular immunity. It also 
has an antiproliferative effect, which is 
relevant in case of EBV infection, which is an 
antigen of many tumours and neoplasia. 
However it is known that EBV is capable of 
suppressing the IFN-γ synthesis and thus 
suppressing cellular immunity, creating 
conditions for its lifelong persistence [11]. 
OBJECTIVE 
The purpose of this work was to study the 
cytokine status features in patients with 
chronic EBV infection, depending on the 
level of viral replication. 
MATERIALS AND METHODS 
We examined 78 patients with chronic 
EBV infection, the main clinical 
manifestations of which were various 
immunopathological and immunodeficient 
conditions. All patients in the main group 
were divided into 3 groups according to the 
level of viral replication: Group I – with low 
degree of viral replication, composed of 
25 people (11 men and 14 women); Group II 
– with an average degree of viral replication, 
included 27 patients (12 men and 15 women); 
Group III – with a high degree of viral 
replication, consisted of 26 patients (12 men 
and 14 women). The age of patients ranged 
from 19 to 57 years (mean age was 33 years ± 
11.7 years). The control group consisted of 20 
practically healthy people aged from 20 to 
35 years. 
The work was performed at the 
Department of General and Clinical 
Immunology and Allergology of the Medical 
Faculty of the V. N. Karazin Kharkov 
National University and clinical bases of the 
department: Regional Clinical Infectious 
Hospital in Kharkiv and the Clinical Hospital 
«City Polyclinic № 6», as well as on the basis 
of the SI «I. I. Mechnikov Institute of 
Microbiology and Immunology of the 
National Academy of Medical Sciences of 
Ukraine» in the period of 2014–2018 in the 
framework of the research topic: «The study 
of the role of immune, autoimmune and 
metabolic disorders in pathogenesis and the 
consequences of the infection process caused 
by herpesviruses», state registration number 
0112U005911. The analysis of samples and 
their technical implementation was carried 
out in the clinical diagnostic laboratory of the 
Regional Clinical Infectious Hospital, part of 
the analyses were carried out in the 
laboratories «Virolos» and «Analitika». The 
TIFA method was used by means of the 
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reagent kits of CJSC Vector-Best 
(Novosibirsk, Russia) using the 
manufacturer's instructions to investigate the 
cytokine profile in the blood serum of 
patients with EBV infection. Determination 
of alpha and gamma fractions of serum 
interferons was performed using a solid phase 
immunoassay method by means of the set of 
ProCon IF2 plus reagents manufactured by 
the Protein Contour LLC (St. Petersburg, 
Russia). 
The statistical processing of the results of 
the study was conducted using the 
STATISTICA 10.0 statistical software 
package. 
RESULTS AND DISCUSSION 
IFN-α level was reduced in patients with 
chronic WEB infection with different levels 
of virus replication in all studied groups 
compared with the control group (tab. 1). 
Table 1 
The content of IFN in serum in patients with chronic WEB infection 
Indicator I group II group III group Control group р 
IFN-α, pg/ml 30,3 ± 1,7 27,5 ± 1,9 25,6 ± 1,8 32,4 ± 2,3 р < 0,001 
IFN-γ, pg/ml 37,1 ± 1,8 35,3 ± 1,6 25,4 ± 1,7 38,2 ± 1,6 р < 0,001 
 
Thus, IFN-α was 30.3 ± 1.7 g/ml in I 
group patients, in group II – 27.5 ± 1.9 g/ml, 
in group III – 25.6 ± 1.8 g/ml. Thus, there 
was a correlation between the level of viral 
replication and a decrease in the level of IFN-
α in chronic EBV infection. Possibly, EBV 
conversion from a latent state and its 
replication (reactivation of EBV infection) 
occurred under favourable conditions. A 
significant decrease in IFN-α and, as a 
consequence, a significant inhibition of 
antiviral defence, contributed to the 
accumulation of an active infectious agent 
that was actively multiplying. 
According to many studies, in the majority 
of patients with acute EBV infection, a 
significant increase in IFN-γ levels is usually 
observed in comparison with relatively 
healthy people. This indicates cellular 
immunity level and its predominance over the 
humoral link. Probably, therefore, in many 
cases, the acute form of the EBV infection 
ends with a rapid and, as a rule, complete 
recovery [12–13]. 
Among our patients with chronic forms of 
EBV infection, IFN-γ was decreased in all 
studied groups compared with the control 
group. Thus, IFN-γ was 37.1 ± 1.8 pg/ml in 
group I patients, in group II patients – 35.3 ± 
1.6 pg/ml, in group III patients – 25.4 ± 1.7 
pg/ml. So, it is probably the IFN-γ deficiency 
that led to protracted forms of infection with 
possible latent (for several years), or recurrent 
course. Probably the decrease in the content 
of IFN-γ may be considered as one of the 
indicators of prolonged EBV infection. 
It was found an increase in all indicators 
in all three groups (I, II, III) compared to the 
control group during the studying of the 
content of cytokines in blood serum of 
patients with chronic EBV infection, but 
these changes, had their own characteristics 
due to the level of replication of the virus 
(tab. 2). A higher anti-inflammatory 
cytokinemia and a deeper cytokine imbalance 
were recorded in patients of groups II and III 
compared with patients in group I. 
Table 2 
The content of the main serum cytokines in patients with chronic EBV 
Indicator I group II group III group Control group р 
IL-1β, pg/ml 59,1 ± 2,1 56,4 ± 2,4 56,3 ± 2,3 29,5 ± 1,9 р < 0,001 
IL-6, pg/ml 91,2 ± 2,1 100,3 ± 2,7 104,4 ± 3,6 39,2 ± 1,7 р < 0,001 
TNF-α, pg/ml 52,8 ± 2,4 62,4 ± 2,2 65,7 ± 2,8 32,6 ± 1,8 р < 0,001 
IL-2, pg/ml 78,1 ± 2,5 68,4 ± 2,4 68,3 ± 2,6 40,2 ± 2,1 р < 0,001 
IL-10, pg/ml 91,3 ± 1,8 88,3 ± 2,1 88,2 ± 1,9 19,1 ± 1,5 р < 0,001 
IL-4, pg/ml 80,3 ± 2,3 75,6 ± 2,6 75,5 ± 2,2 21,2 ± 1,7 р < 0,001 
TGFβ1, pg/ml 172,4 ± 3,1 166,5 ± 2,9 166,3 ± 2,2 58,3 ± 2,2 р < 0,001 
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Thus, there was a more pronounced 
increase in IL-1β (59.1 ± 2.1 pg/ml) in case of 
the group I than in patients in groups II and 
III (56.4 ± 2.6 pg/ml and 56.3 ± 2.3 pg/ml, 
respectively) in comparison with the control 
group (29.5 ± 1.9 pg/ml). 
It was found during the study that IL-6 
increase was observed in all patients with 
chronic EBV infection in comparison with 
the control group, but this indicator increased 
to a greater extent in patients of groups II and 
III (100.3 ± 2.7 pg/ml and 104.4 ± 3.6 kg/ml, 
respectively). IL-6 was at 91.2 ± 2.1 pg/ml in 
patients of group I, while in the control group 
it was 39.2 ± 1.7 pg/ml. 
The level of TNF-α was elevated in all 
patients with chronic EBV infection 
compared to the control group, but it was 
higher in patients of groups II and III (62.4 ± 
2.2 g/ml and 65.7 ± 2.8 g/ml in accordance). 
In patients of Group I, the FNP-α was 52.8 ± 
2.4 pg/ml and in the control group it was 32.6 
± 1.8 pg/ml. 
It is known that IL-2 is an important factor 
in the activation of immune cells and the 
development of a full-fledged immune 
response [14–16]. IL-2 levels were also 
elevated in all patients with chronic EBV 
infection, but this increase was not as 
significant as an increase in IL-1, IL-6 and 
FNP-α levels. Thus, IL-2 levels were higher 
(78.1 ± 2.5 pg/ml) in group I patients than in 
patients of groups II and III (68.4 ± 2.4 pg/ml 
and 68.3 ± 2.6 pg/ml, respectively). In the 
control group, IL-2 was at 40.2 ± 2.1 pg/ml. 
Concentration of IL-10 in serum was 
elevated in all patients with chronic EBV 
infection compared to control group. 
However, IL-10 levels increased to a greater 
extent (91.3 ± 1.8 pg/ml) in group I patients, 
compared with patients in groups II and III 
(88.3 ± 2.1 pg/ml and 88.2 ± 1.9 pg/ml, 
respectively). In the control group, this 
indicator was 19.1 ± 1.5 pg/ml. 
The level of IL-4 was elevated in all 
patients with chronic EBV infection 
compared to the control group, but it reached 
much higher figures (80.3 ± 2.3 g/ml) in 
group I patients, compared to patients of 
groups II and III (75.6 ± 2,6 pg/ml and 75.5 ± 
2.2 pg/ml, respectively). In the control group, 
this figure was 21.2 ± 1.7 pg/ml. 
The concentration of TGFβ1 was elevated 
in all patients with chronic EBV infection 
compared to the control group, but in patients 
of group I it level increased greater (172.4 ± 
3.1 pg/ml), compared to patients of groups II 
and III ( 166.5 ± 2.9 μg/ml and 166.3 ± 2.2 
μg/ml, respectively). This indicator was 58.3 
± 2.2 pg/ml in the control group. 
Thus, anti-inflammatory cytokinemia was 
more compensated in patients of group I, 
compared with patients of groups II and III, 
as indicated by the ratio of proinflammatory 
and anti-inflammatory cytokines. It is known 
that anti-inflammatory cytokines are involved 
in limiting the inflammatory response, inhibit 
the secretion of proinflammatory cytokines, 
and reduce the damaging effect of 
inflammation on tissues [17–20]. 
CONCLUSIONS 
Thus, our study of cytokine status in 
patients with chronic EBV infection showed 
that a significant increase in all three groups 
in both proinflammatory (IL-1β, IL-6, FNP-
α) and anti-inflammatory cytokines (IL-10, 
IL-4, TFRβ1). However, the following 
features were revealed depending on the level 
of viral replication: elevation of IL-1β, IL-10, 
IL-4, TFRβ1 to a greater extent was observed 
in patients of group I, compared to patients in 
groups II and III, in which IL-6, FNP-α 
prevailed. Thus, anti-inflammatory 
cytokinemia was more compensated in 
patients group I compared to patients of 
groups II and III, as shown by the ratio of 
proinflammatory and anti-inflammatory 
cytokines. IL-2 levels were also elevated in 
all patients with chronic EBV infection, but 
this increase was not as significant as the 
increase in other cytokines levels, which in 
turn affected the process of activation of 
immune-competent cells and prevented the 
formation of a complete immune response. 
IFN-α and IFN-γ levels were decreased in 
all patients with chronic EBV infection when 
interferon status was studied. A correlation 
was found between the level of viral 
replication and a decrease in IFN-α and IFN-γ 
levels. A significant decrease in IFN-α 
contributed to significant inhibition of 
antiviral defence, which in turn effected the 
accumulation of an active infectious agent 
that was actively multiplying. The IFN-γ 
deficiency did not allow forming a sufficient 
immune response and contributed to the 
development of a chronic form of infection. 
Probably the decrease in the content of IFN-γ 
may be considered as one of the indicators of 
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the prolong course of EBV infection and the 
development of chronic forms of EBV 
infection. 
PROSPECTS FOR FUTURE STUDIES 
The revealed features of cytokine status in 
patients with chronic EBV infection can be 
used to optimize therapy depending on the 
level of viral replication and will help to 
develop a differentiated approach to immune 
correction of such patients. 
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MODERN FEATURES OF CHICKEN POX COURSE IN ADULTS 
Olha Volobuieva, Tetiana Liadova, Tetiana Sevastianova, Daniil Volobuiev 
V. N. Karazin Kharkiv National University, 6 Svobody Sq., Kharkiv, 61022, Ukraine,  
e-mail: med@karazin.ua 
 
The article presents the epidemiological and clinical data of the modern course of chickenpox. A high 
incidence among adults with a bright manifestation of the clinical picture was shown. Recurrent episodes of 
chicken pox were marked. 
KEY WORDS: VZV, chicken pox, epidemic process, clinical picture, adults 
 
СУЧАСНІ ОСОБЛИВОСТІ ПЕРЕБІГУ ВІТРЯНОЇ ВІСПИ У ДОРОСЛИХ 
Волобуєва О. В., Лядова Т. І., Севаст’янова Т. В., Волобуєв Д. А. 
Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
У статті представлені епідеміологічні та клінічні дані сучасного перебігу вітряної віспи. Показана 
висока захворюваність серед дорослого населення з яскравою маніфестацією клінічної картини. 
Відзначено повторні епізоди вітряної віспи. 
КЛЮЧОВІ СЛОВА: VZV, вітряна віспа, епідемічний процес, клініка, дорослі 
 
СОВРЕМЕННЫЕ ОСОБЕННОСТИ ТЕЧЕНИЯ ВЕТРЯНОЙ ОСПЫ У ВЗРОСЛЫХ 
Волобуева О. В., Лядова Т. И., Севастьянова Т. В., Волобуев Д. А. 
Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
 
В статье представлены эпидемиологические и клинические данные современного течения ветряной 
оспы. Показана высокая заболеваемость среди взрослого населения с яркой манифестацией 
клинической картины. Отмечены повторные эпизоды ветряной оспы. 
КЛЮЧЕВЫЕ СЛОВА: VZV, ветряная оспа, эпидемический процесс, клиника, взрослые 
 
INTRODUCTION 
Chickenpox is a disease with global 
prevalence. 80–90 million cases of chickenpox 
are registered worldwide every year. The 
incidence of varicella remains stably high with 
small variations over the years and is 
determined by the presence of acquired 
immunity in the population. In the European 
Region, chickenpox is also characterized by a 
high intensity of the epidemic process. The 
incidence rates were: in Spain – 2.5–5.5 %, 
France – 1000–1350 %, Slovenia – 770.0 %, in 
Latvia – 277.9 %, in Estonia – 580.8 %, the 
Netherlands – 253.5 % [1]. In addition, in the 
last decade there has been a tendency to an 
increase in the incidence rate in Ukraine [2]. 
According to experts, in the near future in 
Ukraine there may be a large-scale epidemic of 
chickenpox [3]. 
The current epidemic process of chickenpox 
is characterized by the tendency of «maturity» 
of the infection, especially among the urban 
population. Every year from 5 to 6 % of cases 
are diseases among adults. Sero-
epidemiological studies show regional 
differences in the proportion of susceptible 
adults [4]. Some studies has shown that there 
was a remarkable increase in the incidence rate 
of chickenpox in middle and older age groups 
till 2014 and before chickenpox and shingles 
vaccination [5–7]. Varicella zoster has also 
been associated with elevated risk for 
cerebrovascular disease and contributes to 
vasculopathy that is especially important matter 
in adults [8–9]. Despite the low incidence of 
chickenpox in adults, the risk of severe 
 Volobuieva O. V., Liadova T. I.,  
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complications and even death is 10–20 times 
higher than in children. Most often the disease 
is benign, but in 1 out of 50 cases of the disease 
there are complications, the most severe are 
pneumonia and encephalitis among them. The 
incidence of encephalitis, which is 
predominantly manifested by cerebral ataxia, is 
about 1 in 4000 cases of chicken pox. 
Pneumonia can be both primary viral and 
bacterial in nature [10–11]. 
The significance of chickenpox is also 
determined by the presence of a chronic 
recurrent form of the infection – shingles, the 
frequency of which is about 70 per 100,000 
people who have had chickenpox. The 
Varicella-Zoster virus (VZV) is epitheliotropic 
and neurotropic, but it is also possible to 
generalize the process with damage to the 
internal organs: liver, lungs, and gastrointestinal 
tract [12–14]. The most important risk factors 
associated with the severity of varicella, 
generalization of the process and death are age 
and impaired function of the immune system 
[15–17]. 
OBJECTIVE 
The aim of this study is to assess the 
increase in the chickenpox incidence and the 
current course of the disease among the adult 
population of the Kharkiv region on the basis 
of hospitalization data from 2015 to 2018 
years. 
MATERIALS AND METHODS 
There were 174 patients with diagnosed 
chickenpox under our supervision, who were 
hospitalized in the Regional Clinical Infectious 
Diseases Hospital during the period from 2015 
to 2018. The median age of the examined 
patients was 23 ± 5.8 years. Gender analysis 
showed the prevalence of males – 106 (61 %) 
men versus 68 (39 %) women. This distribution 
among the adult population is explained by 
varicella outbreaks among military personnel 
living in barracks – 42 (24 %) cases. The 
diagnosis was established on the basis of 
clinical, epidemiological data and was 
confirmed by serological and molecular genetic 
techniques. Serological studies were performed 
by the method of enzyme-linked 
immunosorbent assay (ELISA) with the 
detection of specific antibodies, IgM 
(qualitative) and IgG (quantitative), to the 
antigens of the VZV. Molecular genetic studies 
of samples for the detection of presence of VZV 
DNA were carried out by PCR with 
hybridization-fluorescence detection of results 
in real time. 
RESULTS AND DISCUSSION 
162 (93.1 ± 3.8 %) patients among the 174 
observed had contact with chickenpox patients. 
In particular, 15 people had contact with sick 
children (9.2 ± 0.4 %), at the work place – 21 
people (12.9 ± 4.6 %), 138 patients (85.2 ± 
5.9 %) were hospitalized not only according to 
clinical, but also epidemiological indications: 
persons living in hostels and military personnel 
hospitalized from barracks where varicella 
outbreaks were recorded; in 12 cases (6.9 ± 
0.4 %), no direct contact with patients with 
chicken pox was detected. Thus, the majority of 
patients had direct contact with patients with 
chickenpox during the height of the disease, 
that is, during the period of the greatest 
infectiousness of patients. At the same time, an 
important role belongs to close contact 
(accommodation in hostels, barracks). 
Recurrent chickenpox disease was diagnosed in 
12 (6.9 %) patients, the interval between these 
episodes ranged from 5 to 12 years. In this 
group of patients the clinical course of the 
disease did not have any features. There was a 
characteristic winter-spring seasonality of 
chicken pox with a maximum frequency of 
seeking medical help in March, December, 
January (fig. 1). 
Chickenpox in adults is characterized by a 
longer prodromal period, if it is 24-72 hours in 
children, then in adults it can reach 7-10 days, 
thereby making it difficult to timely diagnose 
and increasing the risk of infection of contact 
persons. The prodromal period in our patients 
lasted for 2.5 ± 1.5 days and was characterized 
by an increase in temperature of 38.7 ± 1.3 ºС, 
general weakness, decreased performance, 
lethargy, and drowsiness in all patients. An 
increase in body temperature was observed on 
the first day of the disease – in 108 (62.3 ± 
5.7 %) patients. However, this symptom 
appeared on the second day of the disease in 41 
(23.6 ± 4.7 %) patients, on the 3–4th day of the 
disease in 17 (9.8 ± 2.7 %), and it was short-
term for one day in 8 (4, 6 ± 0.7 %) patients 
(temperature rise to 37.2 ± 0.5 ºС). Clinical 
manifestations of the prodromal period are 
presented in fig. 2. 
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Fig. 1. Dynamics of incidence of chickenpox depending on seasonality 
 
 
 
Fig. 2. Clinical manifestations of the chickenpox prodromal period in adults 
 
 
Hospitalization of 139 (80.1 ± 5.0 %) 
patients was carried out during the rash on the 
2–3rd day of illness. However, hospitalization 
of 6 (12.8 ± 4.0 %) patients was noted and in 
the later stages of the disease – on the 4–5th 
day. The period of rash began predominantly 
with the appearance of several spotty-
papullosis elements, which were localized on 
the face and scalp (48.5 %), in the ear areas 
(22.8 %) or simultaneously on the scalp and 
behind the ear (28.5 %). In the next 1–4 days, 
the rash began to spread to the neck, torso, 
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upper and lower extremities. At the same 
time, the rash was scanty on the lower limbs 
in 131 (75.3 ± 5.2 %) patients. Within a few 
hours, the rash acquired the character of 
vesicles with transparent contents. These 
rashes were characterized by the phenomenon 
of pouring in addition, while in every second 
patient the rash was accompanied by skin 
itch. The rash became polymorphic – spotty-
papular-vesicular on the 3–4th day from the 
beginning of the appearance of the first 
elements, then gradually began to dry out 
with the formation of crusts, which 
completely fell away on the 7th–12th day. The 
rash was abundant in 45 (25.9 ± 5.7 %) 
patients. A distinctive feature of the rash was 
rapid and abundant pustulization, which was 
observed in almost half of the patients (54.3 ± 
5.9 %). Pustalization was accompanied by a 
significant (39–40 °C) rise in temperature, 
and in 14 (20 %) patients pyoderma was so 
pronounced that it required additional 
antibacterial therapy, and in 7 cases the 
disease had severe coarse of the disease 
associated with the severity of pyoderma. It 
should also be noted that the period of rash 
was accompanied by intoxication and asteno-
vegetative syndromes: severe headache, 
malaise and weakness in 100 % of patients. 
The febrile period lasted 6.0 ± 2.0 days in 
uncomplicated cases, with the development 
of complications that continued to 9.0 ± 2.0 
days. Usually, the temperature returned to 
normal with the end of the period of pouring. 
Catarrhal phenomena were observed in all 
patients at the height of the disease. So, the 
mucosa of the oropharynx was vividly 
hyperaemic in 84 (48.3 ± 5.2 %) patients, 
moderate hyperaemia was observed in 58 
(33.3 ± 4.6 %), and weak – in 32 (18.4 ± 
5.9 %) patients, at the same time the 
granularity of the tonsils, palatine arches and 
posterior pharyngeal wall was observed in all 
patients. The exanthema was accompanied by 
exanthema on the oral mucosa, mainly in the 
palatal arches and the soft palate, in 80 (45.6 
± 5.8 %) patients. Exanthema initially had the 
appearance of bright pink papules, and then 
turned into bubbles, which quickly opened to 
form sores, covered with a white and yellow 
patina. Stomatitis developed, causing severe 
pain while eating. Rashes were observed on 
the conjunctiva in 63 patients (36.2 ± 5.6 %), 
which was accompanied by the development 
of scleritis and conjunctivitis during the 3–
5 days period of the rash. The disease was 
accompanied by lymphadenopathy with an 
increase in the cervical (57.1 ± 5.9 %) and 
occipital (42.8 ± 5.9 %) lymph nodes in 161 
(92.5 ± 3.1 %) patients. 
Etiotropic therapy included acyclovir 
(85 % of cases) both in case of primary 
infection and in repeated cases of the disease. 
Antibacterial drugs (third generation of 
cephalosporins, penicillins, macrolides) were 
prescribed in case of the additional bacterial 
complications. 
CONCLUSIONS 
The modern course of varicella in Ukraine 
is characterized by an increase in the 
incidence among the adult population. 
Infection is manifested by a long prodromal 
period, a pronounced intoxication syndrome, 
lymphadenopathy, and an abundant 
polymorphic rash. At the same time, the rash 
had a pustular character in 54.3 % of patients; 
exanthema was observed with scleritis and 
conjunctivitis in 45 % of cases. There are 
repeated cases of chickenpox, the interval 
between these episodes ranged from 5 to 12 
years. 
PERSPECTIVES FOR FUTURE 
STUDIES 
Taking into account the epidemiological 
situation in the country it remains relevant to 
study main features of the course of 
chickenpox in individuals against the 
background of pulmonary tuberculosis, 
depending on the age and duration of the 
underlying disease. 
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PARAMETERS OF THE HEMODYNAMIC AFTER ABLATION 
ATRIAL FIBRILLATION AND/OR FLUTTER DEPENDING ON THE 
FUNCTIONAL CLASS OF CHRONIC HEART FAILURE 
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Evaluated parameters of the hemodynamic before and after ablation atrial fibrillation and/or flutter 
depending on the functional class of chronic heart failure in 74 patients. It was found that patients with the I 
functional class of chronic heart failure have significantly lower left atrium size compared to III functional 
class, which is associated with the better efficiency of the radiofrequency ablation in the remote period. 
Patients with the I and III functional class of chronic heart failure are having increasement of QTc duration in 
acute period of radiofrequency ablation that could be used as an independent predictor of arrhythmia 
recurrence. Patients with the I functional class chronic heart failure who failed drug therapy for atrial 
fibrillation and/or flutter alternative treatment in the form of the radiofrequency ablation should be considered 
as choice therapy. 
KEY WORDS: parameters of the hemodynamic, atrial fibrillation, radiofrequency ablation, functional 
class, heart failure 
 
ПОКАЗНИКИ ГЕМОДИНАМІКИ ПІСЛЯ АБЛЯЦІЇ ФІБРИЛЯЦІЇ ТА/АБО  
ТРІПОТІННЯ ПЕРЕДСЕРДЬ В ЗАЛЕЖНОСТІ ВІД ФУНКЦІОНАЛЬНОГО КЛАСУ 
ХРОНІЧНОЇ СЕРЦЕВОЇ НЕДОСТАТНОСТІ 
Золотарьова Т. В.1, Більченко О. В.1, 2 
1 Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
1, 2 Харківська медична академія післядипломної освіти, вул. Амосова, 58, м. Харків, 61176, Україна 
 
Вивчені показники гемодинаміки до та після абляції при фібриляції та/або тріпотінні передсердь в 
залежності від функціонального класу хронічної серцевої недостатності у 74 хворих. Виявлено, що 
пацієнти I функціонального класу хронічної серцевої недостатності мають значно нижчий розмір 
лівого передсердя у порівнянні з III функціональним класом, що пов'язано з кращою ефективністю 
радіочастотної абляції у віддалений період. У пацієнтів I та III функціонального класу хронічної 
серцевої недостатності спостерігається збільшення тривалості QTc в гострому періоді радіочастотної 
абляції, що може використовуватися як незалежний предиктор рецидиву аритмії. 
КЛЮЧОВІ СЛОВА: показники гемодинаміки, фібриляція передсердь, радіочастотна абляція, 
функціональний клас, серцева недостатність 
 
ПОКАЗАТЕЛИ ГЕМОДИНАМИКИ ПОСЛЕ АБЛЯЦИИ ФИБРИЛЛЯЦИИ И/ИЛИ 
ТРЕПЕТАНИЯ ПРЕДСЕРДИЙ В ЗАВИСИМОСТИ ОТ ФУНКЦИОНАЛЬНОГО КЛАССА 
ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ 
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Изучены показатели гемодинамики до и после абляции при фибрилляции и/или трепетании 
предсердий в зависимости от функционального класса хронической сердечной недостаточности у 74 
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пациентов. Выявлено, что пациенты I функционального класса хронической сердечной 
недостаточности имеют значительно меньший размер левого предсердия по сравнению с III 
функциональным классом, что связано с лучшей эффективностью радиочастотной абляции в 
отдаленный период. У пациентов I и III функционального класса хронической сердечной 
недостаточности наблюдается увеличение продолжительности QTc в остром периоде радиочастотной 
абляции, которая может использоваться как независимый предиктор рецидива аритмии. 
КЛЮЧЕВЫЕ СЛОВА: показатели гемодинамики, фибрилляция предсердий, радиочастотная 
абляция, функциональный класс, сердечная недостаточность 
 
INTRODUCTION 
Dilatation of right and left atrium is a 
common complication in atrial 
fibrillation/flutter (AF/AFL), especially in the 
long-term existence of these arrhythmias, due to 
a violation of the function of the left ventricle, 
leading to the development of chronic heart 
failure (CHF) and its progression according to 
growth of the functional class (FC). This 
suggests that AF/AFL can lead to significant 
morphological and functional changes in the 
heart [1–3]. Radiofrequency ablation (RFA) of 
arrhythmias in the right or left atrium is 
effective for the strategy of rhythm control, 
disappears or significantly reduces the number 
of arrhythmia paroxysms, which positively 
affects hemodynamic parameters of the heart, 
especially the size of the atrium, that is, it 
affects the risk of progression of CHF [3–6]. 
It seems expedient to study hemodynamic 
parameters in patients with AF/AFL and CHF 
in the early postoperative period of RFA 
depending on FC CHF to determine which of 
them can affect the progression of CHF. 
OBJECTIVE 
To evaluate parameters of the hemodynamic 
after ablation atrial fibrillation and/or flutter 
depending on the functional class of chronic 
heart failure. 
MATERIALS AND METHODS 
On the basis SI «Zaycev V. T. Institute of 
General and Urgent Surgery NAMS of 
Ukraine», Kharkiv, Ukraine 74 patients were 
evaluated after RFA of AF/AFL at age 
60.6 ± 7.05 ((М ± sd)) (44 men and 30 women). 
Patients were divided into groups based on FC 
CHF (according to the New York Heart 
Association (NYHA)): 23 patients with CHF I 
FC, 32 – II FC, 19 – III FC. Patients IV FC 
CHF were absent. 
Evaluated: heart rate (HR), pulse, systolic 
and diastolic blood pressure (SBP and DBP, 
respectively); electrocardiographic (ECG) 
characteristics – QRS, QTc; echocardiographic 
(ECHO) parameters: ejection fraction of left 
ventricle (LVEF), left ventricle end-diastolic 
diameter (LVED), left ventricle end-systolic 
diameter (LVES), left and right atrium size (LA 
and RA, respectively). For measuring the 
duration of the QT interval and subsequent 
calculation of QTc, the ECG was recorded on 
the computerized cardiologist Cardiolab + 
(HAI-Medica). The length of the corrected QT 
(QTc) was calculated using the Bazett formula: 
QTc = QT/(RR^0.5), the accuracy of the 
measurement is 0.5 ms. SBP and DBP were 
measured by the Korotkov method with the 
tonometer GAMMA 700k, accuracy of 
measurement – 1 mm Hg. ECHO study was 
performed on the apparatus Toshiba Applio 
400. To calculate LVEF the Teichholz formula 
was used: LVEF = 
((7 / (2.4+LVED)) •LVED^3-(7/(2.4+ LVES)) • 
LVES ^3)/((7/(2.4+LVED))•LVED^3))•100%. 
Parameters were evaluated in FC CHF 
groups until and within 3–5 days after RFA. 
The obtained data after the formation of the 
database was processed in Microsoft Excel, 
SPSS 17.0. For statistical evaluation of the 
results parametric criteria were used (mean 
value – M, standard deviation – sd), 
nonparametric criteria (absolute (n, number)). 
Reliability of the differences between groups 
was evaluated using the nonparametric Mann-
Whitney U Test. The results were considered 
reliable at the significance levels p ˂ 0.05. The 
Spirman correlation analysis (nonparametric), 
which shows the degree (rs) of the statistical 
dependence between the observation pairs, 
where 0 > rs ≤ 0.5 is a weak link, 0.5 > rs ≤ 0.6 
– moderate, 0.6 > rs ≤ 1 – strong. The reliability 
of the obtained correlation coefficients was 
determined from the table «Standard correlation 
coefficients» based on the calculation of the 
number of degrees of freedom, followed by the 
definition of the critical value of the Spirman 
rank correlation coefficient, p ˂ 0.01. 
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RESULTS AND DISCUSSION 
Table shows hemodynamic parameters in 
patients with AF/AFL in the acute period after 
ablation, depending on the functional class of 
CHF. 
Table 
Parameters of the hemodynamic after ablation of AF/AFL depending on the FC CHF 
Parameter I FC CHF II FC CHF III FC CHF 
before 
RFA 
After RFA before 
RFA 
After RFA before RFA After RFA 
HR (M ± sd, 1/min) 90.4 ± 
20.1* 
68.34 ± 
10.66 
74.2 ± 12.6 
72.06 ± 
21.3 
84 ± 12.1* 69.3 ± 11.67 
Pulse (M ± sd, 
1/min) 
85.6 ± 
20.3* 
68.01 ± 
10.66 
73.2 ± 12.8 
72.08 ± 
21.6 
82 ± 14.2* 
69.01 ± 
11.69 
Atrerial 
blood 
pressure 
SBP (M 
± sd, 
mmHg) 
130 ± 12.6 
128 ± 
10.18 
125 ± 12.8 
124.7 ± 
12.08 
135 ± 10.6 
127.89 ± 
13.87 
DBP (M 
± sd, 
mmHg) 
82 ± 6.2 82 ± 5.98 80 ± 7.14 80 ± 6.35 81 ± 6.35 82.36 ± 8.39 
LVEF (M ± sd, %) 60.8 ± 
10.16 ** 
65.1 ± 
10.15 ** 
60.1 ± 7.02 
59.65 ± 
7.02 
55.23 ± 
5.04** 
55.73 ± 
5.04** 
LVED (M ± sd, cm) 5.02 ± 0.51 5 ± 0.51 5.21 ± 0.55 5.20 ± 0.55 5.3 ± 0.82 5.3 ± 0.82 
LVES (M ± sd, cm) 3.4 ± 0.51 3.2 ± 0.51 3.5 ± 0.58 3.5 ± 0.53 3.7 ± 0.56 3.7 ± 0.56 
LA (M ± sd, cm) 4.2 ± 0.81 
† 
4.1 ± 0.81 
† 
4.4 ± 0.47 4.4 ± 0.47 5 ± 0.57† 4.9 ± 0.57† 
RA (M ± sd, cm) 
4.1 ± 0.75 4.1 ± 0.75 
3.86 ± 
0.55† 
3.77 ± 
0.55† 
4.5 ± 0.75† 4.5 ± 0.75† 
QRS (M ± sd, 
msec) 
91.75 ± 
11.03 
93.04 ± 
16.61 
90.7 ± 
13.54 
92 ± 15.12 97 ± 25.32 96.3 ± 15.31 
QTc (M ± sd, msec) 380 ± 
36.32* 
424 ± 
33.37* 
406 ± 
32.04 
407 ± 
39.74 
398 ± 55.16* 432 ± 32.37* 
М – average value; n – number; sd - standard deviation; * р < 0,05 before and after ablation inside of the 
groups of FC CHF; ** р < 0,01 between groups of FC CHF; † р < 0,05 between groups FC CHF. 
 
Parameters as level of SBP and DBP, 
LVED, LVES, QRS have not significant 
difference, so FC CHF was not related to these 
indicators. 
In I FC and III FC CHF, HR and pulse were 
significantly higher before ablation. 
I FC CHF was associated with significantly 
higher LVEF both before and after RFA in 
comparison with III FC CHF. 
LA and RA size were significantly lower in 
I FC CHF both before and after RFA compared 
to the III FC. 
I FC and III FC CHF were associated with 
significantly incensement in QTc duration after 
RFA, in II FC CHF no such trend has been 
identified. 
Below are correlations (Fig. 1–3a) between 
different pairs of observations, depending on 
FC CHF before and after ablation. 
Accordingly, levels of communication 
strength are indicated by three types of lines: 
weak link – dotted line ; 
moderate link – simple line ; 
strong link – thick solid line 
 
On the correlograms I FC CHF (both before 
and after ablation) were determined the 
appearance of strong connections between the 
SBP and DBP (rs = 1,0; р < 0,01); у II FC CHF 
– between LVES and LVEF, LVED (rs = 0,7; р 
< 0,01), was maintained between SBP and DBP 
(rs = 0,62; р < 0,01). Also for III FC CHF the 
maximum numbers of strong links has been 
clearly defined, especially new between LVEF 
and QRS (rs = 0,64; р < 0,01), LVES and 
LVED, RA (rs = 0,66; р < 0,01), LA and LVED 
(rs = 0,65; р < 0,01). There were no differences 
between periods of observation. 
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Fig.1. Correlogram for I FC 
CHF before RFA 
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The size of the RA was a characteristic 
feature of the III FC CHF, which was noted in 
the study Luong С. and Xiao H. [7–8], as an 
important indicator for the development of 
recurrence of AF. Further researches are needed 
to clarify the impact of these indicators on the 
efficacy of RFA at various stages after 
intervention and the risk of CHF progression to 
a higher FC. 
We showed that a smaller LA size was 
observed in I FC CHF, that was reflected in the 
study Park J.K. et al. [9–11], where it was 
shown that a smaller LA size was associated 
with a better outcome of RFA in the late period, 
probably due to fewer structural and 
hemodynamic changes in the heart. 
Also, the dilatation of both atriums in the 
study Xiao H. B. et al. [8, 12–13] was 
associated with a poor prognosis in patients 
with AF, which was confirmed in our study: the 
increase in atrial size was associated with an 
increase of FC CHF. 
QTc interval could used as an independent 
predictor of arrhythmia recurrence [14–15]. 
Research of Ning Ma et al. showed that 
recurrent AF patients had a longer QTc 
interval than non-recurrent patients. Also, 
abnormal QT interval predicts AF because it 
reflects alterations in atrial refractoriness [16]. 
As a result of the correlation analysis, it was 
determined that there was a change in the 
number of correlations and an increase in the 
correlation between the indicators from I to III 
FC CHF, which showed a causal relationship, 
that is, one change led to a mandatory change of 
another indicator. According to our 
correlograms, it can be proposed that the 
dilatation of LA and RA with the background 
of inadequate treatment of arrhythmia led to the 
progression of CHF from a clinically 
insignificant course, such as patients I FC, to III 
FC CHF due to the dilatation of LV – an 
increase in LVED. Similarly, in patients with I 
FC CHF with poorly drug controlled 
arrhythmia alternative treatment as RFA should 
be considered as the choice of therapy as early 
as possible. 
There are several limitations to our study. 
The observation was done in the acute period 
RFA, so it is not yet possible to reliably talk 
about the degree of RFA efficiency, however, 
parameters such as a size of the LA, RA, 
LVEF, duration QTc are required further 
monitoring in the delayed period and can serve 
as reliable predictors of arrhythmia. 
CONCLUSIONS 
1. The levels of heart rate and pulse 
decreases in I and III functional class of the 
chronic heart failure in the acute period 
radiofrequency ablation; systolic and diastolic 
blood pressure, QRS, left ventricle end-diastolic 
and left ventricle end-systolic diameter do not 
change after radiofrequency ablation. 
2. Patient I and III functional class of the 
chronic heart failure are having increasement of 
QTc duration in acute period of radiofrequency 
ablation that could be used as an independent 
predictor of arrhythmia recurrence. 
3. Patients with I functional class of the 
chronic heart failure have significantly lower 
left atrium size compared to III functional class 
of the chronic heart failure, which is associated 
with the best outcome of effectiveness of 
radiofrequency ablation in the late period. 
PROSPECTS FOR FUTURE STUDIES 
It is expedient to study the hemodynamics 
and features of the treatment of chronic heart 
failure, depending on the functional class in 
patients at various stages after interventional 
interventions for fibrillation and atrial flutter. 
The research was carried out within the 
framework of the research work 
«Pharmacological and interventional 
approaches to the treatment of patients with 
heart rhythm disorders and arterial 
hypertension» (state registration number 
0116U000973). 
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Our clinical case shows patient with worsening clinical signs of angina without obstructive lesions of 
coronary artery which requires further control. Recommendations for lifestyle modification as well as further 
treatment tactics are described. 
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СТЕНОКАРДІЯ ТА ІШЕМІЯ МІОКАРДУ ЗА ВІДСУТНОСТІ ОБСТРУКТИВНОЇ ХВОРОБИ 
КОРОНАРНИХ АРТЕРІЙ: КЛІНІЧНИЙ ВИПАДОК 
Караванова М. М., Лісова Н. О., Шевчук М. І. 
Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
Наш клінічний випадок свідчить про погіршення клінічних ознак стенокардії без обструктивних 
уражень коронарної артерії, що вимагає подальшого контролю. Описані рекомендації з модифікації 
способу життя, а також подальша тактика лікування. 
КЛЮЧОВІ СЛОВА: кардіальний синдром Х, ішемія, мікроваскулярна дисфункція 
 
СТЕНОКАРДИЯ И ИШЕМИЯ МИОКАРДА ПРИ ОТСУТСТВИИ ОБСТРУКТИВНОЙ 
БОЛЕЗНИ КОРОНАРНЫХ АРТЕРИЙ: КЛИНИЧЕСКИЙ СЛУЧАЙ 
Караванова М. Н., Лесовая Н. А., Шевчук М. И. 
Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
 
Наш клинический случай показывает пациента с ухудшением клинических признаков стенокардии 
без обструктивных поражений коронарной артерии, что требует дальнейшего контроля. Описаны 
рекомендации по модификации образа жизни, а также дальнейшая тактика лечения. 
КЛЮЧЕВЫЕ СЛОВА: кардиальный синдром Х, ишемия, микроваскулярная дисфункция 
 
INTRODUCTION 
Cardiac syndrome X (CSX, microvascular 
angina) is a pathological condition 
characterized by the presence of signs of 
myocardial ischemia (typical angina-like chest 
pain with evidence of myocardial ischemia: ST 
segment depression ≥ 1.5 mm [0.15 mV] for 
more than 1 minute, during 48-hour ECG 
monitoring) in the absence of ﬂow-limiting 
stenosis on coronary angiography and spasm of 
the epicardial coronary arteries during coronary 
angiography. The cost of case management of 
patients with chest pain and no obstructive 
CAD is not cheap as a result of challenges in 
diagnosis and treatment. [1–2]. Most patients 
with cardiac syndrome X are postmenopausal 
women [3–5]. However, the «female-pattern» 
terminology may soon be irrelevant [6]. CSX is 
likely to be multifactorial in these patients and 
 Karavanova M. M., Lisova N. O.,  
Shevchuk M. I., 2018 
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it is conceivable that risk factors such as 
hypertension, hypercholesterolemia, diabetes 
mellitus and smoking can contribute to its 
development. Additional factors such as 
abnormal pain perception may contribute to the 
pathogenesis of chest pain in patients with 
angina pectoris and normal coronary 
angiograms [7]. 
CLINICAL CASE 
The patient С., a man born in 1959, was 
admitted to the clinical base of internal 
medicine department in Railway Clinical 
Hospital № 1 of «HC» JSC «Ukrzaliznytsia» in 
December, 11.10.17 with complaints of 
pressing pain behind the sternum radiating to 
the back with moderate severity of physical 
exertion, not relieved by nitro-glycerine, 
shortness of breath when rising to the 3rd floor, 
periodic numbness of the extremities, high 
blood pressure periodically to 150/90 mm Hg. 
ANAMNESIS MORBI 
In May 2017, patient was admitted at 
hospital for treatment of arterial hypertension, 
and from that time the pressing pain behind the 
sternum began to disturb. In June 2017, patient 
was hospitalized at The Endocrinology 
department for treatment of diabetes mellitus. 
There was performed ECG recording, ischemia 
was detected in the form of ST-segment 
depression; treadmill test was positive 
(ischemia detected). It was recommended a diet 
and patient received bisoprolol 5 mg 1 time per 
day, valsartan 40 mg 1 time per day in the 
morning, which he is taking now. Regarding the 
treatment of diabetes, patient takes 
glibenclamide 5 mg in the morning before 
breakfast. However, after the treatment, there 
was no positive dynamics in the patient's 
condition. Currently, general condition of the 
patient is worsening during the last 3 weeks in 
the form of aggravation of the above 
complaints. 
ANAMNESIS VITAE 
1989 – appendectomy, 2000 – hymorotomy, 
since 2006 – diabetes mellitus type II, since 
2011 – arterial hypertension. Ex-smoker – for 
40 years until May 2017, 1 pack per day). 
Family history: mother and father - have high 
blood pressure. Infections, injuries, 
tuberculosis, sexually transmitted diseases were 
denied. Allergic history is not burdened. 
OBJECTIVE EXAMINATION 
General condition is satisfactory; 
consciousness is clear, emotionally stable. 
Height – 1.75 m, weight – 83 kg, BMI – 
27.13 kg/m2 (overweight = 25.1 – 30 kg/m2). 
Skin is pale-pink, without any scars. There is 
symmetrical oedema of the lower extremities, 
up to the middle third of the leg, aggravated in 
the evening, not passing after a night rest. 
Peripheral lymph nodes are not palpable, on 
palpation of the thyroid gland painless. Signs of 
eyelid retraction, periorbital oedema, proptosis 
are absent. 
Respiratory system: on percussion – normal 
percussion sound above both lungs, on 
auscultation– symmetrical decreased vesicular 
breathing. RR= 20/min. 
Cardiovascular system: heart borders 
extended to the left on 2 cm of midclavicular 
line, HR =70 bpm, regular. Ps= 70 bpm. No 
pulse deficiency. Auscultation of the heart – 
heart sounds heart tones are rhythmic, clear. 
Blood pressure (BP) dextr = 145/88 mm Hg, BP 
sin = 140/86 mm Hg, (on the background of 
antihypertensive therapy). 
Gastrointestinal system: abdomen is 
symmetrical, soft, painless, no discrepancies of 
the abdominal muscles. No visible peristalsis. 
Liver edge is smooth, painless, palpated 1.5 cm 
below the costal arch. Spleen and pancreas are 
not palpable. 
Pasternatskiy sign is positive on the right. 
Urination is free, painless. 
LABORATORY AND INSTRUMENTAL 
TESTS  
Tests were conducted according to the 
Protocol approved by order of the Ministry of 
Health of Ukraine from 02.03.16 No. 152: 
assessment of the pre-test probability of stable 
coronary artery disease (CAD), complete blood 
count, urinalysis, biochemical analysis of blood 
(potassium, sodium, creatinine, GFR, AlAT, 
AsAT), lipidogram (total cholesterol, TG, low-
density lipoprotein; HDL, high-density 
lipoprotein), glucose, HbA1c, 12-lead 
Electrocardiography, echocardiography, 
treadmill and/or bicycle ergometer (bike) 
exercise tests, coronary angiography, abdominal 
ultrasound (additional), X-Ray (additional). 
RESULTS OF LABORATORY AND 
INSTRUMENTAL DIAGNOSIS 
Assessment of the pre-test probability of 
stable CAD: corresponds to medium to high 
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pretest probability of 66–85 %, non-invasive 
functional tests with visualization are 
recommended to confirm the diagnosis. 
Complete blood count: normal. 
Urinalysis: normal. 
Biochemical analysis: all parameters within 
the normal range. 
Fasting glucose test: 8 mmol/l. 
HbA1c: 6.53 % (N 4.8–5.9 %). 
Lipidogram: total cholesterol 6 mmol / l, TG 
2.3 mmol/l. 
ECG: HR 79 bpm. Depression of the ST 
segment > 1 mm in leads II, V4–V5, regional 
disturbances of ventricular contractility. Diffuse 
disturbances of repolarization processes, signs 
of left ventricular hypertrophy (LVH). 
Echocardiography: Sclerotic changes of 
aortic walls, aortic and mitral valves. Dilatation 
of the ascending aorta. Dilatation of the left 
atrium. Left ventricular hypertrophy. Mitral 
regurgitation of the 1nd degree. EF 51 % – 44 
(N: 55–78 %). 
Abdominal ultrasound: Diffuse changes in 
the parenchyma of the liver and pancreas 
without enlargement of them. Thickening of the 
gallbladder wall. Congestion bile in gallbladder.  
Right-sided hydrocalycosis. Cyst of the right 
kidney. Split of pyramid-shaped lobes the left 
kidney. Kidney microcalculus. 
Angiography: Right type of coronary blood 
flow. Moderate of coronary tortuosity on the 
coronary blood flow. The left coronary artery - 
the trunk is not changed, circumflex and left 
anterior descending coronary artery and its 
branches is not visible angiographic signs of 
atherosclerotic lesion. The right coronary artery 
– no plaque was detected. 
CLINICAL DIAGNOSIS 
Essential arterial hypertension stage II, 1 grade. 
Hypertensive heart (LVH). The risk is 
moderate. Ischemic heart disease: 
microvascular angina (positive stress echoCG 
20.06.17). Coronary arteries without obstructive 
lesions (angiography 12.10.17.). Combined 
dyslipidaemia. Heart failure with preserved 
ejection fraction II A stage, NYHA II. 
Co-morbidity: Diabetes mellitus type 2, 
moderate severity, compensation. 
OUR RECOMMENDED TREATMENT 
ACCORDING LAST GUIDELINES 
Non-pharmacologic: 
 Lifestyle modification: adequate 
physical activity (aerobic exercise for 30 min 3 
or more times a week), body weight correction 
(BMI 18.5 – 24.9 kg/m, waist circumference 
less than 102 cm in men) 
 Dietary recommendations – 
Mediterranean diet: 
– decrease sodium intake to 4–6 g/day; 
– adequate fluid intake; 
– saturated fatty acids should provide less 
than 10 % of the total energy value of the daily 
diet, they should be replaced by 
polyunsaturated fatty acids; 
– 200 g of fruit per day (2–3 times); 
– 200 g of vegetables per day (2–3 times); 
– fish, at least 2 times per week, one of the 
times – sea fish; 
– 30–40 g of dietary fiber per day in the 
form of whole grain products, vegetables and 
fruits. 
 BP monitoring (target level less than 
140/90 mm Hg). 
 Glycemia control. 
Treatment strategy: 
 Perindopril 5 mg once daily 
continuously, under BP control 
 Indapamide 2.5 mg once daily 
continuously 
 Acetylsalicylic acid 75 mg once daily 
continuously 
 Rosuvastatin 40 mg 1 time in the 
evening for 4 weeks. Control AlAT, AsAT after 
4 weeks 
 Trimetazidine 60 mg per day for 3 
months 
 Kvamatel (famotidine) 20 mg 2 times a 
day for 14 days 
 Omega-3 polyunsaturated fatty acids 
1000 mg daily for 3 months 
 Medical therapy of diabetes 
PROGNOSIS 
Although prognosis is good regarding 
survival, patients with cardiac syndrome X have 
an impaired quality of life. 
In a recent survey conducted in four large 
European countries, women reported more 
severe angina, a higher number of angina 
attacks per month, and more frequently 
accompanying symptoms (dyspnoea, 
arrhythmias/tachycardia), than men. Atypical 
symptoms were more common for women as 
well [8]. 
PREVENTION 
Secondary prevention include lifestyle 
modification; good blood pressure control, 
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decrease sodium intake, lipid lowering diet, 
aerobic non strenuous exercises; control of fluid 
balance and check up for decompensation of 
heart failure; control of compliance to our 
medical recommendations. 
DISCUSSION 
The mechanisms underlying angina pectoris 
in essential arterial hypertension patents 
without obstructive coronary artery disease are 
still largely unknown, but such association 
doesn’t rarely occurs [9–11]. Furthermore, 
hypertensive patents have a higher likelihood of 
presenting with features of the metabolic 
syndrome, e.g., hypertension, dyslipidaemia, 
obesity and іnsulіn resistance, compared with 
the general population, which makes the 
diagnosis and treatment of such comorbid cases 
more complex and multicomponent [12–13]. 
Insulin resistance, therefore, may represent an 
important mechanism for vascular dysfunction 
іn this setting [14–16]. Moreover, cardiac 
syndrome X is now recognized as a condition 
that can cause a significant morbidity and 
increases the risk for CV events [1] 
Evidence-based guidelines for treating CSX 
are still lacking as well as optimal methods of 
identification of CMD patients although 
research in this direction continues [1, 17–23]. 
Therefore, the presentation and study of cases 
of successful management of patients with this 
pathology remains relevant. 
Our clinical case shows patient with 
worsening clinical signs of angina without 
obstructive lesions of coronary artery which 
requires further control with all the necessary 
diagnostic methods. This article describes the 
subsequent management of our patient, which 
includes both non-drug methods of treatment 
that cannot be neglected, based on the 
comorbidity of the disease and the material 
burden on the patient in general, and medication 
management. 
As a result of our research, our patient 
needed further correction of the treatment of 
AH and more accurate diagnosis (and 
treatment) of angina pectoris and first of all, 
modification of the lifestyle and reconsideration 
of the regularity of taking medicines. 
CONCLUSION 
1. This case is іnterestіng іn the 
development of decompensatіon (oedema of the 
lower extremities, reduced tolerance to stress) 
in a patient with cardiac syndrome X. 
2. Management of patents with angina and 
evidence of myocardial schema on stress testing 
without obstructive coronary artery disease by 
angiography (previously referred to as cardiac 
syndrome X, or CSX) is a challenge. 
3. Key points for the clіnіcіan include 
recognition of schema and deployment of 
guideline-endorsed therapy for angina and 
reduction of cardiac risk factors. 
4. Systemic hypertension is often 
associated with mіcrovascular angіna. Several 
pathogenic mechanisms have been іdentіfіed 
which represent suitable targets for treatment. 
Mіcrovascular dysfunction needs to be 
іnvestіgated (and treated if present) іn patents 
with systemic hypertension, angina and 
angіographically normal coronary arteries. 
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Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are consistently 
associated with morbidity and mortality among the critically ill or injured. Thus, avoiding or potentially 
treating these conditions may improve patient outcomes. Despite a large number of special publications 
devoted to this problem, very little attention is paid to the ACS in patients with severe burn injuries. 
Severe burns have been shown to be a risk factor for developing IAH. Fluid resuscitation practices used in 
burns management further predispose patients to increase intra-abdominal pressure. The incidence of intra-
abdominal hypertension in patients with severe thermal injury is, according to different authors, 57.8–82.6 %. 
The mortality associated with IAH in severe burns is very high once organ dysfunction occurs. 
The purpose of this work is to collect and analyze the problem of abdominal hypertension in burn patients, 
as well as to draw conclusions on the prevention of this condition and improve the results of treatment of 
patients with severe burn injury. 
KEY WORDS: Abdominal compartment syndrome, Intra-abdominal hypertension, Burns, Fluid 
resuscitation 
 
АБДОМІНАЛЬНИЙ КОМПАРТМЕНТ СИНДРОМ У ОПІКОВИХ ХВОРИХ 
Белозьоров І. В.1, Литовченко А. М.1, Олійник Г. А.2, Литовченко О. Ю.1, Матвєєнко М. С.1 
1 Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
2 Харківська медична академія післядипломної освіти, вул. Амосова, 58, м. Харків, 61176, Україна 
 
Внутрішньочеревна гіпертензія і абдомінальний компартмент синдром тісно пов'язані з 
захворюваністю і смертністю серед критично хворих і уражених. Уникаючи або проводячи адекватне 
лікування цих потенційно небезпечних для життя станів можна поліпшити результати лікування 
пацієнтів.  
Незважаючи на досить велику кількість спеціальних публікацій, присвячених даній проблемі, дуже 
мало уваги приділяється абдомінальному компартмент синдрому у хворих з важкою термічною 
травмою. 
У ряді досліджень показано, що важкі опіки є фактором ризику розвитку внутрішньочеревної 
гіпертензії. Великі обсяги інфузійної терапії, що використовуються при лікуванні важкої опікової 
травми, додатково привертають пацієнтів до збільшення внутрішньочеревного тиску. Частота 
розвитку інтраабдомінальної гіпертензії у хворих з тяжкою термічною травмою становить, за даними 
різних авторів 57,8–82,6 %. Летальність, пов'язана з внутрішньочеревної гіпертензією при великих 
опіках досить висока після виникнення поліорганної дисфункції. 
Мета даної роботи – зібрати і проаналізувати проблему абдомінальної гіпертензії у опікових 
хворих, а також зробити висновки щодо профілактики даного стану і поліпшенню результатів 
лікування постраждалих з важкою термічною травмою. 
КЛЮЧОВІ СЛОВА: абдомінальний компартмент синдром, інтраадомінальна гіпертензія, опіки, 
інфузійна терапія 
 
 
 
 
 Belozorov I. V., Lytovchenko A. M.,  
Oliynyk G. A., Lytovchenko O. Y., 
MatvieienkoM. S., 2018 
Journal of V. N. Karazin` KhNU. 2018 
64 
АБДОМИНАЛЬНЫЙ КОМПАРТМЕНТ СИНДРОМ У ОЖОГОВЫХ БОЛЬНЫХ 
Белозеров И. В.1, Литовченко А. Н.1, Олейник Г. А.2, Литовченко Е. Ю.1, Матвеенко М. С. 
1 Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 
61022, Украина 
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Внутрибрюшная гипертензия и абдоминальный компартмент синдром тесно связаны с 
заболеваемостью и смертностью среди критически больных и пораженных. Избегая или проводя 
адекватное лечение этих потенциально опасных для жизни состояний можно улучшить результаты 
лечения пациентов. 
Несмотря на достаточно большое количество специальных публикаций, посвященных данной 
проблеме, очень мало внимания уделяется абдоминальному компартмент синдрому у больных с 
тяжелой термической травмой. 
В ряде исследований показано, что тяжелые ожоги являются фактором риска развития 
внутрибрюшной гипертензии. Большие объемы инфузионной терапии, используемые при лечении 
тяжелой ожоговой травмы, дополнительно предрасполагают пациентов к увеличению 
внутрибрюшного давления. Частота развития интраабдоминальной гипертензии у больных с тяжелой 
термической травмой составляет, по данным разных авторов 57,8–82,6 %. Летальность, связанная с 
внутрибрюшной гипертензией при обширных ожогах очень высокая после возникновения 
полиорганной дисфункции. 
Цель данной работы – собрать и проанализировать проблему абдоминальной гипертензии у 
ожоговых больных, а также сделать выводы по профилактике данного состояния и улучшению 
результатов лечения пострадавших с тяжелой термической травмой. 
КЛЮЧЕВЫЕ СЛОВА: абдоминальный компартмент синдром, интраабдоминальная гипертензия, 
ожоги, инфузионная терапия 
 
Abdominal compartment syndrome (ACS) is 
a pathological condition in which organ 
dysfunction is the result of intra-abdominal 
hypertension (IAH). It is determined by a 
steady or repeated increase of intra-abdominal 
pressure (IAP) over 20 mm Hg. and/or 
abdominal perfusion pressure (APP) less than 
60 mm Hg in combination with newly 
discovered dysfunction of one system or 
multiple organ failure [1]. 
Much good evidence now supports the 
concept that elevated IAP may impair 
physiology and organ function by producing the 
ACS. Complex, adverse physiological 
consequences of increased IAP develop as the 
pressure is transmitted to adjacent spaces and 
cavities, decreasing cardiac output, restricting 
pulmonary ventilation, diminishing renal 
function and visceral perfusion, and increasing 
cerebrospinal pressure [2]. 
Intra-abdominal hypertension (IAH) and 
abdominal compartment syndrome (ACS) are 
associated with increased morbidity and 
mortality among multiple types of patient 
populations [3]. 
The World Society of the Abdominal 
Compartment Syndrome (WSACS) has 
published definitions and guidelines for the 
diagnosis and management of patients with 
IAH and ACS [4]. 
Final 2013 consensus definitions of the 
World Society of the Abdominal Compartment 
Syndrome: 
1. IAP is the steady-state pressure 
concealed within the abdominal cavity. 
2. The reference standard for intermittent 
IAP measurements is via the bladder with a 
maximal instillation volume of 25 mL of sterile 
saline. 
3. IAP should be expressed in mmHg and 
measured at end-expiration in the supine 
position after ensuring that abdominal muscle 
contractions are absent and with the transducer 
zeroed at the level of the midaxillary line. 
4. IAP is approximately 5–7 mm Hg in 
critically ill adults. 
5. IAH is defined by a sustained or 
repeated pathological elevation in IAP ≥ 
12 mm Hg. 
6. ACS is defined as a sustained IAP > 
20 mm Hg (with or without an abdominal 
perfusion pressure (APP) < 60 mm Hg) that is 
associated with new organ dysfunction/failure. 
7. IAH is graded as follows: 
Grade I – IAP 12–15 mm Hg; 
Grade II – IAP 16–20 mm Hg; 
Grade III – IAP 21–25 mm Hg; 
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Grade IV – IAP > 25 mm Hg. 
8. Primary IAH or ACS is a condition 
associated with injury or disease in the 
abdominopelvic region that frequently requires 
early surgical or interventional radiological 
intervention. 
9. Secondary IAH or ACS refers to 
conditions that do not originate from the 
abdominopelvic region. 
10. Recurrent IAH or ACS refers to the 
condition in which IAH or ACS redevelops 
following previous surgical or medical 
treatment of primary or secondary IAH or ACS. 
11. APP = MAP – IAP (MAP – mean 
arterial pressure). 
12. A polycompartment syndrome is a 
condition where two or more anatomical 
compartments have elevated compartmental 
pressures. 
13. Abdominal compliance is a measure of 
the ease of abdominal expansion, which is 
determined by the elasticity of the abdominal 
wall and diaphragm. It should be expressed as 
the change in intra-abdominal volume per 
change in IAP. 
14. The open abdomen is one that requires 
a temporary abdominal closure due to the skin 
and fascia not being closed after laparotomy. 
15. Lateralization of the abdominal wall is 
the phenomenon where the musculature and 
fascia of the abdominal wall, most exemplified 
by the rectus abdominus muscles and their 
enveloping fascia, move laterally away from the 
midline with time [4]. 
There are a lot of risk factors for intra-
abdominal hypertension and abdominal 
compartment syndrome. Major burns are one of 
these factors [4]. 
It should be noted that an increase in IAP is 
not always accompanied by the occurrence of 
ACS. The regularity is known: the higher the 
IAP and the more factors leading to its increase, 
the more likely is the development of the ACS 
[1]. 
High abdominal pressures lead to several 
systemic impairments: cephalad movement of 
the diaphragm leads to cardiac and lung 
compression, reduced venous return and, 
subsequently, contributes to hypoxemia, 
hypercapnia, atelectasis and ventilation-
perfusion mismatch. ACS will also compress 
renal vessels, activating sympathetic drive and 
the renin-angiotensin system; these effects 
contribute to a decrease in urine output. 
Primarily, renal vasoconstriction leads to a 
significant decrease in urine output, and is 
typically the first indicator of the onset of ACS 
– oliguria is noted at IAPs > 15 mm Hg and 
anuria at IAPs of 30 mm Hg. Reports document 
a decrease in mesenteric blood flow at 10 
mmHg IAP; intestinal mucosa perfusion 
decreases at 20 mm Hg IAP, and celiac and 
superior mesenteric artery flow is compromised 
at IAPs > 40 mm Hg. To further exacerbate the 
effects on gastric circulation, the increased 
pressure may compress mesenteric veins, 
impairing drainage and exacerbating ACS, 
ultimately leading to further gut hypoperfusion, 
ischemic bowel, decreased intramural pH and 
worsening lactic acidosis [5–8]. In the context 
of tissue injury consistent with severe burn 
trauma, inflammatory responses can also 
exacerbate an ischemic bowel. The 
inflammatory cytokines released will increase 
capillary permeability, leading to more edema 
and higher IAP [9]. This is a vicious cycle in 
which edema results in injury, which in turn 
worsens edema. 
The generalized increase in capillary 
permeability that occurs in severe burn patients 
contributes to extensive edema formation and 
intra-peritoneal accumulation of «third-space» 
fluid [10]. 
Capillary leak and third spacing are 
universal in major burns. In patients with burns 
of more than 60 % of their body surface area 
and without abdominal pathology, the 
pathogenesis for increased IAP is most likely 
due to massive fluid resuscitation with third 
spacing and secondary extrinsic compression by 
burn eschars. «Capillary leak» following shock, 
with ischemia-reperfusion injury and the release 
of vasoactive substances and oxygen-derived 
free radicals increases extracellular volume. 
Especially when it occurs with associated 
inhalational injury, delayed resuscitation, and 
abdominal wall injuries [11–12]. 
Bowel edema and fluid translocation is 
further worsened by venous hypertension 
caused by elevated IAP [13]. This increasing 
volume in the abdominal cavity, however, is 
reduced after capillary permeability improves. 
Therefore, secondary IAH in burn patients 
generally occurs within 48 hours after injury, 
during the initial resuscitation period, while 
ACS usually occurs after the acute phase, 
during subsequent septic episodes [14–15]. 
Burn patients are also at risk of tertiary or 
recurrent ACS any time they require aggressive 
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resuscitation as, for instance, after any overly 
aggressive burn excision [10, 13]. 
IAH/ACS should be suspected in all patients 
with severe burns. The incidence of IAH in 
major burn patients is variable in the literature 
and is associated with the burn area. Patients 
with > 20 % TBSA burned presented a very 
high prevalence of IAH. Development of organ 
failure occurred even at moderately increased 
values of IAP. In this scenario, monitoring of 
IAP is the first step for establishing the 
importance of IAH/ACS in this patient 
population [16–17]. IAP measurement should 
therefore be performed every 2 to 4 hours 
throughout the resuscitation period in burn 
patients with more than 20 % TBSA [18]. 
The use of mechanical ventilation is also 
associated with an increased incidence of IAH 
and to a worse prognosis in untreated cases 
[19]. This risk factor is proportional to the 
severity of respiratory symptoms and the 
mechanical ventilation requirement. 
Malbrain ML at al. [18] believes that IAH 
will develop in most (if not all) severely burned 
patients, and may contribute to early mortality 
[18]. A recent systematic review showed that 
the prevalence of ACS and IAH in severely 
burned patients is 4.1−16.6 % and 64.7−74.5 %, 
respectively [20]. The risk of ACS is higher in 
burned patients with a higher percentage of 
total body surface area (TBSA) burned; 
however, patients with a lower burned TBSA 
may develop IAH/ACS as well [15]. ACS 
typically occurs when resuscitation volumes are 
greater than 275 mL/kg during the first 
24 hours or TBSA burned is larger than 60% 
[21–22]. Patients with severe burn injuries 
greater than 60 % of TBSA, associated 
inhalational injuries, delayed resuscitation, and 
intra-abdominal injuries are at the highest risk 
of developing IAH and ACS [23]. The 
mortality rate of patients developing ACS is 
50−84 %, even when treated [18, 24]. 
The effects of IAH/ACS in patients with 
severe burns are multifactorial. Raised IAP can 
lead to organ dysfunction and can affect all 
organ systems. The use of excessive fluid 
resuscitation in combination with increased 
capillary permeability as a result of the 
systemic inflammatory response to burn injury 
makes these patients particularly vulnerable to 
the development of IAH and ACS and 
cardiovascular, respiratory, and renal system 
dysfunction [15]. In severe burn patients, the 
kidneys are especially vulnerable to elevated 
IAP-related injury [25]. 
Talizin TB at al. evaluated the frequency of 
intra-abdominal hypertension in major burn 
patients and its association with the occurrence 
of acute kidney injury (AKI) [25]. A total of 46 
patients were analyzed. Of these, 38 patients 
developed IAH (82.6 %), thirty-two patients 
(69.9 %) developed acute kidney injury. The 
median time to development of acute kidney 
injury was 3 days. The individual analysis of 
risk factors for acute kidney injury indicated an 
association with intra-abdominal hypertension, 
use of glycopeptides, use of vasopressors [25]. 
The use of nephrotoxic drugs, such as 
glycopeptides, is associated with direct kidney 
injury and the consequent dysfunction of this 
organ. Changing organic perfusion in the case 
of circulatory instability, as evidenced in the 
literature, is a risk factor for kidney injury [26]. 
The IAH patient also presents hemodynamic 
changes with impaired renal perfusion [20]. An 
association between AKI and higher 30-day 
mortality in intensive care patients has been 
found [25]. 
Since an elevated IAP affects renal blood 
flow, urinary output is an unreliable index of 
the preload and intravascular volume resulting 
in the loss of an important physiologic 
parameter. 
Moreover, ACS as well as abdominal 
decompression for ACS increases susceptibility 
to multiple organ dysfunction syndrome 
(MODS) for severe burn patients and may also 
induce acute lung injury [18]. 
One should pay attention to the fact that 
IAH/ACS might occur in patients without 
circumferential 3rd degree burns of their trunk. 
Burn patients with smoke inhalation may also 
be at risk of fluid sequestration [21]. 
It is fundamental to: 1) recognize IAP and 
ACS; 2) resuscitate effectively; and 3) prevent 
the development IAP-induced end-organ 
dysfunction and failure [27]. 
The WSACS medical management 
algorithm for IAH/ACS is based on five 
treatment options: 1) evacuation of intra-
luminal contents; 2) evacuation of intra-
abdominal space occupying lesions; 3) 
improvement of abdominal wall compliance; 4) 
optimization of fluid administration; 5) 
optimisation of systemic and regional perfusion 
[4]. 
According to WSACS recommendations if 
patient has IAP ≥ 12 mm Hg medical 
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management to reduce IAP should be started. If 
IAP > 20 mm Hg and new organ 
dysfunction/failure is presented, patient’s 
IAH/ACS is refractory to medical management. 
Strongly consider surgical abdominal 
decompression (GRADE 1D) [4]. 
But management of ACS with 
decompressive laparotomies is associated with 
significant morbility and mortality ranging from 
50 % to 100 % [28]. 
Thus, the main thing is the prevention of 
ACS. Key to the prevention of ACS is the early 
recognition and treatment of IAH [29–30]. 
Many burn physicians lack awareness of the 
deleterious effects of raised IAP and do not 
regularly measure it [29]. 
Resuscitation in the very first hours after a 
burn is a key point in the treatment of severe 
burn shock [31]. Judicious use of fluids and 
avoidance of fluid over-resuscitation is the key 
element in the prevention of secondary ACS. 
Moreover, the choice of resuscitation fluid 
among critically ill patients with burns may 
have a clinical importance [22, 32]. 
There is no perfect resuscitation protocol 
and studies have demonstrated that patients 
frequently receive larger amounts of fluids than 
required a patient. This condition recently 
recognized as «fluid creep», a phenomenon 
which may also be attributed to «opioid creep». 
Fluid creep is an iatrogenic phenomenon 
resulting from misuse of the originally 
described approaches to crystalloid 
resuscitation. It is associated with massive 
edema and compartment syndromes (orbital, 
abdominal, and extremity compartment 
syndrome) [18, 33–35]. 
It is currently unknown whether the 
syndrome is an iatrogenic consequence of 
excessive fluid resuscitation or an unavoidable 
sequelae of the primary injury. A recent 
systematic review of severely burned patients 
concluded that the fluid resuscitation volume 
was directly responsible for the development of 
ACS. It exacerbates splanchnic edema leading 
to an increase in gut permeability, bacterial 
translocation, and increased intra-abdominal 
pressure. Resuscitation-related ACS is 
associated with a mortality of 97 % when burn 
size is greater than 60 % TBSA [12, 36–37]. 
Groups of burn patients that have been 
identified in whom resuscitation requirements 
are usually greater than the parkland Formula 
predictions include patients with inhalation 
injuries, electrical burns, those with additional 
injuries, patients with high alcohol or drug 
intake, and those in whom resuscitation was 
delayed. To avoid «fluid creep», the 
resuscitation formulas have to be used only as 
indicators for the initial fluid resuscitation rate. 
This rate must be adjusted according to several 
parameters, the most important and most 
frequently used being urine output. According 
to a survey of the American Burn Association 
and the International Society of Burn Injuries, 
94.9 % of respondents use urine output as the 
main indicator of successful infusion therapy 
[38]. This parameter should not be allowed to 
exceed the recommended hourly urine output 
range of 0.5 to 1 ml/kg/h [27]. But in 
overhydrated severely burned patients, a 
decreased urine output may reflect 
overresuscitation and the onset of abdominal 
compartment syndrome [35]. 
For patients with severe burn injury, it is 
necessary to strive to restore microcirculation in 
the shortest possible time, using the minimum 
amount of fluid necessary to maintain the 
physiological functions of the body. Both 
insufficient and excessive amount of injected 
fluid leads to the dysfunction of organs and 
tissues, the development of multiple organ 
failure (MOF). 
Ivy has identified 250 ml/kg of volume 
administration within the first 24 hours as a risk 
factor for ACS [21]. Regular calculation of the 
Ivy index will identify patients at risk of 
developing ACS. However, in the eventuality 
of a thick abdominal eschar, abdominal 
distention is restricted, thus the critical point of 
increased IAP is reached with lesser increase in 
intra-abdominal volume and IAH and ACS may 
occur with lesser fluid resuscitation volumes 
[10, 39]. 
Now novel resuscitation strategies in burn 
patients to avoid IAH/ACS are evolving. 
Recent evidence supports the use of hypertontic 
sodium chloride solution and colloids enabling 
less overall fluid volume resuscitation. Despite 
efforts to minimize fluid administration many 
patients end up grossly fluid overloaded leading 
to IAH and ACS [22, 40]. 
Randomized studies have shown that 
hypertonic lactated saline (HLS) or plasma-
based resuscitation requires less fluid and is 
associated with a lower risk of IAH and ACS. 
On the other hand, isotonic resuscitation was 
associated with a 3.5-fold increased risk for 
developing IAH. [22]. 
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Treatment of burns with a hypertonic 
solution reduced the secretion of cytokines by 
cardiomyocytes, decreased their sensitivity to 
the action of lipopolysaccharides against 
cytokine secretion, and improved pumping 
function [41]. 
Some authors add colloids to their 
resuscitation regimen within the first 24h to 
reduce the total resuscitation volumes. 
However, this remains a debatable issue even 
though there is growing evidence of its 
usefulness. Despite some reservation 
concerning the use of albumin in the early 
phases of burn resuscitation, recent work 
demonstrated a decreased mortality rate. 
The use of only salt solutions can be limited 
in cases where dehydration does not reach the 
stage of reducing the volume of circulating 
blood. 
If dehydration progresses to the stage of 
intravascular space reduction, then early 
administration of colloids is necessary. And 
later, saline solutions can be assigned to 
rehydrate the interstitial space. It should be 
noted that dehydration of the vascular space 
occurs after interstitial dehydration, and the 
injected salt solutions will immediately move to 
the interstitial space before filling the vascular 
sector. 
Low molecular weight dextrans (dextran 
40), native plasma, hydroxyethyl starch 130/0.4 
are recommended as colloids. Also, glucose and 
fructose solutions are included in the burn 
shock infusion therapy. 
The ratio of colloids, crystalloids, salt-free 
drugs in patients with severe and extremely 
severe thermal injury is an average of 1: 1: 1, 
but is corrected according to the state of the 
particular patient. The order of their 
administration depends on the hemodynamic 
parameters, especially the central venous 
pressure [42]. 
There is also growing evidence that vitamin 
C supplementation, in the early post-burn 
period, seems to decrease the needed fluid 
volumes. 
A pronounced inflammatory response in 
severe burn injury contributes to the release of 
free oxygen radicals, which further impair the 
microcirculation and contribute to the 
development of interstitial edema [43]. 
Oxidative tissue damage as assessed by 
increased myeloperoxidase (MPO) activity, 
lipid peroxidation, and decreased levels of 
glutathione levels in intestinal and hepatic 
tissue plays an important role in progression 
from IAH to ACS. However, reperfusion of 
decompressed tissue induces a more prominent 
injury compared to ischaemia itself. 
Reperfusion promotes generation of various 
reactive oxygen metabolites via activated 
neutrophils that cause increased microvascular 
permeability, interstitial oedema, impaired 
vasoregulation, inflammatory cell infiltration, 
and parenchymal cell dysfunction and necrosis 
[44]. 
Therefore, antioxidants, prescribed in burn 
shock, binding free radicals, reduce vascular 
permeability, improve the course of burn 
disease, prevent the development of 
complications, reduce damage to internal 
organs [45]. 
Tanaka et al. found that adjuvant high dose 
ascorbic acid (66 mg/kg/h for 24h), 
administered during the first 24h after thermal 
injury, significantly decreased the amount of 
fluid given compared to the control (patients 
who received vitamin C required infusions of 3 
ml/% of burn /kg, while patients who received 
one Ringer's solution lactate, required 5.5 ml/% 
of burn/kg of solutions per day [46]. 
High-dose vitamin C treatment (bolus 
66 mg/kg and maintenance dose 33 mg/kg/hr) 
reduces endothelial damage to sham burn 
levels, whereas half the dose is inefficient. 
High-dose vitamin C should be considered for 
parenteral treatment in every burn patient [12]. 
Octreotide, a synthetic somatostatin 
analogue, has been shown to improve the 
reperfusion-induced oxidative damage in rats 
with ACS by reducing levels of MPO activity 
and malondialdehyde and increasing levels of 
glutathione when given before decompression. 
Therefore, octreotide might ultimately be 
shown to have a therapeutic role as a 
reperfusion injury-limiting agent among 
patients with IAH and ACS [47]. 
So, resuscitation of patients with severe burn 
injuries should be aimed at the early restoration 
of the circulating blood volume and 
microcirculation using a minimum number of 
solutions. This helps to prevent IAH, the 
development of the ACS, MOF in patients with 
severe burn injury. 
Non-operative and percutaneous 
interventions may be applied before surgical 
decompression is considered. Nasogastric 
decompression, the use of neuromuscular 
blocking agents, prokinetic agents, enemas, or 
colonic decompression, the removal of excess 
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fluid by ultrasound-guided percutaneous 
drainage, or by a combination of continuous 
veno-venous hemofiltration (CVVH) with 
ultrafiltration and/or diuretics, are simple and 
possibly effective tools to reduce IAP [3, 44]. 
Cheatham et al. [48] showed in 62 patients 
with IAH/ACS treated with percutaneous 
catheter decompression (PCD) versus 
traditional open abdominal decompression 
(OAD) that both techniques were equally 
effective. Successful PCD therapy was 
associated with either fluid drainage above 
1,000 mL or a decrease in IAP of > 9 mm Hg in 
the first four hours post decompression. PCD 
appears to be most effective in patients with 
secondary ACS due to massive fluid 
resuscitation in burns. Latenser et al. [49] 
showed that PCD reduced IAP and prevented 
ACS in 55 % of burned patients . PCD is a 
relatively simple technique, cost effective and 
less invasive then OAD. Bedside 
ultrasonography to identify intraperitoneal fluid 
or blood is necessary [44]. 
Circumferential abdominal burn eschars 
might also lead to ACS by producing a 
tourniquet effect. At bedside, urgent 
decompressive escharotomy of the abdominal 
wall is a safe surgical procedure that provides 
rapid relief of intra-abdominal pressure. It 
improves ventilation, hemodynamic parameters, 
and oxygen metabolism and can decrease 
morbidity and mortality [27]. An escharotomy 
of the trunk to improve abdominal wall 
compliance should be performed early, 
especially in the presence of 3rd degree burns 
[18]. 
The open abdomen in trauma and non-
trauma patients has been proposed to be 
effective in preventing or treating deranged 
physiology in patients with severe injuries or 
critical illness when no other perceived options 
exist. Its use, however, remains controversial as 
it is resource consuming and represents a non-
anatomic situation with the potential for severe 
adverse effects [50]. 
Although a midline laparotomy may make 
wound management more difficult in 
abdominal burn patients, it remains very 
effective in reducing IAP. 
Regardless of surgical decompression, it is 
important to continue to measure IAP 
postoperatively in order to recognize recurrent 
IAH and/or ACS. The presence of abdominal 
burns may pose specific challenges to the 
management of the open abdomen with regard 
to infectious complications. The presence of 
significant protein loss via an open abdomen 
needs to be considered [51]. Early enteral 
and/or parenteral nutrition is of the utmost 
importance in these hypercatabolic patients, 
although recent literature results may advocate 
the opposite in ICU patients with ACS [52–53]. 
However, strong emphasis needs to be placed 
on the tremendous morbidity and high mortality 
of an open abdomen in patients with burns [18]. 
Its use, therefore, should only be considered in 
patients who would most benefit from it [50]. 
CONCLUSIONS 
Intra-abdominal hypertension is a frequent 
complication in severe burn patients requiring 
massive fluid resuscitation. Development of 
ACS in burn patients is associated with high 
mortality. Prevention, early detection and 
proper management may avoid this usually fatal 
complication. Fluid resuscitation volume is 
directly responsible for the development of 
ACS in severe burned patients. Thus, optimal 
fluid resuscitation can be the best prevention of 
IAH and ACS. 
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Дана стаття являє собою аналіз наукових публікацій, що відображають досвід застосування 
аутологічної збагаченої тромбоцитами плазми у пацієнтів з андрогенною алопецією (АГА) – 
мультифакторіальним захворюванням с генетичною схильністю, зумовлене впливом екзогенних або 
ендогенних тригерів, відповідальних за клінічні прояви патології. Увага до цієї теми зумовлена 
значною поширеністю АГА, а також незадовільними результатами у досягненні позитивного 
терапевтичного ефекту. 
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Данная статья представляет собой анализ научных публикаций, которые отражают опыт 
применения аутологичной обогащенной тромбоцитами плазмы у пациентов с андрогенная алопецией 
(АГА) – мультифакториальном заболевании с генетической предрасположенностью, обусловленное 
влиянием экзогенных или эндогенных триггеров, ответственных за клинические проявления 
патологии. Внимание к этой теме обусловлено значительной распространенностью АГА, а также 
неудовлетворительными результатами в достижении положительного терапевтического эффекта. 
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INTRODUCTION 
Currently, most researchers consider 
androgenic alopecia (AGA) as organ-specific 
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segmental accelerated aging of hair follicles 
that occurs in individuals with a genetic 
predisposition due to the influence of 
exogenous or endogenous triggers that are 
responsible for the clinical manifestations of the 
disease with the leading role of endocrine 
disorders [1]. Significant progress has been 
made in understanding the basic elements of the 
metabolism of the participating androgens with 
a clearly expressed genetic component. 
However, clinical practice has shown that 
simply blocking androgens does not give the 
desired results [2]. Clinical and research 
progress helped to identify several non-
androgenic cofactors of complex etiology of 
AGA, which became a prerequisite for the 
development of new therapeutic strategies, 
among which the use of autologous platelet-rich 
plasma (PRP) is one of the most promising. The 
published data of fundamental and clinical 
studies on the effectiveness of the use of PRP in 
the treatment of AGA will be analyzed in this 
article. 
EFFECTS OF GROWTH FACTORS ON 
THE HAIR FOLLICLE 
Hair follicles are located at the intersection 
of complex neuroendocrine and immune 
regulation, actualizing both local and systemic 
influence of numerous endogenous and 
exogenous factors, genome and epigenome. The 
information we know probably comprises a 
small amount of what future discoveries will 
bring. Increased awareness of the various 
signaling pathways involved in hair growth 
may further lead to the discovery of new targets 
for drug exposure. 
Thus, it was demonstrated in researches 
Botchkarev et al. (Botchkarev V. A. et al, 2003) 
[3] that the transition from the telogen to 
anagen phase is associated with the activation 
of the Shh, Wnt/beta-catenin/ Lef-1 and Stat3 
signaling pathways. A huge number of signal 
transduction pathways (Shh, Wnt, etc.) and 
growth factors (BMP, FGF, HGF, IGF, PDGF, 
SCF, etc.) are activated in the anagen phase in 
the epithelium and mesenchyme, which should 
be well coordinated for hair formation. 
It should be noted that the same factors can 
have a completely opposite effect on the cells in 
the follicle in different phases of the cycle. 
Modern research has opened up an enormous 
potential for developing of methods of 
correcting and managing the hair growth cycle 
with the help of biologically active substances, 
growth factors and hormones and in fact 
revolutionized this direction. 
Growth factors – polypeptides with a 
molecular weight of 5–50 kDa, combined into a 
group of trophic regulatory substances. Like 
hormones, these factors have a wide range of 
biological effects on many cells – they 
stimulate or inhibit mitogenesis, chemotaxis, 
differentiation. Unlike hormones, growth 
factors are produced by unspecialized cells 
located in all tissues as a rule, and possess 
endocrine, paracrine and autocrine action. 
Growth factors – a link between the 
expression of the body genes and the 
environment – play an important role in 
regulating the life of the hair follicle. Currently, 
it has been established that such factors as EGF, 
TGF-β, IGF-1, HGF, KGF, VEGF are involved 
in the regulation of the hair growth cycle [4]. 
The localization of receptors for a number of 
growth factors in various parts of the hair 
follicle was demonstrated by 
immunohistochemistry and in situ 
hybridization. The dermal papilla cells 
demonstrated the highest immunogenic 
reactivity against FGF-7, IGF, HGF and VEGF, 
which play a key role in the regulation of 
follicle growth. Initially it was expected that the 
use of growth factors in vivo will allow having 
a stimulating effect on hair growth. 
Nevertheless, an interesting feature was 
revealed during the research: the effect of 
growth factors on the hair follicle depends on 
the nature of the implementation of their action. 
It was found that growth factors such as 
EGF, TGF-a, FGF-1. FGF-2, slowed hair 
growth. A suppressive effect was also observed 
in TGF-β in tissue culture. This group of 
growth factors was characterized by an 
autocrine mechanism of action. 
At the same time, it was demonstrated that 
subcutaneous injections of FGF-7, IGF-1, HGF 
paracrine growth factors stimulated the growth 
of the hair follicle and modulated the hair cycle 
in vivo. This effect is probably related to the 
paracrine nature of the realization of these 
growth factors synthesized in the hair papilla. 
The reason why only paracrine growth factors 
have a stimulating effect remains not fully 
clarified. 
PLATELET-RICH PLASMA 
The use of autologous PLR as a method 
indirectly stimulating the work of dermal 
papilla cells implies large therapeutic 
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possibilities. The dermal papilla and connective 
tissue shell are formed from the same 
progenitor cells as the fibroblasts in the 
interfollicular dermis, but their gene expression 
profile and biological functions are radically 
different [5–6]. If interfollicular fibroblasts 
promote the growth and differentiation of the 
overlying epithelial cells (keratinocytes), the 
dermal papilla and connective tissue shell play 
the main role in regulating hair growth. The 
method is based on the concept of PRP as a 
natural source of signaling molecules that have 
a paracrine effect on other cells. The main 
functions of platelets in restoring damaged 
tissue are modulation of inflammation through 
the interaction of innate immune cells, 
regulation of angiogenesis, and stimulation of 
cell migration and proliferation. 
PRP, isolated from whole blood, is 
characterized by the presence of growth factors 
and stimulating mediators. PRP is an 
autologous platelet preparation in concentrated 
plasma, with a platelet concentration exceeding 
the physiological one. Activated α-platelet 
granules produce numerous growth factors, 
including follistatin, KGF, VEGF, EGF, IGF. 
These growth factors appear to stimulate cell 
proliferation and differentiation. It was found 
that PRP has a beneficial effect on bone 
transplants performed in maxillofacial, 
orthopedic surgery and cardiac surgery. 
Recently, there has been an upsurge of interest 
in the use of PRP in dermatology, for example, 
in tissue regeneration, wound healing, fatty 
tissue transplantation, and for the rejuvenating 
effects on the skin, suggestions have been made 
to use PRP as a new treatment for AGA. 
THE RESULTS OF THE STUDY OF THE 
PRP EFFECTIVENESS IN THE 
TREATMENT OF AGA 
The possible effect of PRP on hair growth 
has been studied in vitro and in vivo in mice. 
The actual mechanisms of action on the hair 
follicle remain controversial: PRP activates the 
proliferation of dermal papilla cells and 
prevents apoptosis, which provokes an increase 
in Akt and Bcl-2 expression levels in vitro. In 
addition, PRP is involved in the formation of 
the hair epithelium and the differentiation of 
stem cells into cells of the hair follicle. 
Increasing the expression level of FGR-7 
prolongs the anagen phase in the hair growth 
cycle. 
In 2006, Ubel et al. [7] reported about a new 
experience of using PRP in the treatment of 
male-type AGA. The authors of this study 
demonstrated that the treatment of follicular 
units using PRP before transplantation 
contributed to an increase in hair growth and 
density. After this study, several studies were 
conducted to investigate the possibilities of 
using PRP for the treatment of AGA. 
These results became a motive for further 
research, and since 2006 a number of articles 
have been published describing the experience 
of using PRP in the treatment of AGA. Part of 
the work noted a positive effect from the 
described technique, part – a negative one. 
Researches with a positive result 
In 2009, Ggeso et al. [8] published the 
results of a pilot research on studying the effect 
of direct injection of PRP into the scalp skin. 
The study involved 10 people, the evaluation of 
the results was carried out 4 and 8 months after 
treatment. An increase in the average diameter 
of the hair shafts was recorded by 9.7 % at 
4 months and by 6.1 % at 8 months in the group 
of patients receiving PRP. In the control group 
of patients who did not receive PRP, there was 
a decrease in the average diameter of the hair 
shafts by 2.8 % after 4 months and by 3.5 % 
after 8 months. 
In 2010, E. Betsi et al. [9] conducted a pilot 
study of the clinical effectiveness of PRP 
injections in the treatment of alopecia. The 
study involved 42 patients – 8 women 
diagnosed with telogen effluvium and 34 men 
diagnosed with AGA. Evaluation of the results 
of the study before and after treatment was 
carried out using a hair tension test and survey 
photographs. There was a significant decrease 
in the number of hair falling out, a significant 
increase in volume and improvement in hair 
quality after treatment. Then the researchers 
noted that more obvious improvements were 
observed in patients with a history of up to two 
years; the results were worse for men with 6-
7th stage of baldness based on the Hamilton-
Norwood scale. 
Anitua at al. [10] conducted a blind study of 
the use of plasma enriched with growth factors 
in 19 patients with AGA in 2017. Objective 
methods of assessment using computerized 
phototrichogram evaluated the result by the 
following parameters: 1) hair density; 2) 
diameter; 3) the ratio of terminal hair to vellus 
hair; 4) thinned/normal/dense hair rods among 
terminal follicles; 5) independent clinical 
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assessment of observations (degree of 
improvement according to macro-photography); 
6) epidermal thickness, perivascular 
inflammatory infiltrate, the amount of 
epidermal cords, the ratio of terminal hair to 
miniaturized, the number of collagen, reticular 
and elastic fibers (according to 3 mm puncture 
biopsy); 7) proliferation of epidermal/follicular 
cells, newly formed blood vessels and the 
presence of stem cell niches in the bulge zone 
(according to immunohistochemistry). During 
the study, the method of single centrifugation 
was used, the obtained PRP was additionally 
activated by platelet growth factor to stimulate 
the release of growth factors and morphogens 
from the obtained material; centrifuging 
parameters: frequency – 580 revolutions per 
minute, time – 8 minutes; platelet enrichment 
ratio x2 ± 0.3; blood volume 18 ml; PRP 
volume – 3–4 ml. Patients received 5 
intradermal injections in areas of hair loss: 1–4 
procedures with an interval of 1 month, 5th 
procedure – 7 months from the start of the 
study. Evaluation of the obtained results was 
made after 1 year from the beginning of the 
experiment, a positive improvement was noted 
for all 7 evaluation parameters. Subjective 
assessment data: 85 % of patients noted an 
improvement in the quality and density of hair; 
65 % of respondents noted an increase in hair 
density. 
In 2016, a randomized, placebo-controlled, 
blind study was conducted by Alves at al. [11] 
on 25 patients, only 22 of which have fully 
completed the trials (11 men aged from 18 to 65 
years with stage II-V of AGA; 11 women aged 
from 18 to 86 with stage I – III. Subjects were 
divided into 2 groups: group A, which was 
administered 3 ml of PRP in the right half of 
the head and 3 ml of saline (placebo) in the left 
half; and group B, which received the same 
solution in both halves of the head. Parameters 
for evaluating the obtained results (using a 
photo-trichogram and a survey photo): 1) hair 
in the anagen phase (%); 2) hair in the telogen 
phase (%); 3) anagen/telogen ratio; 4) density 
of the hair; 5) density of the terminal hair;  
6) counting the amount of hair. The method of 
single centrifugation was used during the study, 
the obtained PRP was additionally activated 
with 0.15 ml of 10 % calcium chloride; 
centrifuging parameters: centrifugal 
acceleration – 460 g, time – 8 minutes; platelet 
enrichment ratio ×3; blood volume 18 ml; PRP 
volume – 3 ml. Anesthesia was not used. Three 
injection sessions (0.15 ml/cm²) were carried 
out, at an interval of 1 month, in four rounded 
sections of 1×1 cm of the frontal and occipital 
part of the head (marked with a medical tattoo). 
Evaluation of the results was carried out on the 
3rd and 6th month, an improvement in the mean 
values in the anagen/telogen ratio, hair 
thickness, terminal hair thickness were 
observed in the areas of PRP administration 
relative to the initial state, compared with 
placebo, where only improvement in the 
average hair thickness was observed . For the 
first time, the authors were able to detect the 
relationship between the number of anagenic 
hair and the age of patients > 40 years old, the 
onset of AGA ≥ 25 years, the density of hair 
and the male sex, age ≤ 40 years, a positive 
family history of AGA and the duration of the 
disease > 10 years. The authors concluded that 
the use of PRP had a positive effect on the state 
of AGA and could be considered as adjuvant 
therapy for the treatment of this disease. 
In 2015, data was obtained from a 
randomized, placebo-controlled, blind study by 
Gentile et al. [12] on 23 patients, of which only 
20 fully completed the tests (20 men aged from 
19 to 63 years with AGA stage IIa-IV). One-
half of the affected scalp was injected with PRP 
injections, the second – with saline. Parameters 
for assessing the obtained results (1–3 using a 
computerized photo trichogram and a survey 
photo): 1) counting the amount of hair and total 
hair density; 2) density of terminal hair;  
3) epidermal thickness and density of hair 
follicles (according to the data of 3 mm 
puncture biopsy); 4) the proliferation of 
keratinocytes and small blood vessels around 
the hair follicles (according to 
immunohistochemistry); 5) AGA relapse. The 
study used 2 methods: 1) cascade-Selphyl-
Esforax system; 2) the platelet lipotransfer 
system (PRL platelet-rich lipotransfert system) 
obtained PPR was further activated by Ca² +; 
centrifuging parameters were: 1. centrifugal 
acceleration – 1100 g; 2. frequency – 1200 
revolutions per minute; time: 1,2 – 8 minutes; 
blood volume: 1. 18 ml; 2. 60 ml.; PRP volume: 
1. 9 ml; 2. 20 ml. During the study, 3 sessions 
of injections were conducted at an interval of 30 
days, without the use of anesthesia, after 
treatment of the skin with 70 % alcohol, using 
the method of intradermal injections (0.1 
ml/cm²). The observation period for patients 
was 2 years (with the assessment of the 
condition at the beginning of the experiment, at 
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2, 6, 12, 16 and 23 months after the first 
procedure). A significant improvement in all 
estimation parameters was noted. 
In 2014, a randomized, placebo-controlled, 
blind study was conducted by Cervelli at al. 
[13] in 10 patients (10 men aged 20–52 years 
with stage IIa-IV AGA). Parameters for 
evaluating the obtained results (1–4 using a 
computer phototrichogram and a survey photo): 
1) counting the number of hairs; 2) density of 
hair; 3) density of terminal hair; 4) epidermal 
thickness and density of hair follicles 
(according to data of 3 mm puncture biopsy);  
5) the percentage of Ki67 + keratinocytes and 
the density of the network of blood vessels 
(according to immunohistochemistry). During 
the study, the Cascade-Selphyl-Esforax 
centrifugation system was used, the resulting 
PRT was additionally activated by Ca²+; 
centrifuging parameters were: centrifugal 
acceleration – 1100 g; time: 10 minutes; blood 
volume: 18 ml; PRP volume: 9 ml. 3 sessions 
of injections were performed during the study, 
at an interval of 1 month, without the use of 
anesthesia, after treatment of the skin with 70 % 
alcohol, using the method of intradermal 
injections (0.1 ml/cm²). The period of 
observation of patients was 1 year (with the 
assessment of the state at the beginning of the 
experiment, at 14 weeks, 6 and 12 months after 
the first procedure). A significant improvement 
in all estimation parameters was noted. 
In 2015, Singhal et al. [14] conducted a 
placebo-controlled study to compare PRP with 
approved drug treatment in 20 patients (16 men 
aged from 25 to 32 years, 4 women aged from 
32 to 35). The following parameters were 
evaluated: 1) hair tension test; 2) hair growth, 
hair volume, hair quality (method of review 
photos). The method of double centrifugation 
was used during the study, the obtained PRP 
was additionally activated with calcium 
chloride (in the ratio 9:1); centrifugation 
parameters were: frequency: 1. 1500 
revolutions per minute, 2. 2500 revolutions per 
minute; time: 1. 6 minutes, 2. 15 minutes; blood 
volume 20 ml; PRP volume – 8–12 ml. 
4 sessions of injections were conducted, at an 
interval of 2–3 weeks. Injections were carried 
out by the nappage method, after the skin 
surface was treated with alcohol and povidone-
iodine. The observation period for patients was 
3 months (at weekly intervals). A significant 
improvement in all estimated parameters was 
noted. For comparison, patients who were 
offered drug treatment did not notice an 
improvement in the results of the hair tension 
test and hair growth in general. 
The study by Gupta et al [15] was conducted 
on 30 patients (30 men aged from 25 to 35 
years, with stage III–VII) in 2017. The 
following parameters were evaluated: 1) hair 
density (CapilliCare trichoscan); 2) hair dia-
meter (CapilliCare trichoscan); 3) independent 
clinical evaluation of observations (overview 
macrophotography). The method of double 
centrifugation was used during the study. 6 
injections were performed at an interval of 15 
days, patients were monitored for 6 months. A 
mezoroller was used before the injections, after 
which the PRP was injected into the area of the 
crown (10 cm from the glabella). A significant 
improvement in all estimation parameters was 
noted. 
Study Schiavone et al [16] in 2014 were 
conducted on 64 patients (42 males, mean age 
28 years, with AGA stages II-V; 22 females, 
average age 32 years old, with AGA stage I-II). 
The following parameters were evaluated: 
counting the number of hair and hair thickness 
using a 15-point scale evaluation Jaeschke, 
clinical changes (macrophotography studied by 
two independent observers). The study used the 
method of double centrifugation (GPS III 
Platelet Separation System, single 
centrifugation at the first procedure, a two-fold 
– in 3 months). Plasma protein concentrate was 
added to the obtained PRP (1st procedure: 6-8 
ml PRP with 3–4 ml). 2 injections were 
performed at an interval of 3 months; patients 
were monitored for 6 months. Locally irritating 
effect achieved after applying local anesthesia 
(1 % Xylocaine with epinephrine 1:100,000) 
with skalproller exposure with needles length of 
1.0 mm in order to enhance injected platelet 
activation, punctures were made at intervals of 
1 cm. As a result, the positive effects of the 
procedures were obtained. 
The study by Gkini et al [17] was conducted 
on 22 patients, of whom only 20 completed the 
tests completely (18 men, aged from 24 to 72 
years, with AGA stage II-5A, 2 women, aged 
from 58 to 72 years, with AGA stage I) in 2014. 
The following parameters were evaluated:  
1) hair tension test; 2) density and quality of 
hair (dermatoscopic photomicrography and 
macrophotography). Centrifugation was carried 
out using the RegenA-PRPCentri (Regenlab) 
system using a single centrifugation method. 
Calcium gluconate was used as an activator 
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(0.1 ml to 0.9 ml PRP in the ratio 1:9). 
Centrifugation parameters were: centrifugal 
acceleration – 1500 g, time – 5 minutes; platelet 
enrichment × 5.8; blood volume 16 ml; PRP 
volume – 6 ml. There were 3 sessions of 
procedures (plus 1 procedure to enhance the 
effect) and at an interval of 21 days (3 
procedures at an interval of 21 days plus 1 
procedure after 6 months from the beginning), 
the observation of patients lasted 1 year. 
Injections (0.05–0.1 ml/cm²) were injected 
according to the nappage technique into the 
affected areas to a depth of 1.5–2.5 mm. 
Positive results were noted for all parameters 
studied. Subjective assessment data: 85 % of 
patients noted an improvement in the quality 
and thickness of hair, 65 % – an increase in hair 
density. 
Also in 2014, another study by Khatu et al. 
[18] was conducted on 11 patients (11 men, 
aged from 20 to 40 years, with stages II–IV of 
AGA). The following parameters were 
evaluated: 1) hair tension test; 2) counting the 
amount of hair (Trichoscan); 3) hair loss 
(clinical examination data, macroscopic 
photographs). The study used the method of 
double centrifugation (Manual Double Spin). 
Calcium gluconate (in the ratio 1:9) was used as 
an activator. Centrifugation parameters were: 
frequency: 1. 1500 revolutions per minute; 2. 
2500 revolutions per minute; time: 1. 6 minutes, 
2. 15 minutes; blood volume 20 ml; PRP 
volume – 2–3 ml. Conducted 4 procedures at a 
2-week interval, the observation of patients 
lasted 12 weeks. After treating the skin with 
cetavlon, alcohol and povidone-iodine, 
anesthetic cream was applied to the skin. 
Injections were administered by the nappage 
method. As a result, the positive effects of the 
procedures were seen in all parameters of 
evaluation. 
One of the earliest studies is a placebo-
controlled trial by Takikawa et al. [19] in 2011. 
The experiment involved 26 patients (16 men 
and 10 women aged from 28 to 59 years). The 
following parameters were evaluated:  
1) average amount of hair (digital and 
dermatoscopic image); 2) data of cross sections 
of hair (digital and dermatoscopic image); 3) 
epidermal thickness, the number of collagen 
fibers, blood vessels around the hair follicles 
(according to the 4 mm puncture biopsy). PRP 
was used with microparticles of dalteparin and 
protamine (daltepatin and protamine 
microparticles – D/P MPs). The study used the 
method of double centrifugation (Manual 
Double Spin). Parameters of centrifugation 
were: frequency: 1. 1700 revolutions per 
minute, 2. 3000 revolutions per minute; time: 1. 
15 minutes, 2. 5 minutes; platelet enrichment 
× 6; blood volume 15 ml; PRP volume – 3 ml. 
5 procedures were performed at a 2–3 week 
interval, the observation of patients lasted 
12 weeks. Subcutaneous injections (3 ml) were 
made into selected 1x1 cm zones located at a 
certain distance from the tip of the nose and 
auricle. A positive effect from the 
administration of PRPs with D/P MPs was 
noted, and in the administration of simply PRPs 
zones. 
Researches with a negative result 
2 studies were published in 2016, during 
which there was not observed significant 
improvement while using of PRT: Puig et al. 
[20] and the study of Mapar et al. [21]. 
The first double, blind, randomized, placebo 
controlled, multicenter study involved 26 
female patients, AGA stage II. Patients were 
divided into two groups: 15 women were 
included in the group where PRP was used, 11 
– in the placebo group. The following 
parameters were evaluated: 1) counting the 
amount of hair (photo method); 2) counting hair 
mass index (Cohen HairCheck system). 
Centrifugation was performed using the Angel 
PRP system (Cytomedix), platelet enrichment 
ratio ×2.75–3.4; blood volume 60 ml; PRP 
volume – 10 ml. Patients received a single 
subcutaneous injection of PRP or placebo with 
the following evaluation of results after 26 
weeks. Anesthesia used included 2 % lidocaine 
and 0.5 % bupivacaine. No significant changes 
were recorded at the 26th week, although 
patients who were administered PRP, noted a 
slower hair loss, improved hair density, 
easiness of hair styling, which was not noted by 
patients from the placebo group. 
A second randomized, placebo-controlled, 
blind study was conducted with the 
participation of 19 men, of whom only 17 
completed the tests completely (17 men aged 
from 24 to 45 years with stage IV-VI of AGA). 
The following parameters were evaluated 
(using a magnifying glass): 1) counting the 
number of terminal hairs; 2) counting the 
amount of vellus hair. The method of double 
centrifugation (Tubex PRP (Moohan 
Enterprise)) was used in the study. Calcium 
gluconate (0.1 ml to 1 ml of PRP) was used as 
an activator. Centrifugation parameters were: 
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frequency: 1. 3000 revolutions per minute, 2. 
3300 revolutions per minute; time: 1. 6 minutes, 
2. 3 minutes; platelet enrichment ratio x3; blood 
volume 9 ml; PRP volume – 1.5 ml. Square 
areas on the scalp 2.5×2.5 cm in size at a 
distance of at least 3 cm from each other, 
marked with tattoos were selected randomly, 2 
injection sessions were conducted at intervals 
of 1 month. Evaluation of the results was 
carried out on the 1, 3 and 6 months after the 
first procedure, no significant changes were 
observed regarding the initial parameters. 
CONCLUSIONS 
Positive results were obtained during the 12 
clinical studies among the conducted ones, no 
positive dynamics were observed in the end of 
other 2 studies. It can be noted that different 
methods and parameters of centrifugation were 
used to perform these experiments: PRP used 
differ or PRP activators were not used at all, 
variations were observed in methods for 
evaluating the obtained results, the multiplicity 
of procedures and intervals between them, the 
procedure technique (using a mezoroller, 
anesthetics, injections, etc.). Studies with a 
negative result were characterized by the 
smallest number of procedures performed (1 or 
2 procedures), and methods for evaluating the 
results cannot be called sufficiently reliable (a 
magnifying glass). 
It is obvious that the use of PRP has a 
positive effect on the state of AGA and can be 
used with approved methods of this disease 
treatment. However, the published results of 
only a small number of clinical trials on the 
effectiveness of PRP for hair growth cannot be 
considered objective. In addition, there is no 
published agreed protocol for the standard use 
of PRP, and the use of growth factors and 
stimulants in the expression of their genes still 
requires comparative evaluation with 
preparations approved for the treatment of hair. 
Thus, the method of PRP using can be 
considered as a method of treating AGA, 
however, it is necessary to continue research for 
further study and standardization of this 
technique. 
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Endogenous retroviruses (ERV) are the descendants of exogenous retroviruses that integrated into the 
germ cells genome, fixed and became inheritable. ERVs have evolved transcriptional enhancers and 
promoters that allow their replication in a wide range of tissue. Because ERVs comprise the regulatory 
elements it could be assume that ERVs capable to shape and reshape genomic regulatory networks by 
inserting their promoters and enhancers in new genomic loci upon retrotransposition. Thus retroransposition 
events can build new regulatory regions and lead to a new pattern of gene activation in the cell. 
In this review we summarize evidence which revealed that ERVs provide a plethora of novel gene 
regulatory elements, including tissue specific promoters and enhancers for protein-coding genes or long 
noncoding RNAs in a wide range of cell types. The accumulated findings support the hypothesis that the 
ERVs have rewired the gene regulatory networks and act as a major source of genomic regulatory innovation 
during evolution. 
KEY WORDS: endogenous retroviruses, enhancer, promoter, lncRNA, regulatory networks, R-operon, 
mobile elements, genome evolution 
 
ЕНДОГЕННІ РЕТРОВІРУСИ ЯК ГЕНЕТИЧНІ МОДУЛІ, ЩО ФОРМУЮТЬ РЕГУЛЯТОРНІ 
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Ендогенні ретровіруси (ERV) є нащадками екзогенних ретровірусів, які впровадилися в геном 
статевих клітин і стали передаватися у спадок. Впродовж еволюції ERVs ретровіруси придбали 
енхансери і промотори, які дозволили їм експресуватися у різних тканинах. Оскільки ERVs мають 
регуляторні елементи, то можна припустити, що вони здатні форматувати і переформовувати 
регуляторні мережі генома за допомогою впровадження промоторів і енхансерів у нові локуси генома 
при ретротранспозиції. 
У огляді зібрані дані, які підтверджують роль ERVs ретровірусів у формуванні ряду енхансерів і 
промоторів генів, що кодують білки, і генів, які кодують молекули довгих некодуємих РНК у різних 
тканинах. У огляді також підсумовуванні докази ролі ERVs у переформатуванні регуляторних мереж. 
Ці дані підтверджують припущення, згідно якому ERVs ретровіруси сприяють виникненню нових 
регуляторних програм і геномних інновацій впродовж еволюції. 
КЛЮЧОВІ СЛОВА: ендогенні ретровіруси, енхансери, промотори, регуляторні програми, гени 
довгої некодуємої РНК, R- оперон, мобільні елементи, еволюція генома 
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Эндогенные ретровирусы (ERV) являются потомками экзогенных ретровирусов, которые 
внедрились в геном половых клеток и стали передаваться по наследству. В течение эволюции ERV 
ретровирусы приобрели энхансеры и промоторы, которые позволили им экспрессироваться в 
различных тканях. Поскольку ERV обладают регуляторными элементами, то можно предположить, 
что они способны форматировать и переформатировать регуляторные сети генома с помощью 
внедрения промоторов и энхансеров в новые локусы генома при ретротранспозиции.  
В обзоре собраны данные, которые подтверждают роль ERV ретровирусов в формировании ряда 
энхансеров и промоторов генов, кодирующих белки, и генов, кодирующих молекулы длинных 
некодирующих РНК, в различных тканях. В обзоре также суммированы доказательства роли ERV в 
перефоматировании регуляторных сетей. Эти данные подтверждают предположение, согласно 
которому ERV ретровирусы способствуют возникновению новых регуляторных программ и геномных 
инноваций в течение эволюции. 
КЛЮЧЕВЫЕ СЛОВА: эндогенные ретровирусы, энхансеры, промоторы, регуляторные 
программы, гены длинной некодирующей РНК, R-оперон, мобильные элементы, эволюция генома 
 
INTRODUCTION 
It becomes more and more obvious that 
animals and plants live in symbiosis with 
microorganisms. And not only with bacteria 
and the simplest, but also with viruses. 
Understanding the possibility of symbiotic 
relations with viruses came at the very last time, 
before that they were considered only as 
parasites. The reason for the one-sided 
assessment of the role of viruses is the 
difficulty in studying the laws underlying the 
symbiosis, the secrecy of such laws from the 
eyes of researchers. However, as the 
relationship between viruses and animals has 
been studied, it has come to realize that 
parasitic relationships leading to the 
development of pathologies are an exception 
rather a rule in the relationship between viruses 
and organisms. In most cases, co-operative 
relationships are established between them [1]. 
Integration of viral genomes, including 
genomes of RNA viruses, into the host 
genomes occurs with an unexpectedly high 
frequency [2]. Representatives of a number of 
RNA and DNA viruses were found in the 
vertebrate and human genome, among them 
Ebola virus, filoviruses, coronaviruses, 
circoviruses, hepadnaviruses and parvoviruses 
[3–7]. Integration mechanisms are the 
introduction of retroviruses using reverse 
transcriptase, sometimes accompanied by 
recombination with other viral sequences [8], 
and also, possibly, insertion into the genome 
during theDNA breaks repairing using the 
mechanism of joining non-homologous ends 
[9]. 
Viruses participate along with bacteria in the 
horizontal transfer of genetic material, 
including mobile elements between organisms, 
which play a big role in adaptation of 
organisms and evolution to the external 
environment [10]. 
Viruses don’t only carry mobile elements, 
but can also contribute to the emergence of new 
mobile elements. Thus, new DNA transposons 
can arise as a result of merges of transposons 
and DNA-containing viruses. The mechanism 
of such a fusion is recombination. 
Exogenous retroviruses, while integrating 
into the genome during evolution, transformed 
into one of the fractions of mobile elements, 
called endogenous retroviruses (ERV). 
Mobile elements can change the genome 
both actively and passively. ERV, transferring 
genes and cis-regulatory elements, change the 
genome actively. Mobile elements contribute 
passively to ectopic recombination and, 
accordingly, to the occurrence of duplications, 
deletions or karyotypic rearrangements [11]. 
Changing the genome, mobile elements can 
facilitate and accelerate evolution [12–13]. The 
presence of mobile elements in the genomes is a 
certain risk. It reduces somewhat the current 
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adaptation of the organism, but gives 
advantages in the future. Species containing 
many mobile elements in the genome acquire a 
certain evolutionary potential, and if the 
environment, the habits of the animal or the 
habitat change, in case of an animal colliding 
with some challenges, they have a tool for rapid 
genome change and response to challenges. 
Indeed, ERVs played a huge role in the 
formation of vertebrate genomes, and primarily 
in the formation of regulatory elements of the 
genome and the reformatting of genetic 
regulatory programs in the formation of species, 
which will be discussed in detail in the article. 
Emergence of the placenta in mammals is the 
example of evolutionary innovation, in the 
origin of which endogenous retroviruses played 
an important role [13]. 
Thus, mobile elements formed by 
retroviruses or acquired due to horizontal 
transport with the help of viruses are a tool of 
rapid evolutionary changes or saltation that 
contradict the dominant ideas about gradual 
changes in the genome. 
FORMATION OF VERTEBRATE 
GENOMES OF BY ENDOGENOUS 
RETROVIRUSES 
Mobile elements have largely formed a 
fraction of the repeating sequences of the 
genome. In vertebrate genomes, the proportion 
of the repeating sequences is from 1.2 % in 
primitive fish to 38 % in reptiles [11]. The 
genome of birds contains the relatively low 
number of repeats about 6–12 %. At least one 
third of the genome in mammals is formed by 
repeating elements, and the genome of some 
primates is half composed of repeating 
sequences [11]. According to modern estimates, 
69 % of the human genome is repetitive genetic 
elements [14]. 
In general, at least in vertebrates, the 
relationship between the number of repeating 
sequences and the complexity of the organism 
is traced. The more evolutionarily developed 
the species are, the more their genome contains 
non-coding proteins of genes, including 
repetitive DNA [11]. 
Repeating sequences of vertebrates are 
largely formed by mobile elements, including 
ERVs. During the evolution of vertebrates, 
exogenous retroviruses were implanted many 
times in germinal cells and transmitted to the 
offspring, becoming ERVs [15]. All placental 
mammals contain endogenous retroviruses. 
They played a large role in the formation of the 
placenta of mammals as was noted above [13]. 
Currently, it has been possible to observe the 
process of endogenization of retroviruses in 
Australian koalas. This species was transported 
under threat of extinction to the islands in the 
early 20th century. On the islands, coals were 
infected with marmoset retroviruses and gibbon 
leukaemia virus. Many of them died, but some 
survived and gained stability. Retroviruses were 
introduced into germinal cells in surviving 
koalas and viruses were transmitted to offspring 
[16]. 
ERVs compose 8 % of the human genome 
[17]. In comparison, all sequences that encode 
proteins make up about 1.5 % of the human 
genome [17]. Complete ERVs encode a group-
specific protein Gag, Pro protease, Pol 
Polymerase and occasionally envelope protein. 
Long terminal repeats (LTRs) flank ERVs on 
both sides. LTR elements are necessary for 
replication of the retrovirus and contain cis-
regulatory sequences which transcription 
factors specifically bind with, as well as 
promoters which transcription starts from. The 
length of the long terminal repeats is about 
1000 bp. Recombination between 5 'and 3' LTR 
sequences of endogenous retroviruses results in 
the formation of single LTRs, 577,000 of which 
were detected in the human genome [18]. 90 % 
of ERVs are single LTR elements. 
The role of retroviruses in genome 
formation is determined by the fact that they 
contain a wide variety of regulatory elements. 
ERVs are potential sources of enhancers, 
alternative promoters, splice sites [19], and sites 
for polyadenylation [20]. So about 40 
transcription factors can bind to LTR elements 
and regulate the transcription of human ERV 
type K (HERVK) [21]. The presence of 
regulatory elements creates a potential for 
tissue-specific expression of the retroviruses 
themselves, as well as for reformatting the 
expression of genes of the host genome. 
Today, it is not known whether the ERVs 
contain retroviruses cis-regulatory elements that 
allow them to interact with trans-regulatory 
factors of the cell, prior to insertion into the 
genome, or they acquire them after the 
introduction. At least in some cases it was 
possible to show that cis-regulatory elements 
existed in retroviruses before they were 
introduced into the genome. So, elements of 
mice containing the regulatory modules 
RLTR9B2, RLTR9D and RLTR9E inherited 
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these modules and the ability to regulate gene 
expression from progenitor retroviruses prior to 
their introduction into the genome [22]. 
TISSUE-SPECIFIC ACTIVATION OF 
ENDOGENOUS RETROVIRUSES 
For a long time it was believed that mobile 
elements are epigenetically suppressed and 
therefore cannot play an active role in the 
regulation of gene expression. However, a 
number of data allowed overcoming this error. 
First, mobile elements and endogenous 
retroviruses among them form tissue 
specifically DNAase I sensitive regions. These 
regions differ of about 100 times based on 
sensitivity to DNase I. DNase I sensitive 
regions are chromatin regions with an open 
chromatin configuration, that is functionally 
active regions. Scientists have constructed a 
map of DNase I sensitive regions of the 
genomes of a number of human cell lines [23]. 
About 2.9 million DNase I sensitive regions in 
total were found in the human genome. 
Approximately 3 % of the DNase sensitive 
regions are located in the start site region of the 
transcription of the gene-encoding genes, but 
lies within 2.5 kb from the point at which the 
5 % of transcriptions start. The remaining 95 % 
of DNase I sensitive regions are located at a 
great distance from the starting transcription 
areas in introns and in intergenic regions. The 
formation of DNase I sensitivity of sites located 
at large distances is largely tissue-specific. 
44 % of DNase I sensitive regions are 
located in mobile elements. Moreover, if we 
consider primate-specific sensitive regions of 
DNase I sensitive regions, then this value 
reaches 63 % [24]. DNase I sensitive regions 
are mostly concentrated in long terminal repeats 
of LTR endogenous retroviruses. Mapping of 
DNase sensitive sites in normal, embryonic and 
cancer cells has shown that up to 80% of ERVs 
in the human genome form tissue specifically 
DNase I sensitive regions with an open 
chromatin structure [24]. Tissue-specificity is 
determined by cis-regulatory sequences of LTR 
elements. The formation of an open chromatin 
structure by LTR elements is often associated 
with the expression of neighbouring genetic 
loci [24]. 
Secondly, it was previously thought that 
mobile elements inactivity is to a large extent 
due to the hypermethylation of their DNA 
sequences. However, the study of methylation 
of 928 subfamilies of mobile elements in 
embryonic and terminally differentiated human 
tissues showed that the DNA of these elements 
is tissue-specific and specific with respect to the 
kind of mobile element being hypomethylated 
[25]. Certain classes of ERVs were mostly 
tissue specifically hypomethylated. We studied 
the hypomethylation of mobile elements in only 
4 types of cells. About 10 % of the studied TE 
subfamilies are hypomethylated in these tissues. 
However, if we study more cells, it is likely that 
a significantly greater percentage of mobile 
elements are tissue-specific hypomethylated. 
A significant part of the genes among 
located close to the hypomethylated tissue-
specific mobile elements is composed of genes 
encoding proteins necessary for this type of 
tissue, and gene expression correlates with the 
hypomethylation of nearby mobile elements. 
Moreover, hypomethylation is accompanied by 
the acquiring of a typical epigenetic marker of 
enhancers by these areas. Many of the 
hypomethylated mobile elements do have 
enhancer activity, which is detected by the 
reporter method. Also, many of these sequences 
have binding sites to transcription factors that 
are specific to the respective tissues. Therefore, 
hypomethylated sequences of mobile elements 
can potentially function as enhancers. 
Nevertheless, this is not proven. 
Thirdly, an LTR element contains cis 
elements, and often even clusters of cis-
elements which tissue regulatory transcription 
factors binding with. The total number of DNA 
fragments came from human endogenous 
retroviruses is estimated to be 717,778. 
Approximately (~15 %) of the 110,000 
fragments contain at least one binding site with 
a transcription factor [26]. According to recent 
estimates, the human genome contains 794,972 
binding sites with 97 transcription factors [27]. 
On the average, about 20% of binding sites 
with 26 regulatory transcription factors are 
located in mobile elements, mainly in LTR 
elements in human and mouse genomes. Some 
of the mobile elements formed 5 %, and the 
other 40 % of the overall number of all binding 
sites with a certain transcription factor [28]. 
Binding sites with transcription factors have an 
open chromatin structure in the LTR elements, 
and therefore DNase sensitivity, they are 
hypomethylated and contain epigenetic 
modifications of histones typical for enhancers. 
On the average, 66 % of the binding sites of 
transcription factors with mobile elements are 
formed tissue specifically [28]. 
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Three main clusters can be distinguished 
among LTR elements of human ERV (HERV) 
based on binding patterns with transcription 
factors [27]. The first class includes LTR 
elements associated with transcription factors of 
pluripotency (SOX2, POU5F1 and NANOG). 
For example, evolutionarily young LTR7 
elements transcribed actively in pluripotent 
cells and they are enriched with binding sites 
with SOX2, POU5F1 and KLF4 transcription 
factors of pluripotency. The second class 
includes LTR elements that bind to factors 
expressed in the embryonic ectoderm and 
embryonic mesoderm (GATA4 / 6, SOX17 and 
FOXA1 / 2), and the third class elements bind 
to hematopoietic transcription factors (SPI1 
(PU1), GATA1 / 2 and TAL1). There is also a 
group of HERV containing a binding site with 
CTCF factors, i.e. cis sequences capable of 
forming insulators and topological domains 
[27]. 
Binding sites with transcription factors are 
not only tissue-specific, but also species-
specific. Up to 25 % of all binding sites in 
embryonic stem cells of humans and mice with 
key transcription factors of pluripotency OCT4 
and NANOG came from mobile elements 
specific to these species, including HERV [29]. 
More than 98 % of 132,197 0 binding sites 
with 26 transcription factors localized in the 
mobile elements of the human genome, are 
absent in the genome of mice [28]. At the same 
time, there are also conservative binding sites. 
In all likelihood, species-specificity of cis-
regulatory elements arises from the introduction 
and amplification of specific mobile elements, 
which occurred after the separation of the two 
lines leading to the appearance of human and 
mice. Another interesting phenomenon is that 
there is an expansion of species-specific 
binding sites with transcription factors in both 
genomes. 
Finally, ERVs can not only contain 
epigenetic markers of active chromatin and bind 
tissue-specifically to transcription factors, but 
can also be expressed tissue-specifically and 
even in response to environmental conditions. 
Tissue-specificity of ERVs expression is 
confirmed by data obtained from the ENCODE 
program, as well as from the number of other 
studies [30]. Thousands of retroviral sequences 
are specifically activated in cells, especially 
embryonic cells, cancer cells, as well as in 
response to various stimuli [31]. 
ERVs of the human genome are expressed in 
oocytes, zygotes, 2–8-cell embryos, morulae 
and blastocysts, as well as in embryonic stem 
cells. To the greatest extent they are expressed 
at the stage of development of oocytes to 4-cell 
embryos [32]. The expression of ERVs is 
reduced from the stage of the 8-cell embryo. 
ERVs are expressed stage specifically, and also 
specific for differentiated cell populations that 
arise among blastocysts. The majority of ERV 
elements expressed during the listed stages of 
embryonic development are not activated in the 
tissues of an adult organism. Specific cis-
regulatory sequences of LTR elements 
determine the stage specificity of expression of 
ERV. 
In B lymphocytes, expression of endogenous 
human and mouse retroviruses is activated by 
stimulation of cell proliferation in vitro and in 
vivo, as well as in chronic diseases, including B 
cell lymphoma. A small number of LTR 
elements, which are constantly activated in 
stimulated B cells, are detected, with one of the 
Xmv45 retroviruses being expressed in a larger 
amount than the rest of them combined. The 
expression of a large number ERVs is at the 
same time activated during B cell 
transformation [33]. 
Thus, LTR elements acquire DNAase I 
sensitivity in a tissue-specific manner, become 
hypomethylated, acquire epigenetic histone 
modifications typical for transcriptionally active 
loci and enhancers, bind to transcription factors 
and even are transcribed [24–25, 28]. Together, 
these data indicate the biochemical activity of 
cis-regulatory elements of ERVs and suggest 
that they are the source of regulatory sequences 
of the genome. 
However, these data are insufficient to state 
that cis-regulatory elements of ERVs really 
control the expression of protein-coding genes. 
For example, cis-regulating binding sites can 
serve as a buffer for transcription factors, 
landing sites from which transcription factors 
begin to scan DNA in search of an attachment 
site. At the same time, species-specific ERVs 
capable of tissue-specific activation are an 
excellent tool for creating new regulatory 
elements and genetic programs in the evolution 
process. Experimental data confirm the role of 
endogenous retroviruses in the formation of 
alternative promoters and enhancers, as well as 
genes of long non-coding RNAs and the role in 
the reformatting of regulatory networks [29–
33]. 
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ENDOGENOUS RETROVIRUSES AS A 
SOURCE OF REGULATORY ELEMENTS 
AND NON-CODING RNA GENES 
When cis elements of the LTR intrude close 
to the genes, the sequences of ERVs 
retroviruses can form alternative promoters, 
thereby increasing the number of gene 
isoforms, while the gene can acquire new 
tissue-specific expression [34–38]. At the 
moment, a small number of cases of the 
alternative promoters ‘formation by ERVs have 
been well studied. 
A classic example is the acquisition of the 
ability to express in the human salivary glands a 
gene that encodes the enzyme amylase. It 
acquired this ability due to the insertion of the 
LTR element and the formation of an LTR 
alternative promoter [34]. 
The human gene encoding the B3GALT5 
metabolism factor is expressed in many 
differentiated cells, but the primate-specific 
alternative promoter formed by LTR element is 
used in cells of the large intestine [35]. 
Prolactin is not produced by the uterus of a 
number of mammals, such as rabbits, dogs, pigs 
and armadillos. At the same time, it is produced 
during pregnancy by the uterus of the primates, 
mice and elephants. Regulation of the 
expression of the gene encoding the precursor 
of prolactin in the uterus has evolved in 
mentioned mammals. The alternative gene 
promoter contains the DNA transposon in 
humans and spider monkeys, as well as the 
MER39 retrovirus, and the mouse alternative 
promoter originated from the MER77 
endogenous retrovirus [36]. 
The NAIP gene encodes an inhibitory 
apoptosis of neuronal proteins. The NAIP gene 
is regulated by a variety of promoters both in 
humans and in mice that do not coincide 
between them. LTR elements of ERVs in the 
human genome have formed an alternative gene 
promoter that allows the gene to be expressed 
in testicles [37]. Rodents contain several copies 
of the NAIP gene. The main constitutive 
promoter of these genes is formed by LTR 
elements of the ORR1E ERV. In addition, the 
MT-C ERVs formed a minor promoter of two 
copies of the NAIP gene. 
The gene that encodes the erythroid 
transcription of Pu. 1 mice factor has an 
alternative promoter. The promoter is formed 
by the LTR element of the ORR1A0 retrovirus 
located in the intron of the Pu.1 gene [38]. A 
chimeric transcript of Pu.2 is formed when 
expressed from this promoter. It induces 
erythroid differentiation in vitro. 
Thus, cis-regulatory sequences of LTR 
elements of ERVs initiate the synthesis of 
transcripts from gene-encoding genes in 
addition to its own synthesis [34, 36, 38]. 
Transcripts formed are chimeric RNA 
molecules by structure. Chimeric transcripts 
contain sequences of retroviruses at the 5 'end. 
The rest of the transcripts are identical to the 
sequences of the corresponding genes. 
ERV are potentially able to quickly reformat 
regulatory networks possessing the ability to 
move in the genome, and on the other hand, 
being introduced near the genes and supplying 
them with alternative promoters. Indeed, ERVs 
in the evolution participated species-specific 
and tissue-specific in the formation of 
regulatory programs, which will be discussed 
below. 
At the same time, ERVs retroviruses can 
intrude at large distances from genes encoding 
proteins and form distal regulatory elements – 
enhancers. 
LTR9 element located at a distance of 40–70 
kb upstream of human gamma and beta globin 
genes forms an enhancer that activates the 
expression of the β-globin gene in transgenic 
mice [39]. Moreover, even hypermethylated 
ERV9 LTR possesses enhancer activity since in 
vivo deletion of LTR by CRISPR-cas9 method 
suppresses gene activity more than 50 % [40]. 
MaLR LTR is an enhancer that controls the 
expression of the proopiomelanocortin Pomc 
gene in the pituitary and hypothalamus of 
mammalian [41]. And the enhancer, which 
results from the MaLR of LTR element, 
provides about 80 % of the Pomc gene 
expression [42]. 
The tissue-specific enhancer hsERVPRODH 
formed by the ERV controls the transcription of 
the PRODH gene in the hippocampus. The gene 
encodes proline dehydrogenase and, apparently, 
participates in the synthesis of 
neurotransmitters in the central nervous system 
[43]. Expression of the gene is necessary for the 
normal functioning of the central nervous 
system. The enhancer activity of 
hsERVPRODH is manifested in the 
hypomethylated state during the attachment of 
the transcription factor SOX2. 
The enhancer can be formed by co-opting 
the regulatory sequences of several mobile 
elements [44]. 
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So, for example, the region originating from 
AmnSINE1 of the non-autonomous 
retrotransposon does not have enhancer activity, 
but nevertheless preserves its conservatism in 
the platypus and human genome. However, the 
integration of the DNA of the transposon allows 
the acquisition of a binding site with the 
transcription factor Msx1 after the single-pass 
divergence. The endogenous retrovirus 
MER117 is introduced at the next stage after 
the masculine divergence, resulting in the 
formation of a modern enhancer [44]. 
There are reasons to believe that many 
enhancers have been formed in this way. 
Indeed, in the human genome 54 (8.6 %) out of 
626 conservative AmnSINE1 loci are 
associated with other evolutionarily conserved 
mobile elements, among which LTR-containing 
ERVs and DNA transposons. Such sites are 
potential enhancers, however, this has not been 
proved yet. 
Data obtained from the ENCODE project 
showed that at least 75 % of the genome is 
transcribed with RNA formation, despite the 
fact that the protein-encoding DNA sequences 
make up only 1.5 % [45]. These data were 
obtained by studying of 15 cell lines. Therefore, 
the data is understated and in fact the 
percentage can be even higher. As already 
discussed, most of the genome repeating 
sequences, including ERV, are actively 
transcribed [46]. 
A significant portion of the transcribed RNA 
is formed by long non-coding RNA (lncRNA). 
LncRNAs are molecules whose length is above 
200 bp. According to the NONCODE database, 
there were 96,308 genes encoding lncRNA and 
172216 lncRNA transcripts in 2018 [47]. 
The genes encoding lncRNA and mRNA are 
similar in size and structure. The transcription 
of lncRNA starts from promoters that contain 
binding sites with transcription factors and 
epigenetic markers typical for transcriptionally 
active genes [45]. The lncRNAs are mainly 
transcribed by RNA polymerase II. The 
lncRNA molecules contain a cap at the 5 'end 
and are polyadenylated at the 3' end and are 
characterized by alternative splicing [45]. 
The tissue-specificity of expression is more 
characteristic for lncRNA genes than for 
protein-encoding genes. LncRNA genes are 
expressed not only tissue-specifically, but, 
apparently, each cell contains its unique set of 
lncRNA molecules [48]. 
lncRNAs are not a homogeneous class of 
molecules, but a mixture of molecules with 
different biochemical mechanisms of action and 
function. The ability to interact 
complementarily with DNA, modular 
organization and alternative splicing allow 
lncRNA molecules to function as address 
epigenetic modulators, which, deliver 
epigenetic information to the right place in 
response to external actions and the existing 
metabolic situation in the cell. 
Mobile elements play an important role in 
the occurrence of long non-coding RNA in 
vertebrates from fish to humans [49, 50]. ERVs 
played the main role in the formation of 
lncRNA genes in mice and humans, and DNA 
transposon played such role in the genome of 
zebra fish. Mobile elements formed largely the 
primate genes encoding lncRNA as well as. 
Thus, mobile elements were detected in 83 % of 
9241 lncRNA molecules and accounted for 
42 % of the total sequence of all human 
lncRNAs [49]. ERVs appear to be the main 
factor contributing to the emergence of new 
lncRNA genes due to their ability to species-
specific incorporation into genomes and spread 
in them, as well as due to regulatory sequences 
presence in them. Genes of human lncRNA are 
enriched by the sequences of ERV1, ERVL-
MaLR, ERVL and ERVK retroviruses. 
ERV insertion could diversify the already 
existing lncRNA genes in some cases during 
the evolution. At the same time, in other cases, 
new lncRNAs appeared as a result of the ERV 
insertion. Apparently, the presence of cis-
regulatory elements and tissue-specific 
transcription were the main properties that 
allowed retroviruses to form new lncRNA 
genes during evolution [50]. 
Indeed, ERVs are located mainly in the 
region of 5 'ends of lncRNA transcripts in a 
sense orientation, i. e. in a position that allows 
LTR elements to initiate transcription and 
regulate it. For example, transcription of the 
lncRNARoR gene in human embryonic stem 
cells is controlled by the cis-regulatory 
sequences of the LTR7/HERVH element that 
bind to OCT4, NANOG, and SOX2 
transcription factors [50]. 
A new class of lncRNA has recently been 
discovered, which is called chromatin enriched 
RNA (cheRNA). Almost all genes encoding 
completely cheRNA are formed by 
retrotransposons, including ERV. 
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Most cheRNA molecules interact with RNA 
polymerase II and remain bound to chromatin 
by transcription or stopping transcription [51]. 
In general, cheRNA genes are expressed 
tissue-specifically. Proximity to the genes 
encoding the expressed cheRNA cells in this 
type of cell is most accurately combined with 
the transcriptional activity of the protein-
encoding genes. Moreover, such proximity is 
more often associated with the transcriptional 
activity of protein-encoding genes than the 
expression of long non-coding RNAs of other 
classes and even the transcription of enhancers 
in this type of cells. Deletion of several 
cheRNA molecules resulted in a significant, 
about 75 % reduction in the transcription of a 
nearby lying gene. Together, these data indicate 
that cheRNA acts as a transcriptional activator. 
However, it is not clear if the transcription of 
these loci itself causes such an effect, or 
synthesized RNA molecules are needed. 
A number of data suggest that a rapid 
species-specific formation of new lncRNA 
genes occurs due to mobile elements during 
evolution [50, 52]. A significant portion of the 
genes of human lncRNA arouse recently, 
apparently due to the activity of mobile 
elements. Indeed, 40 % of lncRNA containing 
the mobile elements are specific for primates 
[50]. 
Very interesting data were obtained during 
the study of tomatoes. Comparison of the 
lncRNAs of two tomato species Solanum 
lycopersicum and Solanumpimpinellifolium 
showed that a small part 6.7 %, (24 of 353) of 
lncRNA molecules appeared to be common for 
both species [52]. And only less than 0.4 % of 
lncRNAs are common for all sequenced 
genomes of tomatoes and potatoes. Apparently, 
the appearance of lncRNA genes is associated 
with mobile elements in the genomes of two 
species of tomato, since 85 % of Lycopersicon-
specific lncRNA molecules contain mobile 
elements. 
Thus, ERVs can regulate gene activity, not 
only by forming enhancers and alternative 
promoters, but also by species-specifically 
creating genes of lncRNA. LncRNA promoters 
are formed thanks to retroviruses, as well as 
tissue-specific regulatory networks controlling 
the expression of lncRNA genes. LncRNA, 
regulate the transcription of protein-coding 
genes in turn, including the transcription of 
adjacent genes. And, finally, mobile elements, 
which ERVs are among, can cause rapid 
evolutionary changes of lncRNA genes. 
REFORMATTING REGULATORY 
NETWORKS BY ERVS 
Changes in genetic regulatory programs 
underlie phenotypic differences between 
species and within the species. However, the 
mechanisms of changes in regulatory networks 
in evolution are poorly understood. Extremely 
intriguing is the regulatory networks feature to 
change quickly and consistently. In order for 
the genome to acquire a certain set of regulatory 
elements for coordinated regulation, a number 
of corresponding single mutations must appear 
in those regulatory regions of the genome that 
regulate the corresponding genes. So that is 
necessary that a multiplicity of identical 
mutations arose in a variety of regions of the 
genome in a short evolutionary time interval. At 
the same time, several implementations of 
mobile elements containing regulatory elements 
in several regions of the genome are needed to 
form a new regulatory network. 
LTR elements of ERVs contain not only cis-
regulatory elements, but also cis-regulatory 
modules, which significantly expands their 
potentialities in the formation of new regulatory 
networks [22]. Cis-regulatory modules are a set 
of cis-regulatory sequences binding 
transcription factors that co-regulate the activity 
of target genes. Thus, ERVs containing single 
cis-regulatory elements and clusters of binding 
sites with transcription factors are a good 
natural tool for rapid and consistent changes in 
regulatory chains. 
One can imagine at least three ways in 
which ERVs form and reformat regulatory 
networks. First, they can distribute alternative 
promoters in the genome. Secondly, they can 
contribute to the acquisition of new enhancers 
by multiple genes. And thirdly, they can form 
networks of tissue-specific and species-specific 
expressed lncRNA genes. 
The spread of alternative promoters by 
ERVs is confirmed by a variety of data. 
Synthesis of about 6–30 % transcripts 
containing cap at the 5 'end isolated from 
various embryonic and differentiated cells of 
mice and humans starts with mobile elements 
[53]. These transcripts are mainly tissue-
specific. 
Expression of a number of ERVs is activated 
in mature oocytes and at the stage of the double 
cellular embryo of mice, but with further 
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development of the embryo their expression is 
suppressed. Chimeric transcripts are 
synthesized when LTR elements are activated 
in mature ovum, their transcription starts from 
alternative promoters formed by MaLR and 
ERVK retrovirus families [54]. It was possible 
to detect more than 500 chimeric transcripts, in 
the formation of which 307 protein coding 
genes take part, using sequencing RNA 
sequences of cells isolated from a population of 
mouse embryonic stem cells and corresponding 
to cells of a 2-cell embryo. Synthesis of 
chimeric transcripts begins with LTR elements 
of the retroviruses of the MERVL family and 
extends beyond the retrovirus, including genes 
[55]. 
When the mouse 2–4-cell embryos 259 
transcript were sequenced, the relationship 
between activation of LTR elements of ERVs 
and a temporary and strong increase in the 
transcription of adjacent genes were confirmed. 
LTR elements regulating significantly the 
transcription of neighbouring genes have been 
enriched by binding sites with home box 
containing transcription factors [56]. As it is 
known, home box-containing transcription 
factors are key regulators of morphogenesis in 
embryonic development. 
However, the question arises whether 
chimeric transcripts has the function. In, firstly, 
the fact that more than 90 out of the 626 
chimeric transcripts synthesized in mouse 
embryonic stem cells retain the open reading 
frame proves their functional significance [55]. 
Secondly, genes encoding critical for the 
differentiation of early embryonic cells 
transcription factors GATA and TEAD, use 
LTR as alternative promoters [55]. 
The promoter of the Dicer1 gene is the 
promoter containing the CpGIsland in most 
cells, and the promoter in mouse oocytes is the 
LTR element of the ERVs – MaLR [57]. 
Deletion of an alternative promoter reduces the 
expression of the Dicer1 gene in oocytes and 
causes infertility [58]. 
Thirdly, cultured mouse embryonic cells that 
express transcripts from LTR sequences and 
cells that do not express transcripts from LTR 
elements have different phenotypes [55]. 
Regulatory networks that are altered by 
ERV-derived enhancers are found in cells of 
tissues associated with sexual reproduction, in 
embryonic stem cells and on the early stages of 
embryogenesis, in erythroblasts and in 
terminally differentiated liver cells and the 
immune system. 
The cis-regulatory element of the MaLR 
retroviruses binds to the Tbx6 transcription 
factor. Expression of at least four genes, whose 
enhancers are formed by MaLR LTR, 
significantly decreases in mice deficient in 
Tbx6 transcription factor [59]. Tbx6 regulates 
gene expression during early embryogenesis. 
Mice placenta cells used ERVs for species-
specific reformatting of the regulation of gene 
expression. A class of retroviruses RLTR13D5 
was detected by revealing the profile of 
epigenetic markers and binding sites with the 
transcription factors of stem cells of 
trophoblasts in mice and rats. It forms a 
significant part of active in the placenta 
enhancers [60]. These ERVs retroviruses 
contain binding sites with transcription factors 
Eomes, Cdx2 and Elf5, which play key 
roleintrophoblast regulatory networks. Ehancers 
made by retroviruses have formed a network 
consisting of hundreds of elements, and control 
the synthesis of one-third of all placental 
specific transcripts [60]. 
However, the RLTR13 family of ERV, 
which formed a regulatory network of 
trophoblast stem cells, is specific for mice. 
Even in rats, most mouse enhancers formed by 
the ERVs of the RLTR13 family are absent. 
LTR elements played a significant role in 
the formation of new regulatory networks that 
evolved in monkeys in the liver. 
Indeed, 77.1 % of the cis-regulatory 
elements specific for monkeys and virtually all 
the cis-regulatory elements those are specific 
for the human genome, cis-regulatory elements 
of the liver overlap with retrotransposons [61]. 
Regulatory activity of a number of elements 
containing retrotransposons was confirmed by 
studying the activity of synthesized consensus 
sequences in cultured liver cells HepG2 using a 
luciferase reporter assay. 
The LTR elements of ERVs and the SVA 
retrotransposons containing retroviral elements 
contributed to the greatest extent to the 
formation of regulatory programs that appeared 
at the last stages of the evolution of regulatory 
programs. At the same time, only 16.0 % of 
evolutionarily conserved cis-regulatory 
sequences contain mobile elements. Thus, 
cortical regulatory programs that ensure the 
identity of liver cells persist throughout the 
evolution of primates, while peripheral 
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regulatory programs are rapidly evolving with 
the help of ERV. 
The formation of a line-specific and tissue-
specific regulatory network activated by 
interferon is the most rigorously demonstrated 
example of the participation of ERVs in the 
reformatting of regulatory networks by the 
formation of new enhancers. 
Researchers used the CRISPR-Cas9 method 
for deletion part of ERVs specific for primates 
of the MER41 family containing cis elements 
which transcription factors activated by 
interferon bind to [62]. The genes were no 
longer regulated by interferon as a result of the 
deletion, their expression decreased, which 
manifested among other things in the alteration 
of various phenotypic signs, among which 
decreased inflammatory response in response to 
infection. Thus it was possible to show that the 
human genome contains 962 ERVs of the 
MER41 family, which bind to the transcription 
factors STAT1 and IRF1 in at least one type of 
cells. Together, these data show that the 
MER41 elements have formed a regulatory 
network controlled by interferon. 
MER41 contains a tandem sequence that 
binds to the transcription factor STAT1. The 
same sequence contains MER41-related 
retroviruses of lemurous, bats, carnivores and 
artiodactyls. Therefore, it can be assumed that 
related ERVs form interferon-induced 
enhancers in different mammalian species. 
Indeed, the consensus sequence of MER41-like 
LTR elements of dogs and cows shows activity 
in the luciferase reporter assay in the HeLa cell 
line in response to induction by interferon. 
Mice do not have a MER41 family of 
retroviruses, but endogenous gamma-
retroviruses RLTR30B specific for mice also 
formed enhancers controlled by interferon. 
Methods of bioinformatics allowed revealing 
the connection between RLTR30B elements 
and genome loci containing the immune 
response genes. Consequently, two different 
families of endogenous retroviruses formed 
convergent interferon-regulated immune 
response programs in two mammalian species: 
humans and mice. 
Next ERV have formed regulatory networks 
consisting of lncRNA genes. 
LTR elements of mice ERVs control the 
transcription of lncRNA genes in the post-
mitotic phase of the cell cycle of spermatocytes 
and round spermatids [63]. LTR elements have 
formed tissue-specific lncRNA promoters, thus 
creating a regulatory network that allows them 
to regulate the expression of lncRNA genes in 
spermatogenesis. Interestingly, a small part of 
the transcript elements initiated with ERVs 
encodes the open reading frames, which allow 
the peptides synthesis. 
LTR elements of the ERV1 form regulatory 
sequences that control the tissue-specific 
expression of lncRNA in human testes [64]. 
The synthesis of transcripts starts from a 
number of HERV expressed in oocytes, 
zygotes, 2–8 cell embryos, morulae and 
blastocysts, as well as in embryonic stem cells, 
and extends beyond the retrovirus. Then, RNA 
molecules are formed as a result of splicing 
containing exons of non-retroviral nature. For 
example, 95 % of the elements of the MLT2A1 
family of retroviruses encode such RNA 
molecules. Most of the non-retroviral exons are 
unannotated and, apparently, form a non-coding 
lncRNA [32]. 
The lncRNA genes containing human H 
retroviruses of the HERVH family are 
specifically expressed in embryonic stem cells 
and induced pluripotent stem cells. Expression 
of HERVH containing lncRNA genes is 
necessary to maintain pluripotency in cells [49]. 
127 lncRNA genes are transcribed in the 
embryonic stem cells, containing the LTR7 
elements of the HERVH in the sense orientation 
near the sites of the beginning of transcription. 
LTR elements of HERVH containing lncPHK 
genes bind with OCT4 and NANOG 
pluripotency transcription factors [49]. 
Another method by which endogenous 
retroviruses can form regulatory networks is 
found in erythroblasts, which ERV9 human 
retroviruses have formed a regulatory network 
in, creating both enhancers, and lncRNA genes 
[65]. 
lncRNA transcribed from LTR 
retrotransposons of ERV9 activates the 
transcription of key erythroid genes and 
modulates erythropoiesis ex vivo. 
Theoretically, ERV9 lncRNA can regulate the 
transcription of key erythropoiesis genes by 
acting in cis or in trans, diffusing from the site 
of synthesis to the target gene, which can be 
located on another chromosome. To understand 
the mechanism of action of ERV9 lncRNA, the 
synthesized transcripts were analysed before 
and after the global deletion or locus-specific 
deletion of ERV9 lncRNA in human 
erythroblasts containing ~ 4000 copies of ERV9 
LTR and in mice erythroblasts containing one 
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transgenic copy of the primate specific ERV9 
LTR in the locus, which encodes the beta-
haemoglobin gene. 
As a result, it was shown that ERV9 
lncRNA, synthesized from the ERV9 LTR 
element, which controls the transcription of the 
beta-globin gene, remains associated with LTR 
and interacts with transcription factors and 
polymerase II, forming an enhancer complex. 
The enhancer complex interacts with the 
downstream gene promoter, thereby activating 
transcription. 
In ERV9 erythroblasts, lncRNA is 
transcribed from many of 4000 copies of ERV9 
retrovirus, stabilizes the enhancer complex and 
activates the transcription of a number of genes 
in cis, including key erythropoiesis genes, 
including haemoglobin genes, as well as genes 
encoding the transcription factors of 
erythropoiesis KLF1 and CCNDBP1. 
So, the regulatory networks of early 
embryonic tissues, pluripotent embryonic cells, 
liver cells, erythroblasts, interferon-induced 
gamma genes are reformatted species-
specifically by endogenous retroviruses. These 
data support the hypothesis that ERVs are used 
during evolution for species-specific 
reformatting of regulatory programs. Moreover, 
ERVs are convergent used by various species to 
form regulatory networks induced by gamma 
interferon. Examples of convergent use of 
ERVs for the formation of promoters were 
given earlier. These examples of completely 
amazing convergence remain a mystery of 
evolution. Is the use of mobile elements for 
similar regulatory programs creation in 
different species of animals due to chance? Or 
as Shapiro writes in his article: the elements 
responding to some as-yet-to-be-defined 
regulatory process that guides the adaptive 
integration of newly established regulatory 
signals? To answer this question, it is necessary 
to calculate the probability according to which 
such a regulatory network can form in 
evolution, based on the assumption of chance. 
On the other hand, there is data currently 
accumulating according to which the 
introduction of mobile elements is not a random 
process, but occurs localized in time and space 
[11]. It is interesting that another type of 
retrotransposon, long LINE intersperse 
elements, are activated in neurons during 
differentiation [66]. The sites for introducing 
LINE elements in neurons are not accidental. 
They are predominantly localized in enhancers 
actively transcribed in the neurons genes [67]. 
Moreover, it is assumed that LINE elements are 
implanted into double DNA ruptures that are 
formed in genes and actively transcribed in 
terminally differentiated neurons. In other 
words, the localization of retrotransposon 
introduction sites is determined by the 
functional activity of neurons [68]. 
HYPOTHESIS OF R-OPERON 
It is well known that homologous DNA 
sequences have the ability to recognize and 
interact with each other. The interaction 
between homologous sequences will inevitably 
affect the location of DNA molecules in the 
core space. Therefore, a model has been 
proposed, according to which repeated 
homologous elements of the genome form 
and/or stabilize the specific spatial structure of 
both interphase chromatin and mitotic 
chromosomes [69–70]. 
According to the model, when interphase 
chromatin is laid, an association occurs between 
the homologous mobile elements resulting in 
the formation of homologous pairs, which then 
form a repetition assembly (RA). The 
organization of interphase chromatin is the 
basis for formation of mitotic chromosomes. 
More and more homologous pairs establish 
contact with each other during the laying of 
mitotic chromosomes. The chromatin filaments 
gradually become denser, forming mitotic 
chromosomes accordingly. Thus, repeating 
elements form the skeleton of interphase 
chromatin and mitotic chromosomes. 
However, the question arises whether the 
localization of repetitions, mainly formed by 
mobile elements, is primary. Whether it is the 
driver of the process of laying interphase 
chromosomes or just a consequence of 
chromatin packing. 
The following data are further indication of 
the assumption of the primacy of the interaction 
between homologous mobile elements 
Firstly, it is well established that chromatin 
has the ability to localize in loci with 
homologous DNA sequences [71–73]. 
Secondly, it has been studied the 
interchromosomal contacts of various families 
of repeats in the genomes of human embryonic 
stem cells, drosophilas and mice, and also in 
three human cell lines to test this hypothesis 
and built a global picture of the spatial 
organization of repeats in chromosomes [72]. 
The degree of localization of repeats formed by 
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different families of mobile elements, including 
LTR-containing ERV, DNA transposons, short 
interspersed elements (SINE) and long 
interspersed elements (LINE) was 
quantitatively evaluated. 
All families of mobile elements contained 
subfamilies prone to localization in nuclear 
space. That is, the formation of clusters in 
three-dimensional space turned out to be a 
common feature of mobile elements genomes of 
different organisms. 
It was possible to show the conservatism of 
the organization of synthetic blocks in the 
nuclear space of mice and humans. Synthetic 
regions containing a similar set of mobile 
elements form similar spatial contacts in the 
genomes of mice and humans. 
The most frequently collocated mobile 
elements in space are evolutionarily more 
ancient and contain binding sites with 
transcription factors. The presence of cis-
regulatory sequences in the localizing elements 
indicates the possibility of regulating the 
formation of three-dimensional contacts 
between mobile elements by transcription 
factors, and, consequently, by the 
environmental conditions and the metabolism 
of the cell. 
Together, these data suggest that contacts 
between retrotransposons are not a passive 
consequence of chromatin packing, but actively 
influence the architecture of interphase 
chromatin. These data are in good agreement 
with the hypothesis of the R-operon [73]. 
According to this hypothesis, the eukaryotic 
genome forms structurally functional domains 
called organized repeats of operons (R-operons) 
in the nucleus by means of homologous 
interactions between mobile elements. Each R-
operon consists of associated mobile elements 
and adjacent gene-encoding protein cells. 
Representations of repetitive R-operons 
significantly expand the possibilities of specific 
regulation of genes and cooperation between 
genes. What does it happen due to? 
Firstly, genes located at large distances in 
the linear genome in R-operons are in contact 
with each other in the three-dimensional 
nucleus space and thus can be regulated by a set 
of those cis-regulatory elements and the 
transcription factors that bind to and regulate 
each of these genes. Indeed, it has been shown 
that enhancers can regulate the work of genes in 
trans while approaching genes in space [74–76]. 
Thus, the R-operons formed by repetition 
assemblies are structures that enable co-
operative gene regulation by a set of those cis-
elements that control the activity of each of the 
genes that are part of regulon. 
Secondly, genes possessing the same cis-
elements can coexist with different repetitions 
and be part of various R-operons accordingly. 
Thirdly, the transcriptional domains formed 
in such way are dynamic. Due to the 
dissociation of repeating assemblies, old R-
operons can disappear, and new domains with a 
different combination of repeats and genes due 
to the association of repetitions can form. 
The dynamics of the formation of 
homologous sequences pairs can be influenced 
by the concentration of ions in the cell, the 
expression of proteins necessary for 
homologous pairing, the pattern of epigenetic 
modifications of histones and mobile elements, 
and the activity of mobile elements regulated by 
transcription factors. 
Transcription factors specifically interacting 
with regulatory elements of ERVs can facilitate 
the establishment of contacts between mobile 
elements that is confirmed experimentally. 
Thus, HERV possessing binding sites with 
transcriptional regulators such as NANOG and 
OCT4 are localized in human embryonic stem 
cells. However, localization disappears in cells 
in which the expression of transcription factors 
is suppressed [74]. 
Transcription itself can lead to the 
establishment of contacts between repetitive 
sequences. A number of experimental data 
confirms the assumption about the existence of 
transcription factories – nuclei regions in which 
transcription occurs and which can contain up 
to hundreds of simultaneously operating RNA 
polymerase molecules [77]. But many ERVs 
are transcribed in a cell and accordingly can be 
localized in transcription factories. In the 
process of differentiation and in response to 
external conditions, the pattern of transcribed 
ERVs can change, and accordingly the contacts 
between them will change. 
Indeed, according to a number of studies, the 
expression of retroviruses in cells of even one 
type varies considerably. This is due to 
epigenetic mechanisms [78–79]. Thus, R-
operons will be formed not only tissue-
specifically, but even specifically for each cell. 
The regulation of association and 
dissociation of repetition assemblies is a 
mechanism of coordinated changes in gene 
activity in response to changes in cell 
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metabolism and promotes the emergence of 
new combinations of expressed genes in 
response to changing environmental conditions. 
Therefore co-expression of genes coordinated 
with the help of R-operons expands essentially 
the possibility for emergence of new temporary 
cooperation between genes dependent on the 
specific context that has developed in the cell. 
CONCLUSION 
Summarizing the data, we can note the 
following. ERVs contain regulatory elements or 
clusters of elements, by means of which they 
can be tissue-activated and transcribed. ERVs 
participated in the reformatting of regulatory 
networks and in the creation of gene-specific 
non-coding RNA forming binding sites with 
transcription factors and spreading them inside 
the genome. During the evolution, different 
ERVs were injecting into the genomes of 
different species, but in a number of cases they 
were used by genomes to solve similar 
problems and reformat similar regulatory 
programs. Therefore, it can be assumed that the 
participation of ERVs in the formation of 
regulatory networks obeys certain laws and is 
not completely random. 
In cells, due to homologous interactions, 
ERVs can form regulatory R-operons, which 
provide an additional way for the disintegration 
of old and emerging new gene associations in 
response to cell-building conditions and provide 
a level of genome plasticity that was previously 
difficult to imagine. 
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The innate immune response to viral pathogens is crucial in mobilizing defensive reactions of an organism 
during the development of an acute viral infection. Cells of the innate immunity system detect viral antigens 
due to genetically programmed pattern-recognition receptors (PRRs), which are located either on the cell 
surface or inside the certain intracellular components. These image-recognizing receptors include Toll-like 
receptors (TLRs), retinoic acid-inducible gene I-like receptors (RIG-I-like receptors), nucleotide 
oligomerization domain-like receptors (NOD-like receptors), also known as NACHT, LRR and PYD domains 
of the protein, and cytosolic DNA sensors. The trigger mechanisms for these receptors are viral proteins, and 
nucleic acids serve as activators. The presence of PRRs that are responsible for the determination of viral 
antigens in cellular components allows the cells of innate immunity to recognize a wide range of viral agents 
that replicate in various cellular structures, and develop an immune response to them. This article summarizes 
the disparate data presented in modern English literature on the role of PRRs and the associated signaling 
pathways. Understanding the recognition of viral pathogens required triggering a cascade of cytokine and 
interferon production provides insights into how viruses activate the signal paths of PRRs and the effect of the 
interaction of viral antigens and these receptors on the formation of the antiviral immune response. 
KEY WORDS: pattern-recognition receptors, Toll-like receptors, RIG-I-like receptors 
 
ПАТЕРН-РОЗПІЗНАВАЛЬНІ РЕЦЕПТОРИ ТА ПРИРОДЖЕНА  
ІМУНОЛОГІЧНА ВІДПОВІДЬ НА ВІРУСНУ ІНФЕКЦІЮ 
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Харківський національний університет імені В. Н. Каразіна, пл. Свободи, 6, м. Харків, 61022, 
Україна 
 
Вирішальне значення в мобілізації захисних реакцій організму протягом розвитку гострої вірусної 
інфекції має вроджена імунологічна відповідь на вірусні патогени. Клітини системи вродженого 
імунітету виявляють вірусні антигени за допомогою генетично запрограмованого патерн-
розпізнавання рецепторів (PRRs), які розташовані або на поверхні клітини, або всередині певних 
внутрішньоклітинних компонентів. Ці образ-розпізнавальні рецептори включають Toll-подібні 
рецептори (TLRs), RIG-I-подібні рецептори (RLRs), NOD-подібні рецептори, також відомі як домени 
NACHT, LRR та PYD білків, та цитозольні ДНК-сенсори. Пусковим механізмом для цих рецепторів є 
вірусні протеїни, а активаторами слугують нуклеїнові кислоти. Наявність PRRs, що відповідають за 
визначення вірусних антигенів у клітинних компонентах, дає клітинам природженого імунітету 
можливість розпізнавати широкий спектр вірусних агентів, що реплікуються в різних клітинних 
структурах, і виробляти імунологічну відповідь на них. В даній статті узагальнено розрізнені дані, які 
представлені в сучасній англомовній літературі, щодо ролі PRRs та пов'язаних з ними сигнальних 
шляхів. Розуміння розпізнавання вірусних патогенів, необхідних для запуску каскаду продукції 
цитокинів і інтерферонів, дозволяє збагнути, як віруси активізують сигнальні шляхи PRRs і як впливає 
взаємодія вірусних антигенів і цих рецепторів на формування противірусної імунної відповіді. 
КЛЮЧОВІ СЛОВА: патерн-розпізнавальні рецептори, Toll-подібні рецептори, RIG-I-подібні 
рецептори 
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ПАТЕРН-РАСПОЗНАЮЩИЕ РЕЦЕПТОРЫ И ВРОЖДЕННЫЙ  
ИММУННЫЙ ОТВЕТ НА ВИРУСНУЮ ИНФЕКЦИЮ 
Веклич К. А. 
Харьковский национальный университет имени В. Н. Каразина, пл. Свободы, 6, г. Харьков, 61022, 
Украина 
 
Решающее значение в мобилизации защитных реакций организма во время развития острой 
вирусной инфекции имеет врожденный иммунный ответ на вирусные патогены. Клетки системы 
врожденного иммунитета обнаруживают вирусные антигены благодаря генетически 
запрограммированным образ-распознающим рецепторам (PRRs), которые располагаются либо на 
поверхности клетки, либо внутри определенных внутриклеточных компонентов. Эти образ-
распознающие рецепторы включают в себя Toll-подобные рецепторы (TLRs), RIG-I-подобные 
рецепторы (RLRs), NOD-подобные рецепторы, известные также как NACHT, LRR и PYD домены 
белка, и цитозольные сенсоры ДНК. Пусковым механизмом для этих рецепторов являются вирусные 
протеины, а активаторами служат нуклеиновые кислоты. Наличие PRRs, отвечающих за определение 
вирусных антигенов в клеточных компонентах, дает клеткам врожденного иммунитета возможность 
распознать широкий спектр вирусных агентов, реплицирующихся в различных клеточных структурах, 
и выработать в отношении их иммунный ответ. В данной статье обобщены разрозненные данные, 
представленные в современной англоязычной литературе, относительно роли PRRs и связанных с 
ними сигнальных путей. Понимание  распознавания вирусных патогенов, необходимых для запуска 
каскада продукции цитокинов и интерферонов, позволяет получить понимание того, как вирусы 
активируют сигнальные пути образ-распознающих рецепторов и какое влияние взаимодействие 
вирусных антигенов и этих рецепторов оказывает на формирование противовирусного иммунного 
ответа. 
КЛЮЧЕВЫЕ СЛОВА: образ-распознающие рецепторы, Toll-подобные рецепторы, RIG-I-
подобные рецепторы 
 
 
INTRODUCTION 
Cells of the innate immune system use 
pattern-recognition receptors (PRRs) that 
identify pathogen-associated molecular patterns 
(PAMPs) located on the surface of viral cells 
and differ from those of the host cell to identify 
viral pathogens. The ability to identify nucleic 
acids has become a major component of the 
antimicrobial link of the immune system. A 
wide range of pathogens are identified by 
recognizing their genome or nucleic acids that 
accumulate during the replication of viruses. 
PRRs are activated in response to viral 
molecules such as 5′-triphosphate RNA, as well 
as viral DNA, which is determined by sensory 
elements located in the cytoplasm. 
The main PRRs are Toll-like receptors 
(TLRs). They are type 1 transmembrane 
proteins providing communication between the 
plasma membrane and endosomal vesicles. The 
main function of TLRs is the detection of 
PAMPs in the extracellular space. Receptors 
located on the plasma membrane are involved 
in the detection of hydrophobic lipids and 
proteins, and receptors located in endosomes 
are able to detect nucleic acids. Such a division 
allows cells of the innate immune system to 
identify components of the viral envelope 
located on the cell surface, such as components 
of the fusion mechanism, and nucleic acids 
located in the endosomes. Entering the 
cytoplasm viral components enter the area 
monitored by RIG-I-like receptors, NOD-like 
receptors and cytosolic DNA sensors, such as 
members of the AIM2 family. Similar to TLRs, 
RIG-I-like receptors and cytosolic DNA sensors 
regulate the expression of transcription factors 
necessary for the production of interferons and 
cytokines. And NOD-like receptors and 
members of the AIM2 family, by contrast, 
activate the process of maturation of IL-1β and 
IL-18 by activating caspase 1. Induction of 
immature forms of IL-1β and IL-18 occurs 
through the activation of TLRs signaling 
pathways, and NOD-like receptors serve as a 
kind of «control mechanism» that regulates and 
activates the release of these powerful effectors. 
Many PRRs are involved in the activation of 
the adaptive immune system by enhancing 
expression of the major histocompatibility 
complex class II and stimulating the expression 
of co-stimulating molecules CD40, CD80 and 
CD86 in addition to the release of pro-
inflammatory components. 
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TOLL-LIKE RECEPTORS 
10 types of TLRs have been identified in 
humans, and 13 types – in mice, 9 of them 
(TLRs of types 1–9) are identical. TLRs of 1, 2, 
4, 5 and 6 types (TPRs 1, 2, 4, 5, 6) are located 
on the cytoplasmic membrane, and TLRs 3, 7, 8 
and 9 are endosomal. All TLRs have a common 
structure and consist of extracellular repeats 
rich in leucine and the Toll/Interleukin-1 
Receptor (TIR) cytoplasmic domain [1]. These 
receptors transmit a signal differentiating the 
adapter proteins Mal (MyD88 adapter-like), 
also known as TIR domain-containing adapter 
proteins (TIRAPs) and Myeloid differentiation 
primary response gene 88 (MyD88), gene for 
primary myeloid differentiation 88, and/or TIR-
domain-containing adapter inducing interferon-
β (TRIF) and Trif-related adaptor molecule 
(TRAM) [1]. Adapters initiate the launch of 
signaling cascades, culminating in activation of 
the nuclear factor κB (NF-κB), mitogen-
activated protein kinase (MAPK) and interferon 
regulatory factors 1, 3, 5 and 7 (INF-1, -3, -5 
and -7) [2]. The combination of these 
transcription factors promotes not only the 
expression of interferons, cytokines and 
chemokines, but also affects the maturation and 
survival of cells. 
Toll-like receptor signaling pathways 
All TLRs, apart from TLR 3, require the 
presence of MyD88 for their activation [3–4]. 
TLR 3 is not capable of MyD88 capturing 
and interacts with the TRIF through the adapter 
protein. TRIF has the ability to directly bind 
TRAF6 and induce NF-κB along a path similar 
to MyD88. TRIF is also capable of involving 
the receptor-interacting protein-1 (RIP-1) in the 
process in contrast to MyD88. RIP-1 interacts 
with TRAF6 that leads to powerful activation of 
NF-κB. TRAF3 is the third protein attracted to 
TRIF. It binds with TANK-binding kinase-1 
(TBK1) and IKKi and is a necessary component 
of the production process of interferon type 1. 
This allows them to undergo a dimerization 
procedure and penetrate the nucleus, where they 
interact with NF-κB and activator protein 1 
(AP-1), that in turn leads to the transcription of 
the target gene. The study, which included 
children with non-functioning MyD88 proteins, 
showed that patients with this pathology are 
predisposed to develop recurrent pyogenic 
bacterial infections [5]. Patients with IRAK-4 
deficiency and with a defect of UNC-93B1, a 
protein that is involved in the transport of TLRs 
3, 7, 8, and 9 into endosomes, had an increased 
susceptibility to the herpes simplex virus type 1 
with predominant brain damage [6–7]. 
Peripheral blood mononuclear cells and 
fibroblasts obtained from these patients 
demonstrated a decrease in type 1 interferon 
activity in response to the introduction of HSV-
1, accompanied by enhancement of viral 
replication [7]. 
Expression and activity of Toll-like 
receptors 
The severity of the inflammatory reaction 
caused by viral PAMPs depends on the 
following factors. 
1. Cellular expression of TLRs varies 
depending on cell type. It is known that 
macrophages express a large number of TLRs 2 
and 4, while plasmacytoid dendritic cells 
(pDCs) mainly produce TLRs 7 and 9 [1]; 
2. The expression level also varies 
between species; for example, TLR 9, 
expressed in the human body by just a few cell 
types, is well represented in mice; 
3. The reaction to identical viral PAMPs 
can vary between cell types, both in the nature 
of the produced effector molecules and in the 
response kinetics. 
INTRACELLULAR NUCLEIC ACID 
SENSORS 
TLRs play an important role in the detection 
of viral PAMPs that present both on the surface 
of cells and in endosomes. The identification of 
additional mechanisms of antiviral protection 
has revealed many classes of innate sensors that 
play an important role in the purification of 
viruses that replicate and locate in the cytosol. 
Specialized classes of cytosolic nucleic acid 
sensors, called RIG-I like receptors (RLRs), are 
capable of recognizing intracellular RNA that 
penetrates into the cytosol during virus 
introduction or accumulates during viral 
replication, as well as DNA that is inside 
cytosol. 
The RLRs family includes three DExD/H 
box RNA helicases: retinoic acid-inducible 
gene (RIG-I), melanoma differentiation-
associated gene 5 (MDA-5), and LGP-2 [8–11]. 
RIG-1 and MDA-5 consist of N-terminal 
caspase activation and recruitment domains 
(CARDs), the following helicase RNA 
DExD/H box domain, which has ATP-ase 
activity, and the C-terminal repressor domain. 
RIG-I controlled by its regulatory domains is 
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inactive in the cytoplasm in the absence of 
pathogenic activation. Conformational changes 
occur in RIG-1, when viruses enter the body, 
RIG-1 dimerizes as a result [12]. The activated 
multimeric form of RIG-1 or MDA5 interacts 
with the mitochondrial antiviral-signaling 
protein (MAVS) located on the outer 
mitochondrial membrane. MAVS activates 
IKK-related kinase after capturing RIG-I or 
MDA5, resulting in the transcription of 
interferons type 1. Also, MAVS also activates 
NF-kB by recruiting a tumor necrosis factor 
receptor type 1-associated death domain protein 
(TRADD), the FAS-associated protein with the 
death domain (FADD), caspase-8 and caspase-
10 [13–16]. LGP-2 does not contain N-terminal 
DARK domains, but consists only of the 
helicase RNA domains. It is assumed that it acts 
as a negative regulator of other RLRs [9, 12]. 
Recognition of RNA RIG-like receptors 
RLRs are important components of antiviral 
protection for many types of cells, including 
fibroblasts, epithelial cells and normal dendritic 
cells. Studies have shown that only MDA-5 is 
responsible for the production of interferon 
through the stimulating of polyI: C [17–18]. 
RIG-I does not have the ability to recognize the 
5'PPP-ssRNA of the host cell; they use the  
5 'end of the transcript to recognize the virus 
RNA and the host cell. In contrast, MDA-5 uses 
not the 5 'end of the transcript, but the length of 
the RNA sequence for recognition of the virus 
RNA and the host cell; long dsRNAs are 
usually absent in the host cell, and, thus, act as 
a ligand for MDA-5. RIG-I is also able to 
recognize short dsRNA, which is a by-product 
of viral replication, in addition to recognizing 
5'-triphosphate RNA. 
RIG-I is involved in the recognition of 
vesicular stomatitis virus (VSV), rabies virus, 
Newcastle disease virus, respiratory syncytial 
virus, measles virus, influenza A and B viruses, 
hepatitis C virus (HCV), Japanese encephalitis 
virus and Ebola virus [18-19]. MDA-5 is 
involved in the recognition of CMV, Theiler's 
encephalomyelitis virus and Mengo virus [20]. 
All of these viruses do not contain 5'-
triphosphate RNA, but are capable of producing 
long dsRNA, that provides additional evidence 
that MDA-5 distinguishes RNA based on 
sequence length, rather than 5'-triphosphate. It 
is proven that Dengue virus, West Nile virus 
and reovirus transmit signals through the use of 
a combination of RIG-I and MDA-5. 
DDX3 
A recent study described the participation of 
another representative of the DExD/H box 
family of RNA helicase, DDX3, in the antiviral 
response. It was found that the K7 protein of 
the measles virus inhibits the induction of INFβ 
through the binding to DDX3, which in turn led 
to the discovery of the positive role of DDX3 in 
activating the RLR signaling pathway. DDX3 
binds to polyI: C and viral RNA penetrating 
into the cytosol and binds to MAVS/IPS-1, 
whereby it takes part in activating the 
production of INFβ, enhances RNA 
recognition, forming a complex with RIG-I and 
MAVS that induces interferon production. 
DNA cytosolic sensors 
Scientists knew that pathogen DNA is 
capable of activating fibroblasts and stimulating 
the production of IFN type 1 even before the 
discovery of TLR 9. 
Cytosolic recognition of DNA and RNA 
leads to activation of TBK1, IRF-3 and 
production of IFN type 1. However, signaling 
pathways connecting upstream DNA and TBK1 
sensors are currently poorly understood. TBK1 
interacts with DDX3, a DEAD box RNA 
helicase, which regulates the transcription of 
IFNβ through the IRF-3. 
DAI 
DNA-dependent activator of IFN-regulatory 
factors (DAI) was one of the first cytosolic 
DNA sensors detected. It consists of two related 
domains capable of recognizing the left-twisted 
Z-forms of DNA and its B-forms. DAI 
increased the dose-dependent production of IFN 
type 1in the L929 cell culture during the 
exogenous expression after stimulation of the B 
and Z forms of DNA. Similarly, turning off 
DAI by means of ssRNA disrupts the 
production of type 1 IFN in response to DNA, 
45 bp interferon-stimulating DNA (ISD) of 
Listeria and herpes viruses, as well as HSV-1. It 
was also found that the production of IFN type 
1 also depends on DAI during the CMV 
introducing. These results suggest that the role 
of DAI may be specific for each individual cell 
type, it plays an excessive role in probing of 
cytoplasmic DNA, and that other sensors must 
be needed to induce these responses. 
Pol III RNA and LRRFIP1 
Viral RNAs trigger the production of IFN 
type 1 by activating RIG-I. It has been proven 
that the B-form of dsDNA in human cells can 
Journal of  V. N. Karazin` KhNU. 2018 
100 
also induce the production of INFβ in a way 
that depends on the adapter molecule RIG-I 
MAVS [21–22]. DNA with a high content of 
antibodies is transcribed into 5'-pp RNA using 
RNA polymerase II, which in turn activates 
RIG-I [21]. 
Another regulator of DNA-controlled innate 
immune signal transmission, a leucine-rich 
repeat flightless-interacting protein 1 
(LRRFIP1) has recently been described in 
addition to DAI and Pol III RNA. It inhibits the 
production of IFN 1 type induced by bacteria. 
Turning LRRFIP1 off inhibits the production of 
IFN in response to polyI: C stimulation, 
synthetic DNA, poly (dG:dC) and poly (dA:dT) 
stimulation, involving LRRFIP1 in the 
recognition of dsRNA, as well as B-and Z-
forms of dsDNA. 
IFI16 
IFI16 was identified as a DNA-binding protein 
that interacts with dsDNA through the process 
of analyzing the immune responses to these 
dsDNA regions obtained from the HSV-1 
genome. IFI16 is a member of the PyHIN 
protein family (containing the pyrin and 
HIN200 domains). The PHYIN family includes 
4 representatives: IFIX, IFI16, MNDA and 
AIM2. They all contain one or more HIN200 
domains that recognize DNA, as well as the 
pyrin domain. Turning IFI16 or p204 (a 
member of the PYHIN family of mice) off leads 
to a decrease in the intensity of the IFNβ 
response to these dsDNA. IFI 16 is localized in 
the nucleus, and in the cytosolic cellules of 
macrophages. IFI16 pooling is required for 
IFNβ production in response to DNA. Turning 
IFI16 and its homologue of p204 in mice off in 
mRNA leads to a decrease in the activation of 
IRF3 and NF-κB, and also leads to the IFNβ 
gene induction in cells once infected with  
HSV-1. 
DDX9 and 36 
DExD/H box RNA helicase – DHX9 and 
DHX36 are found in plasmacytoid dendritic 
cells. Activation of DHX9 leads to activation of 
IRF-7 and increased production of IFNα, and 
activation of DHX36 leads to activation of NF-
κB and increased production of IL-6 and TNFα. 
Turning DHX9 and DHX36 off in mRNA 
inhibits cytokine production in response to 
DNA-containing HSV-1, while the response to 
an RNA-containing influenza A virus remains 
unchanged. 
Inflammasomes, their types 
The recognition of viral DNA is associated 
with the transcriptional induction of IFN type 1 
and other pro-inflammatory cytokines, as well 
as with the launch of caspase-1-dependent 
maturation of pro-inflammatory cytokines IL-
1β and IL-18. IL-1β is involved in the 
recruitment of innate immunity cells, T-
lymphocyte activation and fever induction, and 
IL-18 increases the cytolytic activity and 
production of IFNγ by natural killer cells (NK 
cells), and also affects the recruitment and 
activation of neutrophils. 
The production of IL-1β is controlled at the 
level of transcription, translation, maturation 
and secretion. Many cellular stimuli, including 
TLRs ligands, activate the transcription of pro-
forms of IL-1β and IL-18. Maturation (i.e. 
cleavage) of pro-IL-1β and pro-IL-18 is 
catalyzed by cysteine protease of caspase-1. 
The activity of inflammatory caspase-1 is 
controlled by a large complex called 
«inflammasomes protein complex». Then active 
caspase-1 cleaves pro-IL-1β and pro-IL-18. 
Inflammasomes AIM2 recognize their own 
and foreign cytosolic dsDNA, including viral 
DNA, through the HIN 200 domain. DNA 
recognition provokes the assembly of 
inflammasomes complexes. Upon DNA 
binding, AIM2 undergoes oligomerization and 
binds apoptosis-associated speck-like protein 
(ASC) through the interaction of pyrin-pyrin 
homotypic domains, which in turn recruits pro-
caspase 1. Inflammasomes and AIM2 are an 
integral component of the innate recognition of 
DNA-containing viruses, CMV, as well as 
Francisella tularensis and Listeria 
monocytogenes. 
NLRP 3 inflammasomes play an important 
role in the formation of a response to RNA-
containing viruses, adenoviruses, and DNA-
containing viruses. NLRP3 deficiency weakens 
the normal response of IL-1β and IL-18 to the 
influenza virus and is associated with a 
decrease in cell recruitment of the innate 
immune system [23]. 
CONCLUSIONS AND PROSPECTS FOR 
FUTURE STUDIES 
The understanding of how the innate 
immune system detects viruses and triggers a 
cascade of antiviral reactions has increased 
significantly over the past decade. The 
discovery of Toll-like receptors and nucleic 
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acids led to the discovery of various cytosolic 
RNA and DNA receptors and their downstream 
signaling pathways. However, many cytosolic 
sensors play an excess role in the detection of 
viruses. Such excessive protection strategies 
have evolved to deal with the evasion 
mechanisms of detection inherent in viruses. 
Determining the function of newly identified 
pattern-recognizing receptors in the immune 
defense against viral infection is an important 
step in understanding of their unique or 
auxiliary contribution to the pathogenesis of 
viral protection. 
The mechanisms of nucleic acid sensors 
operation, the aim of which is to distinguish 
their own nucleic acids from the nucleic acids 
of viruses, require clarification, as well as the 
process of recognition of viral RNA and DNA, 
which are becoming available for pattern-
recognition receptors. 
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